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ABSTRACT 
 Genetic engineering is a powerful tool for biologists and geneticists to study the 
natural world.  In general, it allows for asking and answering precise gene or DNA level 
questions about biological systems.  The drawback of genetic engineering is that many 
applications requires a deep knowledge of multiple disciplines from biology to chemistry, 
which can make it inaccessible.  Here I give a brief history of the field and define four 
tenets of necessary actions to begin engineering DNA, and four classes of applications 
using genetic engineering.  I present three papers that define an accessible method of 
genome editing using CRISPR/Cas called GeneWeld, and describe two series of tools 
pGTag and pPRISM that reduce the materials cost of beginning genetic engineering 
experiments.  I describe use cases for each tool, and finally present an expansion of the 
methodology and tools to generate synthetic alleles and examine their function in living 
zebrafish.  We expect that these tools and methods will increase the accessibility of 
genetic engineering using and enable new kinds of research questions.  
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CHAPTER 1.  HOW TO PREFORM GENETIC ENGINEERING IN 2019 
Introduction 
“Genetic power is the most awesome force the planet's ever seen, but you wield it like a 
kid that's found his dad's gun.” – Ian Malcom, Jurassic Park 1993 
 It’s maybe not surprising that in 2019, in the 26 years since Michael Crichton’s 
Jurassic Park debuted on the silver screen, there is not yet an island full of genetically 
engineered dinosaurs created by a biotech firm for the express purpose of 
entertainment.  What is surprising is the rate at which tools that would allow a 
researcher to make a dinosaur have been developed and become available over the 
past two decades.  The field of genetics is currently enjoying a boom of advances in 
precise in vivo DNA targeting and exogenous DNA integration following the emergence 
of TALEN and CRISPR/Cas as quick and efficient programmable nucleases.  Of course, 
the goal of most researchers is not to make a living breathing dinosaur; rather efforts 
are primarily focused on medical therapeutics or agricultural applications. Here, we 
define what is meant by “genetic engineering”, explore the methodology for generating a 
genetically engineered organism, review applications of the technology, and discuss 
where it might lead in the future. 
 Genetic engineering is defined as the act of intentionally breaking, rearranging, 
and ligating segments of genetic material from one or more sources to change gene 
function in a living cell (Merriam-Webster). For a geneticist this could be referring to 
anything from restriction enzyme cloning, to transposon integrations, to homologous 
recombination driven integration of exogenous DNA into a living cell. The first published 
recombinant DNA experiment was performed by Jackson et. al, 1972 where they 
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established a method for covalently linking DNA from different sources, with the stated 
intent of induction of exogenous genes in different organisms, also referred to as 
creating transgenic organisms. This proof of concept was accomplished using viral and 
bacterial DNA, and it laid the groundwork for engineering DNA in any species. By the 
end of the decade transgenic yeast (Botstein, 1979), mice (Jaenisch and Mintz, 1974), 
and bacteria (Curtiss, 1977) had all been created, and from there the umbrella of 
genetic editing has expanded from examples of transgenic organisms to include 
examples of targeted gene knockout under the phrase Genetically Modified Organisms 
(GMO). Many new GMOs were developed in the proceeding decades. From bacteria 
that produce insulin for diabetics (Goeddel, 1979), to knock out mice as medical 
resources (Gordon, and Ruddle 1981), to golden rice as nutrient rich dietary supplement 
(Ye et, al, 2000), the development of a variety of GMOs has become a routine part of 
forward genetics studies and biochemical studies.  
Eight Facets of Genetic Engineering 
 There are eight facets of genetic engineering, the four tenets of how a genome 
edit is enacted, and the four avenues of application for a GMO.  Starting with the tenets, 
first, a researcher must have knowledge of either the gene they intend to insert into their 
model or of the gene within their model that they wish to edit. Second, the researcher 
must deconstruct pieces of DNA that they wish to combine in a way that will allow for 
the DNA ends to bind to each other. Third, the pieces of DNA must be covalently joined 
in the intended order. Fourth, the edited DNA must be applied to a target organism.  
These four tenets are not a step-wise protocol for genetic engineering; rather they 
represent the four types of actions that are necessary.  For example, the second and 
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third tenets are often repeated during the process of initial assembly of donor DNA 
molecules, as well as after the application of exogenous DNA to a target organism.  
Also, when working with stem cells the fourth tenets is repeated as edits are first applied 
to a culture cells before applying screened edited cells to the final recipient.   
Tenet 1 
 Acquiring knowledge of genes and sequences is straightforward, with an ever-
increasing wealth of information thanks to recent advances in high throughput 
sequencing (Slatko et. al, 2018), as well as new publications, and online databases a 
researcher can identify a gene of interest and have sequence data at their fingertips in a 
matter of minutes. It is then up to the researcher to parse related publications for 
relevant information, including understanding how orthologous genes in other species 
function and considering how any homologs and orthologues may interact with their 
target and adjust their experimental design.  From there a researcher can identify where 
in a target gene sequence a modification will best compliment their research goals, and 
begin designing reagents. 
Tenet 2 
 Causing damage to DNA molecules is relatively easy; UV radiation, chemical 
mutagens, and restriction enzymes, are all able to disrupt the chemical bonds between 
base pairs, but breaking a DNA strand in-vivo in a specific place is more complicated. 
Making an in-vitro DSB in a specific place using restriction enzymes has been a staple 
of genetic engineering since the beginning and using the overhangs generated by an 
enzyme has been invaluable to designing complex donor plasmids.  Using typical 6 
base cutter restriction enzymes in the same manner in vivo is not recommended 
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because of the multitude of 6 base targets a genome usually contains, and though 
meganucleases (12 to 40 bp cutters) have been in use since the 1990s there are 
limitations on placement of available targets in relation to a locus of interest (Silva, 
George, et al., 2011).  Initially gene targeting, as it was first described, made use of 
linear donor vectors with long stretches of DNA (more than ten kilobases) homologous 
to the target gene and relied on endogenous homologous recombination repair 
mechanisms to break and repair the target genome (Thomas and Capecchi 1987) to 
circumvent the need to cut the genome directly.   
 With the advent of programmable nucleases gene targeting can also refer to 
directly cutting the genome at a specific locus, and doing so has become both a way to 
try to increase efficiency of homologous recombination at a target site as well as a way 
to make more precise indel alleles of genes of interest.  A programmable nuclease or a 
protein with both a domain for breaking the phosphodiester bonds between DNA bases 
and a separate domain that can manipulated by a researcher to identify a specific 
sequence of DNA.  This allows researchers to essentially design their own custom 
restriction enzymes for use on a living genome where only one target site will incur a 
DSB. There are currently three families of these programmable nucleases; zinc-finger 
nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and 
clustered regularly interspaced short palindromic repeats (CRISPRs).  ZFNs are a 
modifiable FokI restriction enzyme, where a series of three zinc wrapped modular 
recognition domains allow for specifying nine bases for each unit of a dimer pair to bind. 
This allows the complex to span across a stretch of 23 bp to 25 bp for cleavage (Kim 
and Chandrasegaran, 1994). TALENs are similar in that they are also a protein dimer 
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with the TALE DNA binding domain hosing 33-35 engineer-able segments allowing 
targeting of stretches of 45 bp to 65 bp (Boch et al, 2009).  CRISPR/Cas is a single 
nuclease that is guided by a short segment of RNA with 20 bases that dictate the target 
DNA sequence, and requires a protospacer adjacent motif (PAM) in the correct position 
near the target to induce a double stranded break (Jinek et al. 2012). This allows 
CRISPR/Cas to target 23 bp stretches of DNA, and has become a favored 
programmable nuclease due to the simplicity of programming targets as well as the 
specificity of where in the target the nuclease cuts. 
 CRISPR/Cas was originally observed in E. coli in 1987, and later orthologous loci 
were discovered in a multitude of other archaea and bacteria, but it was not until 2002 
that the acronym was established by Jansen et al.  The clustered regularly interspaced 
short palindromic repeats (CRISPR) are defined as a locus consisting of a series of 
repeated sequences interspersed by unique sequences or ‘spacers’.  Additionally, Cas 
or “CRISPR associated proteins” are a collection of protein coding sequences near the 
repeats which make up a collection of polymerases, nucleases, and DNA binding 
proteins that interact with the CRISPR repeats. In 2005, three groups identified these 
spacers as being homologous to a variety of phages and postulated that this genomic 
locus might act as a system for acquired immunity for these bacteria (Bolotin et al. 
2005, Pourcel et al. 2005, Mojica et al. 2005).  Further research into how the 
CRISPR/Cas locus functions showed that modifying the spacers modified phage 
resistance (Barrangou et al., 2007) and also set up three important elements that make 
CRISPR/Cas a viable tool for genome editing; spacers are expressed as a short RNA 
(crRNA) for use against repeat infections as a template guide to identify foreign DNA 
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(Brouns et al. 2008), the targeted sequence homologous to the guide RNA needs to 
have a protospacer adjacent motif for anti-phage activity (Bolotin et al. 2005), a single 
DNA nuclease is responsible for induced DSBs at the specific position of three base 
pairs back into the targeting sequence from the PAM (Garneau et al., 2010).   
 In 2013 additional improvements to CRISPR/Cas as a species independent 
system resulted in the first genetic engineering in human and mouse cells using 
CRISPR (Cong et al. 2013).  This has initiated the current boom in the genetic 
engineering field where eukaryotic codon optimized variants of spCas9, the Cas 
nuclease from S. pyogenes, and single guide RNAs a fused RNA made from the crRNA 
and a second activating tracrRNA (Jinek et al., 2012) are a field standard for 
engineering in nearly all model systems from zebrafish to Arabidopsis; due to the ease 
of targeting and because both the guide RNA and the Cas9 protein can be applied via in 
vivo expression from plasmids, or as RNAs, or as a ribonucleoprotein complex (RNPs) 
suiting the needs of the system.  While the short length (20 bp) of target sequence 
simplifies initial generation of reagents and though there is a lot of flexibility in 
application there is an inherent limitation of spCas9 of the sequence of the PAM.   
 The PAM sequence of spCas9 must be “NGG” where N is any base; this limits 
the number of genomic targets to only those where NGG is located in the genome.  For 
many research applications or those where a gene knock-out is desired this limitation is 
not a hindrance because there are multiple ways to design around the limitation. For 
medical applications where alternate designs are not appropriate the use of other 
targeted nucleases is an option.  Additionally, a variety of CRISPR based tools that are 
being developed as alternatives, such as new protein fusions using the TALE guidance 
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with Cas9 cutting or dead Cas9-Cas9 fusions to drag donor molecules to the desired 
site (Bolukbasi et al., 2018), Cas proteins from other species or modifying Cas9 so that 
different PAM sequences can be used which expands the number of targets available 
(Kleinstiver et al., 2015), and even base editors where the active site of the nuclease is 
modified or replaced to change the function from cleavage to changing one base to 
another (Liang et al. 2017).  In short, while directing DSBs in the genome was difficult, 
the past decade has made doing so much easier, and advancements are still to come. 
Tenet 3 
 By knowing exactly where in a gene a DSB will occur allows for a researcher to 
predict how any ends of a double stranded DNA molecule can be repaired.  In-vitro 
using restriction enzymes repairs primarily uses base pairing between overhangs left 
after the enzymatic activity is complete to line up strands for ligation.  During in-vivo 
genomic integration where there are not exact overhangs generated targeted nucleases 
and each DSB is largely unique in its surrounding sequence, one key to ligating DNA 
strands together precisely is pushing the endogenous repair mechanisms to favor an 
exogenous donor template rather than the sister chromatid.  Using endogenous repair 
mechanisms a DSB can be repaired by either a non-homologous end joining (NHEJ) 
pathway or following a homology search by a homologous recombination (HR) pathway.  
NHEJ repair is error prone due to how DNA strands are forced back together and is too 
imprecise for directing integration of exogenous DNA for precise genetic engineering.  
Repair using longer lengths of homology allows for higher precision due to the 
recruitment additional helicases and recombinases which would normally use sister 
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chromatids as template DNA for repair (Chapman et al., 2012), thus granting an avenue 
for engineered integration of exogenous DNA.  
 Following a DSB, a DNA damage response (DDR) senses the location of the 
break and recruits a host of proteins to the locus.  These protein-kinases, polymerases, 
and other factors bind the ends of the DNA strands and form complexes that are 
responsible for determining repair path by recruitment of additional nucleases, 
helicases, and ligases to process the ends and re-ligate the strands.  For HR in 
mammals following end binding by Ku protein complex and recruitment of Mre11 and 
Exo1 for 5’ to 3’ end resection (Deriano et al., 2013), single strand DNA is bound by the 
recombinase mediator BRAC2 and its co-localized scaffolding protein PALB2 guide the 
recombinase RAD51 to coat the ends.  RAD51 then initiates a homology search via 
strand invasion along homologous duplex DNA forming a displacement loop (D-loop), 
and polymerases initiate repair by synthesis.  Different models are used to explain the 
different ways D-loop is resolved; synthesis-dependent strand annealing (SDSA) 
suggests that following some amount of synthesis to the broken strand the D-loop 
dissociates and the two ssDNA resected strands anneal and ligate without strand 
crossover, and double strand break repair (DSBR) suggests that holiday junction 
migration and decatenation results in no crossing over and D-loop cleavage results in 
crossing over (Chapman et al., 2012, San Filippo et al., 2008).  It is likely that traditional 
HR integration methods drive a DSBR crossing over result as constructs are integrated 
into the target genome. 
 In the first HR gene targeting experiments in mice, integration vectors were 
designed to have 2 to 4 kb of homology on each side of the cassette to target a single 
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locus in embryonic stem cells.  Integration relied on linear DNA being incorporated into 
the genome at the intended location and the inclusion of a selectable marker to select a 
few positive cells from large pools of electroporated cells (Capecchi, 1989).  Advances 
in HR mediated integration have mostly been in showing diversification of targetable 
genes, using negative selection markers in the cassettes, adjusting arm lengths to 
closer to 1 kb, and inducing breaks at the intended genomic target with programmable 
nucleases (Hoshijima et al 2016, Rong et al., 2000), but all still use the HR strategy; 
linear exogenous DNA with 1 kb plus long homology domains.   
 Starting in 2015 several groups began showing that using CRISPR and much 
shorter homology domains in plasmids that are digested in vivo are able to precisely 
integrated.  Using 20 or 40 bp arms Hisano et al., 2015 showed precise integration of 
RFP at a pigmentation gene.  The group’s follow up paper suggested that repair was 
completed through the alternative NHEJ pathway, micro homology mediated end joining 
(MMEJ) as very short (less than 25 bp) lengths of homology were used (Sakuma et al., 
2016).  MMEJ vs SSA (Bhargava et al 2016). Wierson et al. 2018 demonstrated with a 
simplified cutting strategy on the ends of a short homology cassette that precise 
integration efficiencies can be further improved.  By taking knowledge from HR cassette 
designs, considering length of homology arms, cell cycle timing, additional repair factors 
tenet 3 manipulation has room to improve. 
 Tenet 4  
 Introducing an exogenous piece of DNA to a living cell can be accomplished via 
several methods. Classically, transformations are used to force DNA plasmids through 
compromised cell membranes. For animal model systems microinjection is common.  
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While the field is also looking for new ways to apply exogenous DNA including using 
nano sized capsules such as CARTs or “charge-altering releasable transporters” 
(McKinlay et al., 2017), the old techniques are suitable for high efficacy genome editing 
for research purposes (Wierson et al. unpublished) 
 Each application method has its own challenges, for example microinjection of 
RNPs in zebrafish is efficient for the generation of indels, but is unsuitable for some 
methods involving HR (self-generated data, unpublished).  There are many factors that 
affect how a given set of reagents will be responded to during application, from 
immunological response, to time synchronicity with the cell cycle, to molar amounts.  In 
the end all application methods currently result in the addition of exogenous RNA and 
DNA reagents to a live cell, and preforming one’s own titration of reagents and 
normalizing timing for the system in use are the recommended protocol at this time.  
Practical Applications 
 As new methods and techniques expand what is possible for research purposes 
the application for GMOs will improve, and the world will see new uses of GMOs in the 
four classes of applications; basic research, medical, agricultural/industrial, and 
entertainment.  Basic research is defined by the National Science Foundation as 
research of the unknown to better understanding of the particular minutia of laws of 
nature. Genetic engineering can be applied in basic research in several ways, but most 
commonly it is used to break specific genes to examine what happens in known 
pathways.  These reverse genetics approaches are being advanced by more precise 
engineering of gene breakage to generate partial function mutants that are expressed at  
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endogenous levels or new overexpression alleles may be generated by introduction of 
stronger promoters upstream of target loci. 
 Applications for medicine or medical genetics services are defined by the Charles 
Epstein 2006 as clinical and laboratory services derived from research into diseases 
and disorders genetic in nature.  These can take the form of mass-produced drugs such 
as insulin, or as gene therapies such as stem cell therapy for heart disease.  Genetic 
engineering of more precise cell edits means better services, and as possibilities grow 
cure for new diseases can be developed such as direct removal of HIV from patient 
genomes.   
 Large scale application of GMOs for product synthesis, here grouped under the 
‘agricultural/industrial’ simplification, ranges from food generation with BT corn (Saxena 
et al., 1999), or Flavr Savr tomatoes (Kramer et al., 1994) to new microorganism strains 
that synthesize rare compounds.  These applications seem to be solutions for cheaper 
or better consumer goods, but are generally held up by federal regulation and stymied 
by public opinion. As the field moves forward, care will need to be taken to manage 
environmental effects as well as public perception. 
 Applications of GMOs in entertainment would typically be consumer products that 
are not consumables, like Glofish transgenic fluorescent aquatic pets (glofish.com), or a 
zoological attraction like Jurassic Park.  While these applications are few in number at 
the moment more will undoubtedly made as the methods to generate GMOs get 
cheaper and researchers look for ways to generate outside funding for their projects 
and improve public perception.  Additionally, fail safes for consumer products with 
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regard to environmental impact must be kept in consideration due to known consumer 
habits for releasing pets into the wild (Patoka et al., 2014). 
State of the Field 
 The state of the field in my opinion is that in general the field is focused on a few 
things; tool development, advancing addendums to regulations, and getting new 
technologies working in a researcher’s own lab.  While practical applications are being 
developed outside of those intended for basic research federal regulation and review 
can delay new products meaning that public engagement is low due to the level at 
which most genetic engineering happens.  The following three chapters focus primarily 
on development and advancement of a new tool set that takes advantage of tenets two 
and three for generating unique GMOs for basic research purposes with the possibility 
to advance medicinal applications.  Chapter 4 acts as the capstone to this research 
trilogy, it shows how the tools can be applied to study a developmental pathway in a 
novel way by replacing the effective coding sequence with a precisely engineered 
theoretical variant. 
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In Brief  
 Wierson et al. describe a targeted integration strategy, called GeneWeld, and a vector 
series for gene tagging, pGTag, which promote highly efficient and precise targeted integration 
in zebrafish, pig fibroblasts, and human cells. This approach establishes an effective genome 
engineering solution that is suitable for creating knock-in mutations for functional genomics and 
gene therapy applications. The authors describe high rates of germline transmission (50%) for 
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targeted knock-ins at eight different zebrafish loci and efficient integration at safe harbor loci in 
porcine and human cells. 
Abstract 
 Choices for genome engineering and integration involve high efficiency with little or no 
target specificity or high specificity with low activity. Here, we describe a targeted integration 
strategy, called GeneWeld, and a vector series for gene tagging, pGTag (plasmids for Gene 
Tagging), which promote highly efficient and precise targeted integration in zebrafish embryos, 
pig fibroblasts, and human cells utilizing the CRISPR/Cas9 system. Our work demonstrates that 
in vivo targeting of a genomic locus of interest with CRISPR/Cas9 and a donor vector containing 
as little as 24 to 48 base pairs of homology directs precise and efficient knock-in when the 
homology arms are exposed with a double strand break in vivo. Given our results targeting 
multiple loci in different species, we expect the accompanying protocols, vectors, and web 
interface for homology arm design to help streamline gene targeting and applications in 
CRISPR compatible systems.  
Keywords 
CRISPR/Cas9, knock-in, homology mediated-end joining, targeted integration, zebrafish, pig 
fibroblasts, human K-562 cells 
Introduction 
 Designer nucleases have rapidly expanded the way in which researchers can utilize 
endogenous DNA repair mechanisms for creating gene knock-outs, reporter gene knock-ins, 
gene deletions, single nucleotide polymorphisms, and epitope tagged alleles in diverse species 
(Bedell et al., 2012; Beumer et al., 2008; Carlson et al., 2012; Geurts et al., 2009; Yang et al., 
2013). A single dsDNA break in the genome results in increased frequencies of recombination 
and promotes integration of homologous recombination (HR)-based vectors (Hasty et al., 1991; 
Hoshijima et al., 2016; Orr-Weaver et al., 1981; Rong and Golic, 2000; Shin et al., 2014; Zu et 
al., 2013). Additionally, in vitro or in vivo linearization of targeting vectors stimulates homology-
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directed repair (HDR) (Hasty et al., 1991; Hoshijima et al., 2016; Orr-Weaver et al., 1981; Rong 
and Golic, 2000; Shin et al., 2014; Zu et al., 2013). Utilizing HDR or HR at a targeted double-
strand break (DSB) allows base-pair precision to directionally knock-in exogenous DNA, 
however, frequencies remain variable and engineering of targeting vectors is cumbersome.   
 Previous work has shown Xenopus oocytes have the ability to join or recombine linear 
DNA molecules that contain short regions of homology at their ends, and this activity is likely 
mediated by exonuclease activity allowing base pairing of the resected homology (Grzesiuk and 
Carroll, 1987). More recently, it was shown in Xenopus, silkworm, zebrafish, and mouse cells 
that a plasmid donor containing short (≤40 bp) regions of homology to a genomic target site can 
promote precise integration at the genomic cut site when the donor plasmid is cut adjacent to 
the homology (Aida et al., 2016; Hisano et al., 2015; Nakade et al., 2014). Gene targeting is 
likely mediated by the alternative-end joining/microhomology-mediated end joining (MMEJ) 
pathway or by a single strand annealing (SSA) mechanism (Ceccaldi et al., 2016). In contrast, in 
human cell culture, linear donors with homologous ends have been reported to show inefficient 
integration until homology domains reach ~600 bp (Zhang et al., 2017), suggesting that different 
repair pathways may predominate depending on cell type. In the initial reports using short 
regions of homology for in vivo gene targeting in zebrafish, the level of mosaicism in F0 injected 
animals was high, resulting in inefficient recovery of targeted alleles through the germline (Aida 
et al., 2016; Hisano et al., 2015; Nakade et al., 2014). 
Here, we present GeneWeld, a strategy for targeted integration directed by short 
homology, and demonstrate increased germline transmission rates for recovery of targeted 
alleles. We provide a detailed protocol and a suite of donor vectors, called pGTag, that can be 
easily engineered with homologous sequences (hereafter called homology arms) to a gene of 
interest, and a web interface for designing homology arms (www.genesculpt.org/gtaghd/). We 
demonstrate that 24 or 48 base pairs of homology directly flanking cargo DNA promotes 
efficient gene targeting in zebrafish, pig, and human cells with frequencies up to 10-fold higher 
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than other HR strategies. Using short homology-arm mediated end joining, we can achieve 
germline transmission rates averaging approximately 50% across several zebrafish loci. 
Southern blot analysis in the F1 generation reveals that the GeneWeld strategy can yield alleles 
with precise integration at both 5’ and 3’ ends, as well as alleles that are precise on just one 
end. Finally, we present a strategy to delete and replace up to 48kb of genomic DNA with a 
donor containing homology arms flanking two distal CRISPR/Cas9 sites in a gene. These tools 
and methodology provide a tractable solution to creating precise targeted integrations and open 
the door for other genome editing strategies using short homology. 
Design 
The GeneWeld strategy takes advantage of two simultaneous actions to initiate targeted 
integration directed by short homology (Fig. 1a). First, a high efficiency nuclease introduces a 
DSB in the chromosomal target. Simultaneously, a second nuclease makes a DSB in the 
pGTag vector integration cassette exposing the short homology arms. The complementarity 
between the chromosomal DSB and the donor homology arms activates a MMEJ/SSA or other 
non-NHEJ DNA repair mechanism, referred to as homology-mediated end joining (HMEJ). The 
reagents needed for this gene targeting strategy include Cas9 mRNA to express the Cas9 
nuclease, a guide RNA targeting the genomic sequence of interest, a universal gRNA (UgRNA) 
that targets two sites in the pGTag series donor vectors to expose the homology arms, and a 
pGTag/donor vector with gene specific homology arms (Fig. 1a). The universal gRNA (UgRNA) 
has no predicted sites in zebrafish, pig, or human genomes. Alternatively, a gene specific guide 
RNA can be used to expose homology arms in the donor vector. For simplicity we will refer to 
this set of reagents as ‘GeneWeld reagents’. Using GeneWeld reagents to target various loci, 
we demonstrate widespread reporter gene expression in injected F0 zebrafish embryos, porcine 
fibroblasts, and human K-562 cells, indicating efficient and precise in-frame integration in 
multiple species and cell systems.    
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Results 
A Single 48bp Short Homology Domain Drives Efficient CRISPR Targeted Integration  
To develop baseline gene targeting data, we engineered variable length homology 
domains to target noto. Homology lengths were based on observations that DNA repair 
enzymes bind DNA and search for homology in 3 or 4 base pair lengths (Supplemental Fig. 1a)  
(Conway et al., 2004; Singleton et al., 2002). Injection of a noto sgRNA that targets noto exon 1 
and the 5’ homology domain cloned into a 2A-TagRFP-CAAX-SV40 donor vector, efficient 
targeted integration was observed as notochord-specific RFP expression (Supplemental Fig. 
1a-c; Supplemental Table 1-3). The frequency of embryos with notochord-specific RFP 
expression increased with the length of the homology arm up to 48 bp (Supplemental Fig. 1b). 
Somatic junction fragment analysis revealed precise integration efficiencies reaching 95% of 
sequenced alleles (Supplemental Fig. 1d). Following these initial experiments, a 3 bp spacer 
sequence was included in all homology arm designs in order to separate the donor 
CRISPR/Cas9 target PAM and the homology domain (Supplemental Fig. 2a). The spacer was 
included to prevent arbitrarily increasing the length of the targeting domain, since single base 
pair alterations in the homology region affected knock-in efficiency up to 2-fold (Supplemental 
Fig. 2b).  
A Universal Guide RNA to Liberate Donor Homology for Targeted Integration 
To simplify donor design and liberate donor cargo in vivo with reproducible efficiency, a 
universal guide RNA sequence UgRNA, with no predicted targets in zebrafish, pig, or human 
genomes, was designed using optimal base composition in CRISPRScan (Supplemental Fig. 
3a) (Moreno-Mateos et al., 2015). To test the ability of the guide to direct a Cas9 double strand 
break and efficient targeted integration, the UgRNA and CGG PAM sequences were cloned 5’ 
to the noto homology arm in the 2A-TagRFP-CAAX-SV40 donor vector (Supplemental Fig. 3b). 
Zebrafish embryos injected with Cas9 mRNA, UgRNA, noto sgRNA, and donor plasmid resulted 
in 21% of injected embryos showing notochord RFP, demonstrating the efficacy of Cas9 and the 
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UgRNA to expose the donor vector 5’ homology arm and drive precise targeted integration 
(Supplemental Fig. 3c). The high frequency of notochord-specific RFP-positive embryos 
following injection suggests repair of the DSB preferentially utilizes homology in the targeting 
construct over the NHEJ pathway.  
Dual Homology Arm Liberation Directs Precise 5’ and 3’ Integration in Somatic Tissue 
 We leveraged the activity of the UgRNA to develop GeneWeld, a strategy for targeted 
integration that results in high frequency precision repair at both 5’ and 3’ junctions at the target 
site. We built a series of vectors, pGTag, which contain sites on both sides of the cargo for 
cloning a short homology arm that is complementary to the 5’ or 3’ sequence flanking the 
genomic target site. The vectors also include the UgRNA sequence outside the sites for 
homology arm cloning (Fig. 1a, b). The final donor targeting vector will contain a cargo flanked 
by 5’ and 3’ homology arms with UgRNA sequences on both ends. Cleavage by Cas9 at the 
UgRNA sites liberates the DNA cargo from the plasmid backbone and exposes both 5’ and 3’ 
donor homology arms for interaction with DNA on either side of the genomic DSB (Fig. 1c).  
We extended our analysis of the GeneWeld targeted integration strategy to four genes in 
zebrafish, noto, tyrosinase (tyr), esama (endothelial cell adhesion molecule a), and connexin 
43.4 (cx43.4), and measured the frequency of precise targeted integration in somatic tissue 
(Fig. 2 a-d).  Injection of 24 or 48 bp homology arm noto 2A-eGFP-SV40 donors resulted in 24% 
of zebrafish embryos showing extensive reporter expression in the notochord (Fig. 2 a, e), 
indicating a similar precise integration efficiency compared to targeting with the single 5’ 
homology arm 2A-TagRFP-CAAX-SV40 vector (Supplemental Fig. 1, Table 1, 2). The results 
also suggest 24bp of homology directs targeted integration as efficiently as 48bp, further 
simplifying construction of GeneWeld vectors. 
Targeting exon 4 of tyr or exon 2 of esama with a 24bp homology arm 2A-TagRFP-
CAAX-SV40 donor did not result in detectable RFP signal, similar to previous reports (Hisano et 
al., 2015). However, PCR junction fragments from injected embryos showed the donor was 
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precisely integrated in frame into tyr exon 4 (Supplemental Fig. 4), suggesting RFP expression 
was below the threshold of detection. To amplify the fluorescent signal, we built pGTag 24 bp 
homology arm 2A-Gal4VP16-actin3’UTR donors to integrate the Gal4VP16 trans-activator 
into the tyr and esama target sites, and injected into transgenic zebrafish embryos carrying a 
14xUAS-RFP reporter, Tg(UAS:mRFP)tpl2 (Balciuniene et al., 2013). This resulted in strong RFP 
signal in 64% of tyr injected animals (Fig.2b, e), however, the embryos were highly mosaic with 
only 9% of RFP embryos displaying extensive expression throughout most of the pigmented 
cells. Targeting esama exon 2 with 2A-Gal4VP16-actin3’UTR in the Tg(UAS:mRFP)tpl2 
transgenic background resulted in 21% of embryos displaying extensive RFP expression 
specifically in the vasculature (Fig. 2c, e). This approach was further extended to five additional 
loci, targeting 2A-Gal4VP16 to filamin a (flna) exon 4, moesin a (msna) exon 2 and 6, aquaporin 
1a1 (aqp1a1) exon 1, aquaporin 8a1 (aqp8a1) exon 1, and annexin a2a (anxa2a) exon 3. At 
these loci, transient expression of RFP was observed following injection in 4-55% of 
Tg(UAS:mRFP)tpl2 embryos (Supplemental Table 1, 2). Taken together, these results show that 
the GeneWeld targeting method promotes high efficiency targeted integration in zebrafish 
embryo somatic tissue.  
We next compared the frequency of GeneWeld targeted integration in zebrafish embryos 
with previous methods that used TALEN targeting of long homology arm (~ 1kb) donors in 
combination with restriction enzyme digestion to liberate the linear donor template (Hoshijima et 
al., 2016; Shin et al., 2014). Targeted integration of pGTag 24 and 48bp homology arm 2A-
TagRFP-CAAX-SV40 donors into exon 2 of connexin43.4 (cx43.4) resulted in 38-56% and 29-
47% of injected embryos showing broad RFP expression throughout the nervous system and 
vasculature (Fig. 2d, f). Increasing the length of the 5’ and 3’ homology arms to 1kb did not 
significantly change the frequency of targeted integration compared to 24bp (p=0.1693) or 48bp 
(p=0.6520) (Fig. 2 f), with 26-47% of injected embryos showing the expected neuronal and 
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vascular RFP expression pattern (Supplemental Table 1, 2). Injection without the UgRNA leaves 
the 1kb homology circular donor intact and reduced targeting to 0-3% (Fig. 2f Circular HR 1kb; 
p=0.0067; Supplemental Table 1, 2), as expected given the low frequency of homologous 
recombination in embryos. In comparison to the GeneWeld method, the frequency of RFP 
expressing embryos after injection of linear 1kb homology arm donor template was significantly 
reduced to 2-9% (Fig. 2f Linear HR 1kb; p=0.0111; Supplemental Table 1, 2). Together, these 
results indicate long regions of homology in the donor template do not enhance the frequency of 
integration at the genomic target site, compared with short 24 or 48 bp homology, when using 
the GeneWeld approach. The increased efficiency compared to linear donor injection may be 
that introduction of linear DNA into the embryo normally leads to concatemers through NHEJ. 
Simultaneous targeting of DSBs at the genomic site and in the donor prevents early concatemer 
formation, suggesting that it favors homology directed repair. 
The effect of homology length on GeneWeld integration efficiency was also tested with 
the 2A-Gal4VP16-actin3’UTR donor targeting esama exon 2. Increasing homology length 
from 24bp to 1kb dramatically increased the percentage of RFP positive embryos, from 20-23% 
to 82-94% (p=0.0001 Supplemental Fig. 5, Supplemental Table 1, 2).  A high frequency of RFP-
positive embryos was also observed when the donor template was injected without UgRNA (27-
53%) (Supplemental Fig. 5 Circular HR 1kb) or the donor template was linearized before 
injection (83-94%) (Supplemental Fig. 5 Linear HR 1 kb). Common repetitive elements, 
enhancers, or a cryptic promoter in the intronic sequence of the esama 1 kb homology arms 
together may lead to off target integration and ectopic RFP expression. These results 
underscore the utility of the GeneWeld short homology approach for simple donor vector 
construction and efficient precision targeted integration. 
Efficient Germline Transmission of GeneWeld Precision Targeted Integration Events 
Three out of five (60%) noto-2A-TagRFP-CAAX-SV40 injected founder fish raised to 
adulthood transmitted noto-2A-TagRFP-CAAX-SV40 tagged alleles through the germline 
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(Figure 3, Table 1, Supplemental Tables 3 and 4). Although RFP expression in tyr-2A-
Gal4VP16-actin injected Tg(UAS:mRFP)tpl2  embryos was not uniform throughout 
melanophores, three out of eight RFP mosaic embryos raised to adulthood transmitted germline 
tagged alleles (37.5%) (Figure 3, Table 1 and Supplemental Table 3 and 4). Similarly, for 
esama-2A-Gal4VP16-β-actin, 12/18 (66.7%) F0s displaying widespread vasculature RFP 
expression were raised to adulthood transmitted esama-2A-Gal4VP16-β-actin alleles to the F1 
generation. We extended the germline transmission analysis to include 6 additional loci: flna, 
two target sites in msna (exon 2 and 6), aqp1a1, aqp8a1, and anxa2a. Overall, the data reveal a 
combined transmission rate to the F1 generation of 49% across all GeneWeld targeted loci 
(Figure 3, Table 1, Supplemental Tables 3 and 4). Taken together, these results demonstrate 
the GeneWeld method promotes targeted integration that is efficiently transmitted through the 
germline in zebrafish.  
Precise 5’ and 3’ Junctions and Single Copy Integration in F1 Germline GTag Alleles 
 We performed Genomic Southern blot analyses and PCR junction fragment sequencing 
of F1 GTag germline alleles to determine whether GeneWeld targeting lead to precise 
integration at the 5’ and 3’ sides of the genomic target site. Southern blot analysis and 
sequencing of tyr-2A-Gal4VP16--actin F1 progeny demonstrated a single copy integration of 
the Gal4VP16 cassette (Fig. 4 a-c) with precise sequence at both 5’ and 3’ ends of the 
integration site (Supplemental Fig. 6). Analysis of four F1 progeny from two noto-2A-TagRFP-
CAAX-SV40 founder adults confirmed a single copy integration in noto exon 1 (Fig. 4, d-f). 
However, sequencing of PCR junction fragments in F1 progeny revealed precise 5’ integration 
but imprecise integration at the 3’ ends that could represent NHEJ repair (Supplemental Fig. 6).  
 Junction fragment analysis of F1s alleles from 5 additional targeted sites in esama, flna, 
msna, aqp1a1, and aqp8a1 revealed precise events were primarily recovered at the 5’ for all 
genes examined (30/31 or 97% across seven genes) (Supplemental Fig. 6). This result is 
26 
 
expected, since screening for fluorescent reporter expression from the integrated donor cargo 
selects for precise 5’ integration. For esama, the 3’ junctions were also precise in 9/10 of the 
F1s examined from 6 different F0s, and both aqp1a1 and app8a1 had precise 3’ junctions. This 
is compared to msna E2 targeting with 2A-Gal4VP16--actin, where only one out of the 12 F1s 
examined had a precise 3’ junction. Together, these results indicate that GeneWeld reagents 
can promote with high frequency precise single copy integration at a genomic cut site without 
insertion of donor vector backbone sequences, although events involving NHEJ at the at the 3’ 
end are also recovered. 
Homology Engineered to Distal Genomic gRNA Sites Seeds Deletion Tagging in Somatic 
Tissue  
To further demonstrate the utility of GeneWeld targeted integration, we tested whether 
the pGTag donor could function to bridge two CRISPR/Cas9 genomic cuts, resulting in 
simultaneous deletion of endogenous sequences and integration of exogenous DNA to create a 
“deletion tagged” allele. The pGTag-2A-Gal4VP16 donor was cloned with 48bp homology arms 
to two gRNA target sites in the zebrafish retinoblastoma1 (rb1) gene.  Guide RNAs were 
designed to sites in exons 2 and 4, which are located 394 bp apart, or exons 2 and 25 which are 
separated by ~48.4 kb (Fig. 5a). The 5’ homology arm contained sequence upstream of the cut 
site in exon 2, while the 3’ homology arm contained sequence downstream of the cut site in 
either exon 4 or exon 25. GeneWeld targeting with the corresponding exon 2-4 or exon 2-25 
pGTag-2A-Gal4VP16-β-actin donor into Tg(UAS:mRFP)tpl2 embryos resulted in injected 
embryos showing broad and ubiquitous RFP expression (Fig. 5b-c). Using the same approach, 
we targeted the zebrafish gene moesina (msna) at exons 2 and 6, located 7.8 kb apart, with 2A-
Gal4VP16 using 48 bp of homology (Fig. 5d), and found RFP expression in a pattern consistent 
with the expression of msna (Fig. 5 e, e’). The frequency of RFP positive embryos was similar 
after targeting rb1 exon 2-4 (44-78%) and msna exon 2-6 (50-85%), and did not seem to be 
affected by increasing the size of the deleted region from 394 bp to 48.4 Kb in rb1 exon 2-25 
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(49-70%) (Fig. 5f). Somatic junction fragment analysis detected precise integration of 2A-
Gal4VP16 in both genes at the 5’ upstream exon (rb1 97%; msna 85%) and 3’ downstream 
exon (rb1 67%; msna 45%) (Supplemental Fig. 7). However, only one out of 16 (6%) rb1 e2-25-
2A-Gal4VP16 targeted F0 founders transmitted a precise 5’ junction through the germline, but 
the 3’ junction could not be amplified by PCR (Supplemental Table 3, 4). None of the 10 msna 
e2-e6 2A-Gal4VP16 targeted F0 zebrafish transmitted a deletion tagged allele to the next 
generation. In contrast, targeting 2A-Gal4VP16-actin to exon 2 or 6 alone resulted in 2 out of 
7 F0s transmitting a targeted allele to the next generation (Supplemental Table 3, 4).  
Together, these results demonstrate simultaneous targeting of two distal genomic cut 
sites can create precise HMEJ integration at both ends of a pGTag reporter cassette in somatic 
tissue, but these events are not easily passed through the germline. This was reinforced by 
attempting deletion tagging at additional loci, including kdrl, s1pr1, and vegfaa, which showed 
32-81% expression in F0 embryos, but no germline transmission to the F1 generation 
(Supplemental Table 2, 3).  
Integration of Exogenous DNA Using HMEJ in Porcine and Human Cells is More Efficient 
than HR 
 To determine if HMEJ integration directed by short homology functions efficiently in large 
animal systems, we tested the GeneWeld targeting strategy in S. scrofa fibroblasts. The 
ROSA26 safe harbor locus was targeted with a cassette that drives ubiquitous eGFP expression 
from the UbC promoter (Fig. 6a-c). GeneWeld reagents, where the genomic sgRNA was 
replaced with mRNAs encoding a TALEN pair to generate a genomic DSB in the first intron of 
ROSA26, were delivered to pig fibroblasts by electroporation. This strategy was compared to 
cells electroporated with just the TALEN pair and a HR donor containing approximately 750 bp 
of homology flanking the genomic target site. GFP expression was observed in 23% of colonies 
using GeneWeld reagents, compared to 2% of colonies using the HR donor with ~750 bp 
homology arms. Co-occurring precise 5’ and 3’ junctions were observed in over 50% of the 
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GFP+, GeneWeld engineered colonies while none of the GFP+, HR colonies contained both 
junctions. Sequencing of junctions from 8 GFP+, GeneWeld engineered colonies that were 
positive for both junctions showed precise integration in 7/8 colonies at the 5’ junction and 8/8 
colonies at the 3’ junction.  
The GeneWeld strategy was also used to target integration of a MND:GFP reporter 
(Halene et al., 1999) into the AAVS1 safe harbor locus in human K-562 cells (Fig. 6d-f). 
Integrations were attempted with either GeneWeld reagents or an HR donor targeting the 
AAVS1 cut site by electroporation of K-562 cells. Cells were FACs sorted by GFP at day 14 
following electroporation. With GeneWeld reagents over 50% of cells were GFP positive, 
compared to only 6% of cells electroporated with the HR donor. This suggests the GeneWeld 
strategy promoted efficient integration and stable expression of the MND:GFP cassette at the 
AAVS1 locus (Supplemental Fig. 8).  Expression was maintained over 50 days, and 5’ precise 
junction fragments were observed following PCR amplification in bulk cell populations 
(Supplemental Fig. 9). The results above demonstrate that the GeneWeld strategy outperforms 
traditional HR techniques in mammalian cell systems and is effective without antibiotic selection. 
Discussion 
 The results described here demonstrate the utility of short homology-based gene 
targeting for engineering precise integration of exogenous DNA and expand the potential of 
efficient tagging to diverse loci with differing endogenous expression levels. We show that using 
short homology to bridge distal ends together simultaneously creates a deletion and a reporter 
integration, however, these events are not easily passed through the germline.  We 
demonstrate efficient integration of cargos up to approximately 2 kb in length in zebrafish, pig 
fibroblasts, and human cells. Both CRISPR/Cas9 and TALENs are effective as GeneWeld 
genomic editors, providing flexibility in deployment and genome-wide accessibility. 
Several components of the GeneWeld strategy may lead to enhanced somatic and 
germline targeting efficiencies in zebrafish as compared to previous reports (Hisano et al., 
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2015). Canonical NHEJ is highly active during rapid cell divisions in early zebrafish 
embryogenesis (Bedell et al., 2012). However, given the correct sequence context surrounding 
the dsDNA break, MMEJ is the preferred method of non-conservative repair (Ata et al., 2018; 
He et al., 2015; Kent et al., 2015). GeneWeld homology arms are rationally designed based on 
the known homology searching activity of RAD51 and strand annealing activity of RAD52 
(Conway et al., 2004; Singleton et al., 2002). In our experiments at noto, gene targeting is 
significantly reduced when 48 bp homology arms are altered by 1 bp to 47 or 49 bp 
(Supplemental Fig. 3). This suggests that optimal short homology arms should be designed in 
groups of 3 and/or 4 bp increments. We are currently testing this hypothesis further.  
Additionally, Shin et al., 2014 showed the highest rates of somatic targeting when their donor 
was linearized in vitro inside a ~1 kb 5’ homology arm, leaving 238 bp of homology flanking the 
knock-in cargo. Thus, it is tempting to speculate that gene targeting in these experiments 
proceeded not through HR, but through other related HMEJ DNA repair pathway more similar to 
the findings presented here.  
The significant differences observed for the investigated loci demonstrates that working 
with long homology arms can be very challenging. Long homology arms might be formed mostly 
by intronic sequences, which might turn the efficiencies highly locus-dependent. Introns are 
highly enriched of repetitive sequences that can potentially mediate random integrations across 
the genome. In addition, alternative promoters and enhancer sequences present in intronic 
regions can also end up affecting the final efficiency results. Lastly, cloning of the homology 
arms can be arduous, since intronic sequences are highly variable across individuals. Taken 
together, we suggest that using the GeneWeld method with short homology arms is a preferable 
choice for efficient precise exogenous DNA integration. 
The dramatic shift of DNA repair at genomic DSBs from cis-NHEJ to trans-HMEJ using 
GeneWeld donors likely also influences enhanced editing of the germline. Across all zebrafish 
experiments with germline transmission, 49% of founders transmitted tagged alleles, with 17.4% 
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of gametes carrying the edited allele of interest (Supplemental Table 3, 4), demonstrating 
decreased germline mosaicism and increased germline transmission from previous reports. 
Given that our somatic knock-in and germline transmission rates are higher than published 
reports, we conclude that GeneWeld is a more effective homology-based method for generating 
precisely targeted knock-in alleles in zebrafish. 
 While targeting noto with 5’ only homology shows an increase in targeting efficiency with 
longer homology, increasing homologies on both ends of the cargo DNA did not increase 
targeting efficiency (Fig. 2e). Positive events are selected only by fluorescently tagged alleles, 
indicating precise 5’ integration patterns. We speculate that inclusion of homology at the 3’ end 
of our cargo creates competition for the donor DNA ends, as not all editing events are precise at 
both 5’ and 3’ junctions (Fig. 4 and Supplemental Fig. 4). Thus, it is conceivable that precise 
events at the 3’ end could preclude precise integration at the 5’ end during some editing events, 
and vice versa. It is tempting to speculate that this data hints at synthesis dependent strand 
annealing (SDSA) as a possible DNA repair mechanism for pGTag donor integration (Ceccaldi 
et al., 2016). After strand invasion using either of the homology domains and replication through 
the reporter, second DNA end capture may abort before or after replication through the 
opposing homology domain, resulting in imprecision, as greater than or equal to 150 bp is 
required for proper second end capture in yeast (Mehta et al., 2017). Experiments to address 
this hypothesis by varying homology arm lengths flanking the donor cassettes and including 
negative selection markers are of note for future work in determining the genetic mechanisms 
that promote efficient integration. 
Timing and turnover of Cas9 during the genomic editing event can influence cut 
efficiency and somatic mosaicism/germline transmission rates (Clarke et al., 2018; Zhang et al., 
2018), increasing the interest of using RNP during all precision gene editing applications. 
However, we were unable to observe fluorescence following injection of GeneWeld components 
with RNPs or detect targeted integrations at a high frequency (unpublished data). We 
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hypothesize this is due to Cas9 and UgRNA locating and binding to the UgRNA sites on the 
pGTag donors during dilution of the injection mixture. This heteroduplex either activates DSBs 
on the donor in vitro, or directly after injection, before the genomic gRNA can locate and cut the 
genome. Thus, the stochastics of DNA end availability are altered using RNPs and integration 
activity is greatly reduced. Injection of the GeneWeld plasmid donor and RNPs in separate 
injection mixtures does not produce integration in zebrafish embryos (unpublished data).  
Further experiments could address these limitations through the use of inducible nuclease 
systems.  
Targeting genes with lethal phenotypes, such as tumor suppressors or other genes 
required for embryogenesis, is of interest to the zebrafish community. However, using 
fluorescence to screen for targeted events can be misleading. For example, the RFP signal is 
dramatically reduced or lost upon biallelic inactivation of noto, likely when notochord cells 
transfate to muscle cells (Melby et al., 1996; Talbot et al., 1995). Additionally, though deletion 
tagging using two target sites in the genome seems to be robust in somatic tissue, germline 
transmission of deletion tags is rare. This suggests that edited germ cells may be lost to 
apoptosis due to the additional cut in the genome, or that heterozygous deletion tagged alleles 
are recognized during homologous chromosome pairing and are repaired or lost as germ cells 
mature. Similar susceptibility of stem cells to apoptosis following gene editing has been 
previously observed (Ihry et al., 2018; Li et al., 2018). In both of these cases, it may be 
necessary to modulate GeneWeld reagent concentrations in order to avoid biallelic inactivation 
of the genomic target, or to ensure homozygous deletion tagging.  
Amplification of the fluorescence signal using GAL4/VP16 allowed us to target several 
genes for which we did not observe a fluorescence report from integration of a fluorescent 
protein directly. While this approach is advantageous for selecting correctly targeted embryos to 
examine for germline integration, GAL4/VP16 may have toxic effects as reported previously 
(Ogura et al., 2009). For example, we found dominant phenotypes in the F1 generation for both 
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msna and flna which could reflect toxicity from high levels of expression of GAL4/VP16. 
Alternatively, these gene could also display haploinsufficiency or express a partial protein 
product that functions in a dominant manner. Heterozygous msna mutants targeting exon 5 in 
the F1 generation display phenotypes similar to morpholino targeting of this gene (Wang et al., 
2010) (data not shown), suggesting haploinsufficiency or a dominant negative peptide is a likely 
explanation.  
GeneWeld is also an effective strategy to precisely control exogenous DNA integration in 
mammalian cell lines. While our data shows an approximate 10-fold increase in targeted 
integration using 48 bp of homology to drive HMEJ versus HR, Zhang et al. (2017) concluded 
that targeted integration did not appreciably increase until homology arms of ~600 bp were used 
(Zhang et al., 2017). However, this could reflect differences in the experimental design or cell 
types used and suggest different DNA repair pathways may be more prevalent in certain 
conditions. Deciphering the DNA repair pathway used for HMEJ in zebrafish and mammalian 
cells is paramount to increasing editing efficiencies in basic research and for gene therapy.  
Given the high efficiency and precision of GeneWeld, additional applications to efficiently 
introduce other gene modifications, such as single or multiple nucleotide polymorphisms, by 
exon or gene replacement is possible using the deletion tagging method. Further, GeneWeld 
could be used to create conditional alleles by targeting conditional gene break systems into 
introns (Clark et al., 2011). In conclusion, our suite of donor vectors with validated integration 
efficiencies, methods, and web interface for pGTag donor engineering will serve to streamline 
experimental design and broaden the use of designer nucleases for homology-based gene 
editing at CRISPR/Cas9 and TALEN cut sites in zebrafish. We also demonstrate an advanced 
strategy for homology-based gene editing at CRISPR/Cas9 and TALEN cut sites in mammalian 
cell lines. Our results open the door for more advanced genome edits in animal agriculture and 
human therapeutics. 
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Methods 
Contact for Reagent and Resource Sharing 
 Further information and requests for resources and reagents should be directed 
to and will be fulfilled by the Lead Contact, Jeffrey Essner (jessner@iastate.edu). 
Experimental Model and Subject Details 
 Zebrafish were maintained in Aquatic Habitats (Pentair) housing 
on a 14 hour light/10 hour dark cycle. Wild-type WIK were obtained from the Zebrafish 
International Resource Center. The Tg(miniTol2/14XUAS:mRFP, γCry:GFP)tpl2, shortened 
to Tg(UAS:mRFP)tpl2, was previously described (Balciuniene et al., 2013). All experiments were 
carried out under approved protocols from Iowa State University IACUC.   
 The human K-562 chronic myelogenous leukemia cell line (ATCC CCL-243) used in 
gene targeting experiments was cultured at 37oC in 5% CO2 in RPMI-1640 (Thermo Fisher 
Scientific) supplemented with 10% fetal bovine serum (FBS) and 
Penicillin/Streptomycin.  Electroporation was conducted with 1.5 x 105 cells in a 10 l tip using 
the Neon electroporation device (Thermo Fisher Scientific) with the following conditions: 1450V, 
10ms, 3x pulse. Nucleic acid dosages were as follows: 1.5 g Cas9 mRNA 
(Trilink Biotechnologies), 1 g each chemically modified sgRNA (Synthego), and 1 g donor 
plasmid. 
 Fibroblasts were cultured in DMEM (high glucose) supplemented to 10% vol/vol FBS, 20 
mM L-glutamine and 1X Pen/ Strep solution and transfected using the NeonTM system 
(Invitrogen).  Briefly, 1 x 106 fibroblasts were transfected with 1 ug of polyadenylated ROSA 
TALEN mRNA, 1 g of universal gRNA mRNA, 1 g of polyadenylated Cas9 mRNA and 1 g of 
donor plasmid.  Transfected cells were cultured for 3 days at 30oC before low density plating, 
extended culture (10 days) and colony isolation.  Individual colonies were aspirated under 
gentle trypsanization, replated into 96- well plates and cultured for 3-4 days.  
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pGTag Series Vectors   
To build the pGTag vector series, 2A-TagRFP, 2A-eGFP, and 2A-Gal4/VP16 
cassettes were assembled from a 2A-TagRFP-CAAX construct, p494. To clone 
the eGFP cassette, the plasmid p494 was amplified with primers F-p494-XhoI and R-p494-SpeI 
to generate unique enzyme sites in the backbone. The eGFP coding 
sequence (Clontech Inc.) was amplified with the primers F-eGFP-SpeI and R-eGFP-XhoI to 
generate the corresponding enzyme sites on the eGFP coding sequence. Fragments 
were digested with SpeI-HF and XhoI (NEB) and following column purification with the Qiagen 
miniprep protocol, were ligated to the plasmid backbone with T4 ligase (Fisher).    
  The Gal4/VP16 coding sequence and zebrafish -actin 3’ untranslated region was 
amplified from vector pDB783 (Balciuniene et al., 2013) with primers F-2A-Gal4-BamHI and R-
Gal4-NcoI to add a 2A peptide to the 5’ end of the Gav4Vp16 cDNA. The resulting PCR product 
was then cloned into the intermediate Topo Zero Blunt vector (Invitrogen) and used for 
mutagenesis PCR with primers F and R ‘-gal4-Ecofix’ to disrupt the internal EcoRI restriction 
site. The resulting Gal4/VP16 sequence was cloned into the BamHI and NcoI sites in the p494 
backbone.   
  The 5’ universal/optimal guide site and lacZ cassette were added to pC-2A-TagRFP-
CAAX-SV40, pC-2A-eGFP-SV40, and pC-2A-Gal4VP16--actin with the following steps. 
The lacZ was first amplified with primers F-lacZ and R-lacZ, which add the type IIS enzyme 
sites to either end of the lacZ. The resulting PCR product was then cloned into an intermediate 
vector with the Zero Blunt® TOPO® PCR Cloning Kit (Invitrogen). This intermediate was used 
as a template in a nested PCR to add the Universal 
guide sequence GGGAGGCGTTCGGGCCACAGCGG to the end of the lacZ 
sequence. The nested PCR used primers F-lacZ-universal-1 and R-lacZ-universal-BamHI to 
add the first part of the universal guide to one end and a BamHI site to the other.  This was used 
35 
 
as template for PCR with the primers F-lacZ-universal-EcoRI and R-lacZ-universal-BamHI to 
add the remainder of the universal guide and an EcoRI site. The fragment was column purified 
as above, digested with EcoRI-HF and BamHI-HF and cloned into the appropriate sites in the 
three vectors.   
  The 3’ universal guide and type 2 restriction enzyme sites were cloned into each 
vector in two steps. A segment from a Carp beta-actin intron containing a 99 bp spacer flanked 
by two BspQI sites was amplified using the primers F-3’-uni-1 and R-3’-uni-1 to add the 
universal site to one side of the spacer. This product was column purified as above and used as 
template for the second amplification with primers F-3’-uniNco1 and R-3’-uniEagI to add cloning 
sites. This product was column purified and cloned using the Topo zero blunt kit. This 
intermediate was digested with NcoI-HF and EagI, and the BspQI fragment purified and cloned 
into the three vectors as above.  Ligations were grown at 30oC to reduce the possibility of 
recombination between the two universal guide sites.   
Correct clones for pU-2A-TagRFP-CAAX-U, pU-2A-eGFP-U, and pU-2A-Gal4/VP16-
U were selected and used as template for mutagenesis PCR with KOD to remove 
extra BspQI sites from the backbone with primers F/R-BBfix, digested 
with DpnI (NEB), and ligated with T4 ligase. A correct pU-2A-TagRFP-CAAX-U clone was used 
as template for PCR with F/R-TagRFPfix to interrupt the BspQI site in the TagRFP coding 
sequence as above. A correct clone of pU-2A-Gal4/VP16-U was selected and used as template 
with primers F/R-Bactfix to remove the BspQI site in the Beta-actin terminator, the product was 
re-cloned as above. All constructs were sequence verified.   
Homology Arm Design and Donor Vector Construction   
For detailed methods, see Supplemental gene targeting protocol. In brief, 
homology arms of specified length directly flanking a genomic targeted double strand 
break were cloned into the pGTag vector, in between the UgRNA sequence and the cargo. 
A three nucleotide buffer sequence lacking homology to the genomic target site was engineered 
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between the donor UgRNA PAM and the homology arms, in order to maintain the specified 
homology arm length. To generate 1kb homology arms for zebrafish genes cx43.4 and esama, 
~2kb of genomic DNA surrounding the CRISPR target site was PCR amplified from adult WIK 
finclips using the proofreading enzyme KOD, and then sequenced to identify polymorphisms. 
pGTag 1kb homology arm vectors were injected into embryos from adults with the matching 
genomic sequence. See Supplemental Table 4 for all homology arms, gRNA target sites, and 
spacers.   
Zebrafish Embryo Injection  
pT3TS-nCas9n was a gift from Wenbiao Chen (Addgene plasmid # 
46757). XbaI linearized pT3TS-nCas9n was purified under RNase-free conditions with the 
Promega PureYield Plasmid Miniprep System. Linear, purified pT3TS-nCas9n was used as 
template for in vitro transcription of capped, polyadenylated mRNA 
with the Ambion T3TS mMessage mMachine Kit. mRNA was purified using 
Qiagen miRNeasy Kit. The genomic and universal sgRNAs were generated using cloning 
free sgRNA synthesis as described in (Varshney et al., 2015) and purified using 
Qiagen miRNeasy Kit. Donor vector plasmid DNA was purified with the 
Promega PureYield Plasmid Miniprep System. noto, cx43.4, tyrosinase, and moesina, were 
targeted by co-injection of 150 pg of nCas9n mRNA, 25 pg of genomic sgRNA, 
25 pg of UgRNA (when utilized), and 10 pg of donor DNA diluted in RNAse free 
ddH2O. The rb1 targeting mixture contained 300 pg nCas9n mRNA. 2 nl was delivered to each 
embryo.   
Recovery of Zebrafish Germline Knock-in Alleles  
Injected animals were screened for fluorescence reporter expression on a Zeiss 
Discovery dissection microscope and live images captured on a Zeiss LSM 700 laser scanning 
confocal microscope. RFP/GFP positive embryos were raised to adulthood and outcrossed to 
wildtype WIK adults to test for germline transmission of fluorescence in F1 
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progeny. tyr, esama, rb1 and msna embryos targeted with Gal4VP16 were crossed 
to Tg(UAS:mRFP)tpl2.   
DNA Isolation and PCR Genotyping  
Genomic DNA for PCR was extracted by digestion of single embryos in 50mM NaOH at 
95oC for 30 minutes and neutralized by addition of  1/10th volume 1M Tris-HCl pH 8.0. Junction 
fragments were PCR-amplified with primers listed in Supplemental Table X and the 
products TOPO-TA cloned before sequencing. 
Southern Blot Analysis  
Genomic Southern blot and copy number analysis was performed as described 
previously (McGrail et al., 2011). PCR primers used for genomic and donor specific probes are 
listed in Supplemental Table 6.  
Junction Fragment Analysis in Pig Fibroblasts  
Individual colonies were scored for GFP expression and prepared for PCR by washing 
with 1X PBS and resuspension in PCR-safe lysis buffer (10 mM Tris-Cl, pH 8.0; 2 mM EDTA; 
2.5% (vol/vol) Tween-20; 2.5% (vol/vol) Triton-X 100; 100 μg/mL Proteinase K followed by 
incubation at 50oC for 60 min and 95oC for 15 min.  PCR was performed using 
1X Accustart Supermix (Quanta) with the primers: 5’ junction F-5’ 
TAGAGTCACCCAAGTCCCGT-3’, R-5’- ACTGATTGGCCGCTTCTCCT-3’; 3’ junction F-5’- 
GGAGGTGTGGGAGGTTTTT-3’, R-5’- TGATTTCATGACTTGCTGGCT-3’. ROSA TALEN 
sequences are:  TAL FNG NI NI HD HD NG NN NI NG NG HD NG NG NN NN; TAL RHD NN 
NG NI HD NI HD HD NG NN HD NG HD NI NI NG.  
K-592 Flow Cytometry  
K-562 cells were assessed for GFP expression every 7 days for 28 days following 
electroporation. Flow cytometry was conducted on an LSRII instrument (Becton Dickinson) and 
data was analyzed using FlowJo software v10 (Becton Dickinson). Dead cells were excluded 
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from analysis by abnormal scatter profile and exclusion based on Sytox Blue viability dye 
(Thermo Fisher Scientific).   
  Junction PCR to detect targeted integration was conducted using external genomic 
primers outside of the 48bp homology region and internal primers complementary to the 
expression cassette. PCR was conducted using Accuprime HIFI Taq (Thermo Fisher Scientific). 
PCR products from bulk population were sequenced directly.   
Quantification and Statistical Analysis 
 Statistical analysis was performed using GraphPad Prism software. Data plots represent 
mean +/- s.e.m. of n independent experiments, indicated in the text. p values were calculated 
with two-tailed unpaired t-test. Statistical parameters are included in the figure legends. 
Data and Software Availability  
 The webtool GTagHD was developed to assist users in designing oligonucleotides for 
targeted integration using the pGTag vector suite. GTagHD guides users through 
entering: 1) the guide RNA for cutting their cargo-containing plasmid; 2) the guide RNA for 
cutting their genomic DNA sequence; (3) the genomic DNA sequence, in the form of 
a GenBank accession number or copy/pasted DNA sequence; and 4) the length of 
microhomology to be used in integrating the plasmid cargo. If the user is utilizing one of 
the pGTag series plasmids, GTagHD can also generate a GenBank/ApE formatted file for that 
plasmid, which includes the user's incorporated oligonucleotide sequences. GTagHD is freely 
available online at http://genesculpt.org/gtaghd/ and for download at https://github.com/Dobbs-
Lab/GTagHD.  
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FIGURES 
Figure 1. GeneWeld strategy and pGTag vector series (a) GeneWeld reagent components are 
designed for simultaneous genome and donor nuclease targeting to reveal short regions of homology. 
Red arrowheads represent in vivo designer nuclease DSBs. Components include: 1 - Designer nuclease 
mRNA, either Cas9 to target both the genome and donor, or Cas9 to target the donor and TALEN to cut 
the genome; 2 - sgRNA for targeting Cas9 to genome; 3 - Universal sgRNA to liberate donor cargo and 
homologous ends; and 4 - pGTag donor of interest with short homology arms. (b) Type IIs restriction 
endonucleases BfuAI and BspQI create incompatible ends outside of their recognition sequence, allowing 
digestion and ligation of both homology arms into the vector in a single reaction. Homology arm 
fragments are formed by annealing complementary oligonucleotides to form dsDNA with sticky ends for 
directional cloning into the vector. XFP = Green or Red Fluorescent Protein. pA = SV40 or β-actin 3’ 
untranslated region. Red and green fluorescent proteins were cloned into the pGTag vectors, and for 
each color, subcellular localization sequences for either nuclear localization (NLSs) and membrane 
localization (CAAX) are provided (c) Schematic of GeneWeld targeting in vivo. After designer nuclease 
creates targeted double-strand breaks in the genome and donor, end resection likely precedes homology 
recognition and strand annealing, leading to integration of the donor without vector backbone. Red 
arrowheads represent in vivo designer nuclease DSBs.  
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Figure 2. HMEJ strategy promotes efficient somatic targeting of knock-in cassettes in zebrafish. 
(a-d) Live confocal images of F0 injected embryos showing fluorescent reporter expression after 
GeneWeld targeted integration. noto-2A-eGFP-SV40 at mid somite stage (a, a’). tyr-2A-Gal4VP16-β-
actin;Tg(UAS:mRFP)tpl2 at 5 days post fertilization (dpf) (b, b’). esama-2A-Gal4VP16-β-
actin;Tg(UAS:mRFP)tpl2 at 2 dpf (c) and 3 dpf (c’). cx43.4-2A-tagRFP-CAAX-SV40 at 31 hours post 
fertilization (d, d’). (e) Frequency of embryos with reporter gene expression following GeneWeld targeting 
at noto, tyr and esama. 5’ and 3’ homology lengths flanking donor cargos indicated in base pairs as 24/24 
or 48/48. (f) Comparison of the frequency of RFP expressing embryos after targeting cx43.4 exon 2 using  
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Figure 2 continued: 
GeneWeld 24/24 bp homology, GeneWeld 48/48 bp homology, GeneWeld 1kb/1kb homology, Circular 
HR 1kb/1kb (injection did not include UgRNA, *p=0.0067), Linear HR 1kb/1kb (donor was linearized 
before injections, *p=0.0111). Data represents mean +/- s.e.m. of 3 independent targeting experiments. p 
values calculated using Students t test. Scale bars = 100 µm. 
Figure 3. Live confocal images of F1 zebrafish with inherited germline alleles of integrated GTag  
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Figure 3 continued: 
reporters.  (a, a’) Tg(noto-2A-TagRFP-CAAX-SV40) embryo at mid somite stage showing expression in 
the notochord and floor plate. (b, b’) Tg(tyr-2A-Gal4Vp16-β-actin) displaying expression in the 
melanocytes in a 5 dpf larva. (c, c’) Tg(esama-2A-Gal4Vp16- β-actin) larva showing expression in the 
vascular system at 4 dpf. (d, d’) Tg(flna-2A-Gal4VP16- β-actin) embryo at 1 dpf showing widespread 
expression. (e, e’ and f, f’) Tg(msna-2A-Gal4VP16- β-actin) targeted to either exon 2 or exon 6 showed 
expression in the central nervous system and vasculature at 2 dpf. (g, g’ and h, h’) Tg(aqp1a1-2A-
Gal4VP16- β-actin) and Tg(aqp8a1-2A-Gal4VP16- β-actin) display expression in the trunk and tail 
vasculature at 2 dpf. All images are lateral views, and the Gal4VP16 integrations have Tg(UAS:mRFP)tpl2 
in the background for visualization of expression. Scale bars = 100 µm.
  
Figure 4. 
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Figure 4 continued: 
Figure 4. Molecular analysis of F1 GeneWeld GTag targeted alleles at tyr and noto. (a-c) Molecular 
analysis of Tg(tyr-2A-GAL4/VP16) F1 offspring from a single targeted F0 founder. (a) Schematic of 
expected integration pattern for tyr targeted with pGTag-2A-GAL4/VP16. 148 bp tyr probe in Exon 3 and 
583bp probe in GAL4/VP16 are indicated. (b) GAL4/VP16 and (c) tyr probed Southern blots of genomic 
DNA from wild type (WIK) and 4 individual GAL4/VP16 positive F1s. The expected 7400 bp band is 
detected with both probes, suggesting a single copy integration. (d-f) Tg(noto-2A-RFP) F1 targeted 
integration alleles from 2 independent F0 founders. (d) noto gene model with location of restriction 
enzymes used for genomic Southern blot analysis. Location of the 513 bp noto probe is indicated (dark 
lines). The predicted and recovered alleles are shown. (e) Southern blots of F1 Tg(noto-2A-RFP) 
individuals hybridized with RFP probe. F1 from founder F0#1 contain a ~2100 bp band corresponding to 
integration plus deletion of ~400 bp in noto. F1 progeny from founder F0#2 show two bands: a ~3700 bp 
band corresponding to integration of the reporter plus 2000 bp of vector backbone, and a ~1500 bp band 
which may represent an off-target integration. Loading controls (10, 1) correspond to 10 copies or 1 copy 
of RFP containing plasmid. WIK, wild type control DNA. (f) Southern blot in (d) stripped and re-hybridized  
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Figure 4 continued: 
with the noto-specific probe. A 1342 bp band representing the wild type allele was detected in all 
individuals. The integration allele in F1s from F0 #1 was not detected due to deletion of the region 
containing the probe. F1s from F0 #2 contain the ~3700 bp band corresponding to the noto-2A-RFP 
integration allele. 
Figure 5. Deletion tagged alleles created with the GeneWeld strategy in zebrafish somatic tissue. 
(a) Schematic for Gal4VP16 reporter integration to tag a deletion allele of rb1 exons 2-4 (top) and rb1 
exons 2-25 (bottom). Arrowheads designate CRISPR/Cas9 DSBs. CRISPR gRNAs in two exons are 
expected to excise the intervening genomic DNA. The targeting vector contains a 5’ homology arm 
flanking the upstream exon target site and a 3’ homology arm flanking the downstream exon target site. 
(b-c) Live confocal image of F0 Tg(UAS:mRFP)tpl2 embryo after 2A-Gal4VP16 deletion tagging rb1 exons 
2-4 (b, b’) and rb1 exons 2-25 (c, c’). (d) Schematic for 2A-Gal4VP16 deletion tagging of msna exons 2-6.  
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Figure 5 continued: 
 (e, e’) Live confocal image of F0 Tg(UAS:mRFP)tpl2 embryo after 2A-Gal4VP16 deletion tagging at msna 
exons 2-6. (f) Somatic reporter efficiency of targeted deletion tagging using 48 bp homology arms for rb1 
exons 2-4, rb1 exons 2-25, and msna exons 2-6. Data represents mean +/- s.e.m. of 4 (rb1) and 5 (msna) 
independent targeting experiments. Scale bars 200 µm (b, c, c’, e); 100 µm (b’, e’). 
Figure 6. HMEJ-based targeted integration with UgRNA-based vectors promotes efficient knock-in 
in porcine fibroblasts and human K-562 cells. (a) Strategy for integration using HMEJ and HR donors 
into intron 1 of S. scrofa ROSA26 locus. Arrowheads CRISPR/Cas9 (for HMEJ donor) and TALEN 
(genome) DSBs. (b) Targeting efficiency of the HMEJ donor vs the HR donor as reported by GFP positive  
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Figure 6 continued: 
colonies out of total colonies. (c) Percent of GFP positive colonies analyzed containing properly sized 
junction fragments, comparing HMEJ and HR donors. Data are from three independently targeted cell 
populations. Data represents mean +/- s.e.m. of 3 independent targeting experiments. (d) Diagram of HR 
and HMEJ strategies for targeted integration of a MND:GFP reporter cassette into the human AAVS1 
locus. (e) Flow cytometry analysis of GFP expression 14 days post-electroporation for each targeting  
modality: HR (left), HMEJ without universal sgRNA (middle), and HMEJ with universal sgRNA (right). 
Stable gate was drawn to measure the uniformly expressing population formed by targeted integration 
and was set based on episome only controls. (f) Quantitation of stable GFP expressing population as 
measured by flow cytometry at day 14. Data are from three independently targeted cell populations. Data 
represents mean +/- s.e.m. of 3 independent targeting experiments. p values calculated using two-tailed 
unpaired t-test.
 
Supplemental Figure 1. 
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Supplemental Figure 1 continued: 
Supplemental Figure 1. Short homology to the noto gene from a single homology arm 5’ to the 
gRNA target site targets integration in zebrafish embryos. (a) Schematic for noto homology arm and 
donor vector design. gRNA is the noto non-coding template strand. Black bars represent 12, 24, and 48 
bp homology arms. PAM sequences are underlined. (b) Targeting efficiency of 12, 24, and 48 bp noto 5’ 
only donors. Data represents mean +/- s.e.m. of 3 independent targeting experiments. p values calculated 
using two-tailed unpaired t-test. (c) Live confocal image of noto-2A-TagRFP-CAAX-SV40 targeted embryo 
showing specific RFP expression in the notochord. Scale bar = 100 µm. (d) Sanger sequencing of cloned 
5’ junction fragments from RFP positive F0 embryos, aligned to the expected sequence from a precise 
integration event. 
Supplemental Figure 2. Single base pair differences in homology arm length 5’ to the Cas9/gRNA 
cut site influence integration frequencies in zebrafish embryos. (a) Schematic for targeting 2A- 
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Supplemental Figure 2 continued: 
TagRFP-CAAX-SV40 into noto exon 1 with 5’ homology to the Cas9/gRNA cut site containing 47, 48, or 
49 bp of homology. (b) The frequency of injected zebrafish embryos displaying notochord RFP 
expression after targeting noto exon 1 with donors containing 47, 48, or 49 bp of 5’ homology. Data 
represents mean +/- s.e.m. of 3 (47 bp, 49 bp) or 7(48 bp) independent targeting experiments. p values 
calculated using two-tailed unpaired t-test. 
Supplemental Figure 3. The Universal gRNA (UgRNA) promotes high efficiency targeted 
integration. (a) Universal gRNA (UgRNA) sequence. Cas9 PAM underlined. (b) Schematic showing the 
sequence of UgRNA in the targeting domain of the knock-in cassette. Sequence in green from the noto 
gene is the engineered homology in the donor vector for HMEJ. The Cas9 PAM is underlined. (b) 
Frequency of injected embryos displaying RFP expression in the notochord compared to total injected 
embryos following noto targeting using UgRNA to liberate the homology in the donor. 
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Supplemental Figure 4. Integration of Gal4/VP16 amplifies signal of targeted tyr. (a) PCR of 5’ 
junction fragments and sequencing results from junction fragments between the pGTag vector and the tyr 
locus amplified from randomly selected RFP negative embryos after injection with GeneWeld reagents for 
targeting tyr with 2A-tagRFP-CAAX-SV40pA. Most F0 injected zebrafish contain the expected 5’ junction 
fragment (marked with an ‘*’). The junction fragments from F0-1 and -2 were isolated for sequencing, and 
precise integrations were observed (b) Efficiency of 5’ homology integration to target RFP or GAL4/VP16 
into tyr and detect RFP expression. Data represents mean +/- s.e.m. of 3 independent targeting 
experiments. p values calculated using two-tailed unpaired t-test. 
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Supplemental Figure 5. GeneWeld targeting efficiency comparison. Comparison of the frequency of 
RFP expressing embryos after targeting esama exon 2 using GeneWeld 24/24 bp homology, Geneweld 
1kb/1kb homology, Circular HR 1kb/1kb (injection did not include UgRNA), Linear HR 1kb/1kb (donor was 
linearized before injections). Increasing the length of the homology arm to 1kb significantly increased the 
frequency of RFP expressing embryos using GeneWeld (p=0.0001), Circular, or Linear template. Data 
represents mean +/- s.e.m. of 3 independent targeting experiments. p value calculated using Students t 
test. 
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Supplemental Figure 6. 
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Supplemental Figure 6. Sequence of PCR junction fragments amplified from genomic DNA from 
F1 transgenic zebrafish adults generated by GeneWeld targeted integration. Precise integration at 
the 5’ and 3’ ends in F1 progeny from F0 founder fish targeted at tyr, esama, flna, msna, aqp1a1, and 
aqp8a1. noto F1 progeny from founder #1 had a precise 5’ junction and imprecise 3’ junction. noto F1 
progeny from founder #2 had 5’ precise junction; no 3’ junction was amplified by PCR. Lowercase letters  
represent “padding” nucleotides used to bring homology in frame of the coding region based on Cas9 cut 
site. Red letters represent mismatches unless otherwise noted below. esama F1 3’ junctions contain a 
single nucleotide variant shown in red. One esama F1 3’ junction included a 20 bp insertion (strike-
through). 
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Supplemental Figure 7. Sequences of 5’ and 3’ junction fragments from rb1 exon 2-4, rb1 exon 2-
25, and msna exon 2-6 deletion tagged alleles in F0 injected embryos. Detection of precise and 
imprecise 5’ and 3’ junction fragments in somatic tissue of F0 embryos targeted with two guides targeting 
two exons and a pGTag-Gal4VP16 donor with 5’ and 3’ homology arms corresponding to the 5’ exon and 
3’ exon target sites. Cloned PCR amplicons were sequenced from 3 individual embryos for each targeted 
deletion tagging experiment. 
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Supplemental Figure 8. HMEJ-mediated targeted integration of an MND:GFP reporter at the AAVS1 
locus in human K-562 cells. FACs sorted percent of GFP+ cells out of total K-562 cells at day 7, 21, 28, 
and 50. (b) Summary data for percent of stable GFP+ K-562 cells from day 7, 14, 21, and 28. (b’)  
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Supplemental Figure 8 continued: 
Summary data for percent of total cells GFP+ from day 7, 14, 21, 28, and 50. Data represents mean +/- 
s.e.m. of 3 independent targeting experiments. p values calculated using two-tailed unpaired t-test. 
Supplemental Figure 9. Direct sequencing of 5’ junction PCR products derived from three 
independently targeted bulk cell populations. (a) Direct sequencing of 5’ junction PCR products 
derived from three independently targeted bulk cell populations. 48 bp HMEJ homology region and 
remainder of genomic AAVS1 gRNA are indicated. Genomic sequence is directly left of the 48 bp HMEJ 
region and vector sequence is directly to the right of the AAVS1 gRNA cut site.  
58 
 
TABLES 
Table 1. Germline transmission of zebrafish GeneWeld GTag integrations. 
 
Genomic 
target 
 
Exon 
 
Homology F0 expression F0s transmitting 
Germline 
transmission 
percentage 
 
noto  
 
E1 
 
24/24 
 
24% 
 
3/5 
 
60% 
tyr   E4 24/24 64% 3/8 38% 
cx43.4*   E2 24/24 50% 0/1 0% 
cx43.4*  E2 48/48 38% 0/4 0% 
esama E4 24/24 21% 12/18 67% 
flna E4 48/42 100% 3/4 75% 
msna  E2 48/48 55% 1/4 25% 
msna E6 48/48 26% 1/3 33% 
aqp1a1 E1 48/48 4% 2/9 22% 
aqp8a1 E1 48/48 14% 1/1 100% 
anxa2a^ E3 48/48 35% 4/4 100% 
   Total 30/61 49% 
 
F0’s raised to adulthood were outcrossed and screened for germline transmission of properly localized 
fluorescent signal. F0s transmitting/F0s outcrossed x 100 = Germline transmission percentage. F0s were 
considered screened if 75 F1 embryos were examined for fluorescence.  
*Other experiments showed cx43.4 alleles could be transmitted through the germline in 3 out 11 F0 fish 
or 27% with a similar vector (data not shown). TALEN indels of cx43.4 result in sex determination defects, 
suggesting germline defects could contribute to variable frequencies for germline transmission (data not 
shown).  
^Transmission is based on expression in the vasculature only. 
msn and flna integrations display a dominant or haploinsufficient phenotype in the F0 and F1generations. 
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Key resources table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Bacterial and Virus Strains  
NEB Stable Competent E. coli NEB CAT#C3040I 
One Shot TOP10 Chemically Competent E. coli ThermoFisher CAT#C404010 
Biological Samples   
Chemicals, Peptides, and Recombinant Proteins 
Critical Commercial Assays 
pCR4 TOPO TA Cloning Kit for Sequencing ThermoFisher CAT#K457502 
Deposited Data 
Experimental Models: Cell Lines 
Human: K562 cell line ATCC CAT# ATCC CCL-
243 
Porcine: Fibroblast cell line Recombinetics, Inc. Recombinetics, Inc. 
Experimental Models: Organisms/Strains 
Zebrafish: WIK strain ZIRC CAT#ZL84 
Zebrafish: pDB790 Balciunas Lab Upon request 
Oligonucleotides 
See Supplemental table 6 for all primers used  This paper N/A 
Recombinant DNA 
p494-2a-TagRFP-CAAX-SV40 This paper Deposited at 
AddGene 
pGTag-2A-TagRFP-CAAX-SV40 This paper Deposited at 
AddGene 
pGTag-2A-Gal4VP16-bactin This paper Deposited at 
AddGene 
pGTag-2A-eGFP-SV40 This paper Deposited at 
AddGene 
Software and Algorithms 
GTagHD This paper https://github.com/D
obbs-Lab/GTagHD 
Other 
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CHAPTER 3.  GENE TARGETING PROTOCOL FOR INTEGRATIONS WITH PGTAG 
VECTORS USING CRISPR/CAS9 
Modified from a supplemental manuscript to be submitted to Nature Protocols 
GeneWeld: A Method for Efficient Targeted Integration Directed by Short 
Homology Protocol 
Wesley A. Wierson1,8, Jordan M. Welker1,8, Maira P. Almeida1,8, Carla M. Mann1, Dennis 
A. Webster2, Melanie E. Torrie1, Trevor J. Weiss1, Macy K. Vollbrecht2, Merrina Lan1, 
Kenna C. McKeighan1, Zhitao Ming1, Alec Wehmeier1, Christopher S. Mikelson1, Jeffrey 
A. Haltom1, Kristen M. Kwan3, Chi-Bin Chien4, Darius Balciunas5, Stephen C. Ekker6, 
Karl J. Clark6, Beau R. Webber7, Branden Moriarity7, Staci L. Solin2, Daniel F. Carlson2, 
Drena L. Dobbs1, Maura McGrail1, Jeffrey J. Essner1* 
 
1.  Department of Genetics, Development and Cell Biology, Iowa State University, IA, 
USA 
2.  Recombinetics, Inc., St. Paul, MN, USA 
3.  Department of Human Genetics, University of Utah School of Medicine, UT, USA 
4.  Department of Neurobiology and Anatomy, University of Utah Medical Center, UT, 
USA 
5.  Department of Biology, Temple University, PA, USA 
6.  Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 
USA 
7.  Department of Pediatrics, Masonic Cancer Center, University of Minnesota, 
Minneapolis, MN, USA 
8.  These authors contributed equally. 
 
*Corresponding author and lead contact: jessner@iastate.edu 
Written by Jordan M. Welker, Version 6.0 
Targeting Strategy (Figure 1):  
A. Selection of a CRISPR/spCas9 target site downstream of the first AUG in 
 the gene of interest 
B. Synthesize sgRNA and spCas9 mRNA 
65 
 
C. Injection of sgRNA and spCas9 mRNA 
D. Testing for indel production/mutagenesis  
E. Design short homology arms 
F. One Pot Cloning of Homology Arms into pGTag Vectors 
G. Injection of GeneWeld reagents (spCas9 mRNA, Universal sgRNA (UgRNA), 
genomic sgRNA and pGTag homology vector) into 1-cell zebrafish embryos 
H. Examine embryos for fluorescence and junction fragments 
 
Figure 1. Targeting integration of the pGTag vectors into the 5’ region of a gene.  Upon 
CRISPR/Cas9 targeting and cutting of both the genome (with a sgRNA) and plasmid donor (with 
UgRNA), the genomic and plasmid DNA likely undergo end resection mediated by the MRN complex and 
ExoI, resulting in annealing of complementary homology arms. This promotes precise homology-directed 
integration of cargo DNA at the CRISPR/Cas9 double-strand break. 
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A. Selection of a CRISPR/spCas9 Target Site Downstream of the First AUG in 
the Gene of Interest 
1. To select a CRISPR/Cas9 target site in a 5’ exon, find and download the targeted 
gene’s genomic and coding sequences. 
a. At <ensemble.org> Search for the gene name of interest for the species of 
interest and open the Transcript page.   
b. In the left-hand side bar click on ”Exons” to find the first coding exon and initiation 
ATG. If there are alternative transcripts for the gene, make sure there are not 
alternative initiation ATGs. If there are alternative start codons, target the first 5’ 
exon that is conserved in all transcripts to generate a strong allele.  
c. Download the transcript and 5’ exon to be targeted as separate sequence files. 
d. Using ApE: <http://biologylabs.utah.edu/jorgensen/wayned/ape/> annotate the 
coding sequence with the exons. 
2. Use CRISPRScan (http://www.crisprscan.org/) (Moreno-Mateos et al., 2015) to 
efficiently identify target sites and generate oligos for sgRNA synthesis for the target 
gene. 
a. Select the “Predict gRNAs” on the lower right-hand side of the home page of the 
CRISPRScan website. 
b. Paste the 5’ exon sequence into the indicated box. If the exon is very large, start 
with a small amount of sequence. Ideally exon sequence of ~200 bp near the 
desired target site. Do not design CRISPRs to intron/exon borders. If there are 
problems with the copy and pasting of exon sequence, first paste the sequence into 
a new ape file, save, then copy and paste from the new file. 
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c. Select “Zebrafish (Danio rerio)” as the species 
d. Select “Cas9 – nGG” as the enzyme.  
e. Select “In vitro T7 promoter”. 
f. Click on “Get sgRNAs.” Examine the output. The generated targets are ranked 
by CRISPRScan from high to low. Select a target site (the 20 bp that are capitalized 
in the oligo column) from those given by CRISPRScan using the following criteria 
(The best gRNAs will have all of these): 
i. An exact match to the genomic locus., When an oligo is clicked on the 
page will display additional information to the right. In the section called “Site 
Type” any mismatches in the oligo are displayed. Exact matches including 
5’GG- are ideal for in vitro transcription and 100% genomic target match. 
ii. The target is in the desired location of the gene. 
iii. The Target is on the reverse (template) strand. Reverse strand guides are 
more favorable, but either will work 
iv. A high CRISPRScan score, and a lower CFD score. However, lower score 
sgRNA targets may work fine.  
g. Annotate the selected target sequence in the transcript sequence files. 
h. For sgRNA synthesis the entire oligo sequence from CRISPRscan containing the 
selected target will need to be synthesized. This oligo is represented as “Oligo A” in 
Figure 2. 
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Figure 2. Cloning-free gRNA synthesis. Oligo A is composed of the T7 promoter at the 5’ end, target 
sequence for gRNA, and gRNA overlap sequence for gRNA synthesis. CRISPRScan provides direct 
output for Oligo A. The strategy for gRNA production using Oligo A is based on (Varshney et al., 2015). 
3. Alternative to CRISPRScan: Designing “CRISPR Oligo A” from a genomic 
target sequence. Skip this section if Oligo A was designed with CRISPRScan.  If the 
target sequence was identified using tools other than CRISPRScan, Oligo A can be 
designed manually. (Note: CRISPRScan will use a shorter overlap region but this does 
not affect template production). Add T7 and Overlap sequences (see Figure 2) to the 20 
bp of target sequence without the PAM. Oligo A for the targeted gene will look like the 
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example below: 
5’-TAATACGACTCACTATAGGNNNNNNNNNNNNNNNNNNGTTTTAGAGC 
TAGAAATAGC-3’ 
The sequences in blue (first 17 characters) are the T7 promoter, the grey GG are part of 
the T7 promoter and ideally are part of the target sequence (see below), the Ns are the 
target sequence, and the sequence in green (last 20 characters) are the overlap region 
to synthesize the non-variable part of the sgRNA. The T7 promoter works optimally with 
the two grey GGs, however, these GGs will be transcribed by T7 and thus become a 
part of the sgRNA. Target sequences that contain the GGs may work better, but there 
are differing reports in the literature on the importance of this (Moreno-Mateos et al., 
2015). If possible, select a target that starts with GG. Refer to Moreno-Mateos et al., 
2015 for other gRNA architectures with variations on the 5’GG motif. 
a. If the target sequence did not have two Gs at the beginning, additional G’s will 
need to be added to the start of the target sequence for efficient transcription as 
outlined below: 
*The lower case ‘g’ is an extra ‘G’ not in the genomic sequence; the upper-case G is 
in the genomic. Lower case gs will not base pair with the genomic target.  
i. without GG: ggN NNN NNN NNN NNN NNN NNN N (22 bp) – 2 bases are 
 added,  
ii. with one G: gGN NNN NNN NNN NNN NNN NNN (21 bp) – one base is added, 
G is part of the target sequence. 
iii. with two G: GGN NNN NNN NNN NNN NNN NN (20 bp) – no bases are added, 
GG is part of the target sequence. 
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Oligo A is made by taking this target sequence with 5’GG and pasting it into a 
clean file. 
b. Copy and paste the T7 promoter sequence to the 5’ end of the target sequence: 
TAATACGACTCACTATA 
c. Copy and paste the Overlap sequence to the 3’ end of the target sequence: 
GTTTTAGAGCTAGAAATAGC  
d. Check the sequences to ensure they are correct and that the PAM is NOT 
present in this oligo. 
4. Oligo B design (Figure 2) contains the conserved guide RNA sequence: All Oligo 
Bs will be the same and can be ordered in large quantities.  
5’-
GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTT 
AACTTGCTATTTCTAGCTCTAAAAC-3’ 
5. To increase yield of the sgRNA synthesis the primers “T7 primer”           
(5’-TAATACGACTCACTATA-3’) and  “3’gRNA primer”            
(5’- GATCCGCACCGACTCGGTG-3’) are also required. 
6. For checking for mutagenesis at the target site, design ~20 bp DNA primers for 
PCR amplification to amplify at least 130 bp of DNA surrounding the target site. 
Mutagenesis is estimated through comparison of PCR products from injected and 
uninjected embryos, by visualizing small insertions and/or deletions (Indels) using 
electrophoresis, or by sequencing.  
a. Primer 3 is used for primer design: 
http://biotools.umassmed.edu/bioapps/primer3_www.cgi 
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b. Paste DNA sequence surrounding the target site into the web interface. It is 
recommended to use 160 – 300 bp of exon sequence centered on the cut site for 
primer design. Intron sequence can be used, but this often contains polymorphisms 
that can lead to amplification failure.  
c. Locate the target sequence, including the PAM sequence (italicied below), and 
predict the cut site (3 bp into the target sequence from the PAM represented here by 
the ‘x’). Mark the targeted exon sequence approximately 65-150 bp on both sides of 
the cut site by putting [square brackets] around it. Primer3 will design primers 
outside this sequence. This design allows the primers to be used for both checking 
of mutagenesis and for junction fragment analysis when checking for integration.  
Example:  
CGGCCTCGGGATCCACCGGCC[AGAATCGATATACTACGATGAACAGAGCAAA
TTTGTGTGTAATACGGTCGCCACCATGGCCTxCCTCGGTTTGCTACGATGCATTTG
CACCACTCTCTCATGTCCGGTTCTGGG]AGGACGTCATCAAGGAGTTCATGCGCTT
CAAGGTGCGCATGGAGGGCTCCGTGAAC 
d. Set the “Primer Size” variables to Min = 130, Opt = 170, and Max = 300. 
Everything else can be left at the defaults.  
e. Click on “Pick Primers” 
f. Select primers from the output. Note the “product size” expected and the “tm” or 
melting temperature of each primer/pair. Smaller product sizes are easier to 
visualize mutagenesis. 
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B. Synthesize the sgRNA 
General guidelines and good laboratory practices for working with DNA and RNA. 
DNA, RNA and the enzymes are sensitive to contamination from dust and skin. 
Following these guidelines will prevent the degradation of the DNA and RNA you are 
trying to make: 
 Be clean. Clean the workbench, pipetmen, racks, and centrifuges with RNase 
 Away or something equivalent. 
 Wear gloves and change when contaminated. Contamination will occur when 
gloves contact hair, face, skin, or the floor. 
 Keep everything on ice unless the protocol indicates otherwise. 
 Centrifuge components to the bottom of the tube before use, after mixing, after 
use, and after incubation steps.  
 Do not vortex enzymes. Gently flick the tube or pipet up and down to mix 
samples.  
 Avoid touching the walls of the tube when pipetting. 
 Use a new pipette tip for each new dip. 
 Dispense solutions from a pipet to the bottom of the tube, or into the liquid at the 
bottom of the tube when setting up reactions.  
 Only remove 1.5 ml centrifuge tube and PCR tubes from their package while 
wearing gloves. Reseal the tube package after tubes are removed. 
Assembly of CRISPR oligos A + B into a transcription template 
1. For synthesis of the gRNA from Oligo A and B, make a 100 μM freezer stock and 
1 μM working stock for each oligo. All oligos are described in Section A starting 
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on page 7. 
2. Centrifuge ordered oligos briefly before opening, to move all dried DNA flakes to 
the bottom of the tube. 
3. Add a volume (x μL) of RNase-free water to make a 100 μM stock. The tubes 
should be labeled with the gene name as well as the number of nmol in the tube. 
The amount of water to be added will need to calculated based on the 
nanomoles of material contained within. 
4. Vortex for 30 seconds. 
5. Centrifuge briefly. 
6. Make a 100-fold dilution of each 100 μM stock Oligo A and B in separate 1.5 ml 
tubes.  
a. Label one 1.5 mL centrifuge tube per Oligo A with name of oligo, date, and “1 
μM” to indicate working stocks. 
1 μL of 100 μM Oligo A stock or Oligo B 
99 μL of RNF-water 
100 μL total 
b. Vortex. 
c. Briefly centrifuge.  
d. Store all stocks in freezer at -20 oC for long-term storage. 
7. Set up the following reaction in PCR tubes. The next two steps will generate a 
short segment of DNA (gDNA or guideDNA Template) which will be used as a 
template for synthesis of RNA: 
12.5 μL 2X KOD Master Mix 
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1 μL Oligo A (1 μM)  
1 μL Oligo B (1 μM) 
1 uL T7 primer  (10 μM) 
1 uL gRNA 3’ primer (10 μM) 
8.5 μL RNF-water  
25 μL total 
8. Run PCR under the following conditions: 
Denature at 98°C for 2 minutes 
Denature at 98 °C for 30 sec. 
Anneal at 50 °C 30 sec. 
Extend at 70 °C 30 sec. 
Go to (step 2) nine times. 
Extend at 70 °C 2 min 
Hold 4 oC forever. 
9. Run 1.2% agarose gel in 1X TAE to check that the template was synthesized: 
a. Remove 3 μL of the reaction and place in a 1.5 ml tube.  
b. Mix in 1 μL of 6x loading buffer.  
c. Load all 4 μL of the sample on the gel. Run the gel at 125 V for 30 minutes. Be 
sure to load a molecular weight marker.  
d. Check on the transilluminator and image the gel. 
e. A single 120 bp band should be detected when 3 μL is loaded on gel.  
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In vitro transcription (IVT) using the gRNA template 
1. Use the Ambion T7 Megascript Kit for transcription reagents, but follow the 
instructions below. 
2. Thaw the T7 10X Reaction Buffer and RNF-water at room temperature, and thaw 
 the ribonucleotides solutions on ice. 
3. Vortex the T7 10X Reaction Buffer to make sure all DTT is solubilized. No white 
 flecks should be visible. 
4. Microcentrifuge all reagents briefly before opening to prevent loss of reagents 
 and/or contamination by materials that may be present around the rim of the 
 tube(s).  
5. Keep the T7 Enzyme Mix on ice or in a -20 oC block during assembly of the 
 reaction.  
6. Make a master mix for each reaction. Assemble the reaction at room temperature
 on the bench. Add reagents from largest to smallest volume, adding the 10X 
 Reaction Buffer second to last and the T7 Enzyme Mix last.  
Note: Components in the transcription buffer can lead to precipitation of the template 
DNA if the reaction is assembled on ice. If the reaction precipitates, the synthesis 
reaction will not fully occur. 
7. Reagent list: 
10 μL of RNF-water 
5 μL of gDNA template (100 to 500 ng total) 
4 μL of NTP (1 µl of each; A, U, C, G) 
1 μL of 10x transcription buffer – must be fully resuspended at room temp 
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1 μL of T7 polymerase enzyme mix 
8. Incubate at 37 oC for 4 to 16 hours. Longer incubations result in considerably 
 better yields. 
9. Add 1 μL of Turbo DNAse and incubate for 15 min at 37 oC. This will digest the 
 template DNA in the sample. 
10. Optional quality control step: Run 2 μL of sample on a 1.2% gel in 1X TAE. 
a. Clean the gel box, comb and tray with RNase Away, rinse with DI water. 
b. Remove 2 µl of sample into a clean 1.5 ml (Keep RNA on ice!) 
c. Add 3 μL of RNF-water and 5 uL of Ambion RNA loading buffer with formamide.  
d. Vortex briefly. 
e. Spin down samples briefly.  
f. Run all of this mixture on a 1.2% agarose gel/1X TAE, at 100 V for 1 hour. 
g. Image gel. 2 bands should be visible at ~100 and 120 bp. 
 Purification of guide RNA 
1. Use the miRNeasy Qiagen kit for purification of gRNAs according to the 
 manufacturer’s instructions.  
2. After Purification verify presence of RNA by running a 1.2% gel in 1X TAE. 
3. Clean the gel box, comb and tray with RNase Away, rinse with DI water. Run on 
 a 1.5% agarose gel/1X TAE, at 100 V for 1 hour as above.  
4. Image gel. 2 bands should be visible at ~100 and 120 bp. 
5. Nanodrop the RNA sample to determine the concentration.  
6. Store RNA at -20 °C. 
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Preparation of spCas9 mRNA 
1. Digest ~5-10 μg pT3TS-nCas9n plasmid with Xba1 (plasmid Addgene #46757 
 (Jao et al., 2013)). 
2. Purify digested DNA with Qiagen PCR cleanup kit or Promega PureYield Plasmid 
 Miniprep System. Elute in RNF-water. 
3. Run 100-500 ng on 1.2% agarose gel in 1X TAE to confirm the plasmid is 
 linearized. 
4. Use 100 ng to 1 μg DNA as template for in vitro transcription reaction. 
5. Use mMESSAGE mMACHINE T3 kit Life Technologies (AM1348) and follow the 
 instructions in the manual. 
6. Use the miRNeasy Qiagen kit for purification of nCas9n mRNA according to the 
 manufacturer’s instructions.  
7. Verify mRNA integrity by mixing 1 uL of purified Cas9, 4 μL of RNF water, 5 μL 
 glyoxl dye (Ambion).  
8. Heat mixture at 50 oC for 30 minutes, then place on ice. 
9. Clean the gel box, comb and tray with RNase Away, rinse with DI water. 
10. Run all 10 μL of RNA mixture on 1.2% agarose gel in 1X TAE at 100 V for 1 hour 
 as above. One band should be visible at 4.5 kb. 
11. Nanodrop the RNA sample to determine the concentration. Concentrations 
 between 0.45 and 1 μg/μL are expected.  
12. Aliquot and store RNA at -80 °C. 
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C. Injection of sgRNA and spCas9 mRNA 
The injections here are designed to deliver 25 pg of gRNA and 300 pg of Cas9 
mRNA in 2 nL of fluid to embryos at one-cell stage.  
Injection trays are cast with 1.2% agarose with 1X embryo media (Zebrafish 
Book; zfin.org) in polystyrene petri dishes (Fisher No. FB0875713). Injection trays can 
be used multiple times and stored at 4*C for up to three weeks between use. 
1. Trays are pre-warmed to 28.5 oC  prior to injection by placing them in the 28.5 oC 
 incubator.  Try to mitigate tray cooling while not in use.   
2. Glass needles are pulled from Kwik-Fil borosilicate glass capillaries (No. 1B100 
 4) on a Flaming/Brown Micropipette puller (Model P-97). 
3. Injection samples are made to contain the following diluted in RNF water or 
 injection buffer (final concentration: 12.5 mM HEPES pH 7.5, 25 mM Potassium
 Acetate, 37.5 mM Potassium Chloride, 0.0125 % glycerol, 0.025 mM DTT ph 7.5) 
a. 12.5 ng/μL of genomic gRNA 
b. 150 ng/μL of mRNA for Cas9 
4. Needles are loaded with 1.5 to 2.5 μL of sample, and then loaded onto a micro 
 manipulator attached to a micro injector (Harvard Apparatus PLI - 90) set to 30
 40 PSI with an injection time of 200 msec.  
5. Needles are calibrated by breaking the end of the tip off with sterile tweezers, 
 ejecting 10 times to produce a droplet of fluid, collecting the droplet into a 1 μL
 capillary tube (Drummond No. 1-000-0010), and measuring the distance from the
 end of the capillary to the meniscus of the droplet.  This distance is converted to
 volume (where 1 mm = 30 nL) and adjusted to achieve an effective injection
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 volume of 2 nL.  Volumes are adjusted by changing the injection time. There is a
 linear relationship between volume and time at a set pressure. Avoid injection
 times less than 100msec and over 400 msec.    
6. One cell embryos that have been collected from mating cages are pipetted from 
 collection petri dishes to the wells on the injection tray. 
7. Use the micro-manipulator and microscope to pierce the one-cell of embryos on 
 the injection tray at an angle of 30o with the needle. Inject 2 nL of sample in the
 one-cell near the center of the cell-yolk boundary. 
8. After embryos have been injected, wash them from the injection tray into a clean 
 petri dish with embryo media. 
9. Keep 20 - 40 embryos separate as uninjected controls. Treat and score the 
 control embryos in the same way as the injected embryos.   
10. At 3 - 5 hrs post injection remove any unfertilized or dead embryos from the 
 dishes. This will prevent death of the still developing embryos. 
D. Testing for Indel Production/Mutagenesis  
Phenotypic scoring of embryos 
1. The gRNA itself may be toxic to the developing embryos. Injection toxicity can be 
 estimated by the number dead embryos from a round of injection compared to
 the un-injected control dish. Count and remove any brown/dead embryos from
 injected and un-injected dishes. If there are significantly more dead embryos in
 the injected dish then the guide may be toxic, impure, or very effective at
 disrupting a required gene. Reducing the amount of guide or Cas9 mRNA
 injected may help reduce toxicity. 
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2. Score and document embryonic phenotypes on days 1 - 4 post fertilization (dpf). 
 Under a dissection microscope examine the un-injected controls and injected
 embryos, and sort the embryos into categories.  
3. Scoring categories 
o -Severe- These embryos have some parts that look like a control embryos, but 
are missing key features. Examples: embryos that lack their head, eyes, or tail, or 
embryos that have an unnaturally contorted shape or are asymmetric. 
o -Mild- These embryos appear mostly normal, but have slight defects such as 
small eyes, pericardial edema, shortened trunk/tail, or curled/twisted tails.   
o -Normal- appears normal and similar to controls. 
Digestion of embryos for isolation of genomic DNA for mutagenesis 
analysis 
Genomic DNA (GDNA) can be isolated from zebrafish embryos aged between 1 and 5 
dpf using this protocol. Embryos can be analyzed as individuals or as pools (maximum 
5) from the same injection. 
1. Dechorionate embryos, if they have not emerged from the chorion. 
2. It is recommended to screen a minimum of 3 embryos from each scoring 
 category for mutagenesis. Place each embryo, including controls, into separate
 PCR tubes. Remove as much of the fish water as possible. If needed, spin briefly
 and remove additional water.   
3. Add 20 μL of 50 mM NaOH per embryo.   
4. Heat the embryos at 95oC in a thermocycler for 15 minutes.  
5. Vortex samples for 10 seconds. Be sure that the tubes are sealed to prevent 
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 sample loss while vortexing.   
6. Spin samples down and heat for an additional 15 min at 95 oC in a thermocycler. 
7. Vortex samples and then spin the tubes down again. The embryos should be 
 completely dissolved.   
8. Neutralize the samples by adding 1 μL of 1 M Tris pH 8.0 per 10 μL NaOH.  Mix 
 by vortexing then spin down.  
9. Genomic DNA should be kept at 4 oC while in use and stored at -20oC. 
Analysis of CRISPR/Cas9 mutagenesis efficiency at targeted gene locus 
1. Set up the following PCR reactions for each tube of digested embryos using the 
 primers designed at the end of section A, page 10.   
  12.5 μL of 2x GoTaq Mastermix 
  1 μL of Forward Primer (10 uM) 
  1 μL of Reverse Primer (10 uM) 
  1 μL of gDNA template (digested embryos) 
  9.5 μL of nuclease-free water 
  25 μL total 
2. Vortex and briefly spin down the PCR reactions. 
3. Run the following PCR program to amplify the targeted locus. 
  95oC  2 minutes 
  95oC 30 seconds ] 
  55oC* 30 seconds ] x 35 cycles 
  72oC 30 seconds ] 
  72oC 5 minutes 
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  4oC hold 
 *if the primers were designed with higher or lower tm’s than the annealing 
temperature in line three, then that temperature will need to be adjusted to 2oC below 
the designed primer tm. 
4. Run up to 7 μL of PCR product on a 3.0% agarose gel, 1X TAE, for 1 hr at 80 
 100V.   
5. Analyze the gel for DNA bands that appear diffuse or different in size from the 
 control lane. This indicates that the presence of indels in the gene of interest 
6. Alternatively clone and sequence PCR products or sequence them directly to 
 verify the presence of indels. 
E. Design short homology arms 
Homology directed gene targeting allows the integration of exogenous DNA into 
the genome with precision to the base pair level. However, designing and cloning 
individual targeting vectors and homology arms for each gene of interest can be time 
consuming. The pGTag vector series provides versatility for ease of generation of 
knockout alleles (Figure 3). The vectors contain BfuAI and BspQI type II restriction 
enzymes for cloning of short homology arms (24 or 48 bp) using Golden Gate cloning. 
The pGTag vectors require in-frame integration for proper reporter gene function. The 
reporter gene consists of several parts. First, a 2A peptide sequence causes 
translational skipping, allowing the following protein to dissociate from the locus peptide. 
Second and third, eGFP, TagRFP, or Gal4VP16 coding sequences for the reporter 
protein have a choice of sequence for localization domains, including cytosolic (no) 
localization, a nuclear localization signal (NLS), or a membrane localization CAAX 
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sequence. Finally, translation is terminated by one of two different polyadenylation 
sequences (pA); a -actin pA from zebrafish or the SV40pA.  
For many genes, the signal from integration of the report protein is too weak to 
observe. In these cases, the Gal4VP16 vector allows for amplification of the report to 
observable expression levels in F0s and subsequent generations. A 14XUAS/RFP Tol2 
plasmid is provided to make a transgenic line for use with the Gal4VP16 vector.  
Sequence maps for these plasmids can be downloaded at www.genesculpt.org/gtaghd/   
 
 
 
Figure 3. The pGTag vectors allow one step cloning of homology arms.  
All vectors can be obtained through Addgene (www.addgene.org). Because the 
pGTag plasmids contain repeated sequences, they may be subject to recombination in 
certain strains of bacteria. It is strongly recommended that they are propagated at 
30oC to reduce the possibility recombination.  
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The web tool, GTagHD www.genesculpt.org/gtaghd/, allows for quick design of 
cloning ready homology arm oligos for a gene of interest. To use the tool, choose the 
"Submit Single Job" tab. Follow the instructions in the tab.  
There should be 4 oligos (two pairs that will be annealed) generated that should 
be ordered for cloning. If there are any problems with the sequences and values that 
were entered, the web page will display the errors and give advice on how to fix them. 
The following protocol describes how to design homology arm oligos manually: 
 *Note* In the following section when orientation words are used, they are used in the 
context of the reading frame of the genetic locus of interest. Example: A 5’ template 
strand CRISPR means that the target site for the CRISPR is on the template strand at 
the locus and is toward the 5’ end of the gene. Upstream homology domains are 5’ of 
the CRISPR cut and downstream homology domains are 3’ of the cut with respect to the 
gene being targeted. Also note: Upper case and lower case bases are not specially 
modified; they are typed the way they are as a visual marker of the different parts of the 
homology arms. 
For the upstream homology domain 
1)  Open the sequence file for the gene of interest and identify the CRISPR site. (In this 
example it is a Reverse CRISPR target in Yellow, the PAM is in Orange, coding 
sequence is in purple) 
Copy the 48 bp 5’ of the CRISPR cut (the highlighted section below) into a new 
sequence file; this is the upstream homology. 
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2)  Observe the next three bases immediately upstream of the 48 bp of homology, and 
pick a base not present to be the 3 bp spacer between the homology and the Universal 
PAM in the vector. (Here the three bases are “GGA” so “ccc” was chosen for the 
spacer) 
Add the spacer to the new file 5’ (in front) of the homology, see below. The spacer acts 
a non-homologous buffer between the homology and the eventual 6 bp flap from the 
universal guide sequence that will occur when the cassette is liberated and may 
improve intended integration rates over MMEJ events. 
 
3)  Determine where the last codon is in the homology. Here the 3’ G in the homology 
domain is the first base in the codon cut by this CRISPR target.  Complete the codon by 
adding the remaining bases (called padding on GTagHD) for that codon from your 
sequence to ensure your integration event will be in frame. 
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4)  Add the BfuAI enzyme overhang sequences for cloning, to the ends of the homology 
domain. 5’-GCGG and 3’-GGAT. (Here both overhangs are added to prevent errors in 
copying sequence for the oligos in the next two steps.) 
 
5)  The Upstream Homology Oligo A will be this sequence from the beginning to the end 
of the last codon (see highlighted below). Copy and paste this sequence into a new file 
and save it. In this example this oligo sequence is 5’-
GCGGcccGTTTTCTTACGCGGTTGTTGGATGAAATCTCCAACCACTCCACCTTCGtg-
3’. 
 
6)  The Upstream Homology Oligo B will be the reverse compliment of this sequence 
from beginning of the spacer to the end of the sequence (see highlighted below). Copy 
the reverse compliment, paste it into a new file, and save it. In this example this oligo 
sequence is 5’-
ATCCcaCGAAGGTGGAGTGGTTGGAGATTTCATCCAACAACCGCGTAAGAAAACgg
g-3’. 
 
For the downstream homology domain 
7)  Open sequence file for the gene of interest and identify the CRISPR site. (Reverse 
CRISPR target in Yellow, PAM in Orange, coding sequence is in purple) 
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Copy the 48 bp 3’ of the CRISPR cut into a new sequence file; this is the downstream 
homology. 
 
8)  Observe the next three bases downstream of the 48 bp of homology, and pick a 
base not present to be the 3 bp spacer between the homology and the Universal PAM 
in the vector. (Here the bases are “CTG” so “aaa” was chosen for the spacer.) 
Add the spacer to the new file 3’ of (after) the homology. 
 
9)  Add the BspQI enzyme overhang sequences for cloning, to the ends of the 
homology domain. 5’-AAG and 3’-CCG. (Here both overhangs are added to prevent 
errors in copying sequence for the oligos in the next two steps.) 
 
10)  The Downstream Homology Oligo A will be this sequence from the beginning of the 
sequence to the end of the spacer (see highlighted below). In this example this oligo 
sequence is 5’-
AAGTGGGCAAGATATGGCTCACGTTATTCATCATCTTCCGCATTGTTTTGAaaa-3’. 
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11)  The Downstream Homology Oligo B (will be the reverse compliment of this 
sequence from the beginning of the homology to the end of the sequence (see 
highlighted below). In this example this oligo sequence is 5’-
CGGtttTCAAAACAATGCGGAAGATGATGAATAACGTGAGCCATATCTTGCCCA-3’ 
 
F. One pot cloning of homology arms into pGTag vectors 
**Note if the homology arm oligos contain either the sequence “5’-ACCTGC-3’” or “5’-
GAAGAGC-3’” (or their compliments) the cloning reaction will be less efficient.  
*Note some sequences just don’t work very well. Ligation is more efficient with 
annealed homology arms and the purified ~1.2 kb and ~2.4kb fragments from 
vectors that have been digested with BfuAI and BspQI. If problems are 
encountered, one homology arm can also be cloned sequentially.  
1. Homology Arm Annealing 
 Anneal upstream and downstream homology oligo pairs separately: 
 4.5 μL oligo A at 10 µM 
 4.5 μL oligo B at 10 µM 
 4 μL 10x Buffer 3.1 from NEB 
 27 μL dH20 
 total = 40 μL 
 Incubate at 98oC for 4 min, 98oC 45 sec x 90 steps decrementing temp 
 1oC/cycle, 
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 4oC hold 
(Alternatively heat in 95-98oC water for 5 minutes, and then remove the boiling beaker 
from the heat source and allow it to cool to room temp for 2 hours, before placing 
samples on ice.) 
2. 1-Pot Digest 
 Assemble the following: 
 4.0 μL dH2O 
 2 μL Plasmid at 50 ng/uL 
 1 μL 10x Buffer 3.1 from NEB 
 1 μL 5' annealed homology arm 
 1 μL 3' annealed homology arm 
 0.5 μL BfuAI enzyme from NEB 
 0.5 μL BspQI enzyme from NEB 
 10 uL total  
 Incubate at 50oC for 1 hr, place on ice. 
3. Ligation 
  Add the following: 
 3 uL 5x T4 quick ligase buffer 
 1.5 uL dH2O 
 0.5 uL T4 quick ligase 
 15 uL total 
 Incubate 8-10 min at room temperature (to overnight). Store at -20 oC, 
4. Transformation 
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a. On ice, thaw 1 (one) vial competent cells (50 μL) for every 2 ligation reactions. 
 (approx. 5 min). It is recommended to use NEB Stable Competent E. coli 
 (C3040H) cells to limit recombination.  
b. While cells are thawing, label the microcentrifuge tubes for each ligation and put 
 on ice. 
c. Once the cells are thawed, use a pipette to transfer 25 μL of the competent cells 
 into each labeled tube.   
d. Add 1.5 μL of a ligation reaction into competent cells to transform.  
a. Amount of ligation reaction added should be less than 5% of volume of 
 competent cells. 
e. Mix by tapping the tube several times or gently mixing with the pipet tip. 
a. Do NOT mix by pipetting, this will lyse the cells. 
f. Incubate on ice for 5 to 20 minutes. 
g. Heat shock the cells by submerging the portion of the tube containing the cells in 
 a 42oC water bath for 40 - 50 seconds.   
h. Incubate cells on ice for 2 minutes. 
i. Add 125 μL of room temperature LB to each transformation. 
j. Incubate cells at 30oC for 1- 1.5 hour(s) in a shaking incubator. 
k. While the transformed cells are recovering, spread 40 μL of X-Gal solution, and 
 40 μL IPTG 0.8 M on LB Kanamycin selection plates.   
a. X-Gal is lethal to cells while wet, it is recommended to first label the plates and 
 then place them in a 30oC incubator to dry. 
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l. After recovery and the X-Gal is dry, Plate 150 μL of each transformation on the 
 corresponding correctly labeled plate. 
m. Incubate plates overnight at 30oC. 
5. Growing colonies 
Pick 3 white colonies from each plate and grow in separate glass culture tubes with 3 
mL LB/Kanamycin. 
 Or to pre-screen colonies by colony PCR: 
a. Pick up to 8 colonies with a pipet tip and resuspend them in separate aliquots of 
 5 μL dH2O. Place the tip in 3 ml of LB/Kan, label, and store at 4oC. 
b. Make a master mix for your PCR reactions containing the following amounts 
 times the number of colonies you picked. 
 7.5 μL 2x Gotaq mastermix 
 5.5 μL dH2O 
 0.5 μL primer at 10 uM “F3'-check” 5'- GGCGTTGTCTAGCAAGGAAG -3' 
 0.5 μL primer at 10 uM “3’_pgtag_seq”5'-ATGGCTCATAACACCCCTTG-3' 
 14 μL total 
c. Aliquot 14 μL of mixed master mix into separate labeled PCR tubes. 
d. Add 1 μL of colony to each reaction as template. 
e. or 20 ng purified plasmid as control. 
f. Cycle in a thermocycler 
  95oC  2 minutes 
  95oC 30 seconds ] 
  57oC 30 seconds ] x 35 cycles 
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  72oC 30 seconds ] 
  72oC 5 minutes 
  4oC hold 
g. Run 5 μL of PCR product on a 1% agarose gel. You should get bands that are a 
 different size than the control. 
6. Mini Prep Cultures 
 Follow Qiagen Protocol 
7. Sequencing of Plasmids 
The 5’ homology arm can be sequenced by the 5'_pgtag_seq primer:  
5'-GCATGGATGTTTTCCCAGTC-3’. 
The 3’ homology arm can be sequenced with the “3’_pgtag_seq” primer:  
5'-ATGGCTCATAACACCCCTTG-3'.  
G. Injection of GeneWeld reagents (spCas9 mRNA, universal sgRNA (UgRNA), 
genomic sgRNA and pGTag homology vector) into 1-cell zebrafish embryos 
 Prepare and collect the following reagents for injection 
1. Prepare nCas9n mRNA from pT3TS-nCas9n (Addgene #46757 from (Jao et al., 
 2013)) as described above (page 14). 
2. Synthesize UgRNA and purify as described above (page 11) using the following 
 oligo A: 
5’-
TAATACGACTCACTATAGGGAGGCGTTCGGGCCACAGGTTTTAGAGCTAGAAATAG
C-3' 
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 Corresponding to the universal target sequence: 
GGGAGGCGTTCGGGCCACAG 
 Alternatively, the UgRNA can be directly ordered form IDT and resuspended in 
RNF water.  
5’-
GGGAGGCGUUCGGGCCACAGGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAG
GCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCGGAUC-3’  
3. The pGTag homology vectors should be purified a second time prior to 
 microinjection under RNase free conditions with the Promega PureYield Plasmid 
 Miniprep System beginning at the endotoxin removal wash and eluted in RNF 
 water. 
 Embryo injections for integration of pGTag vectors 
 Injections are performed as previously described in 2 nl per embryo with the 
addition of the UgRNA and targeting pGTag DNA.  
Final per embryo:     Injection mixture: 
150 pg of nCas9n mRNA      75 pg/nl of nCas9n mRNA 
  25 pg of genomic gRNA    12.5 pg/nl of genomic gRNA 
  25 pg of UgRNA     12.5 pg/nl of UgRNA  
  10 pg of pGTag DNA        5 pg/nl of pGTag DNA  
H. Examine embryos for fluorescence and junction fragments 
 Embryos are examined for fluorescence under a Zeiss Discovery dissecting 
microscope with a 1X objective at 70-100X magnification. If weak signals are observed, 
embryos are manually dechorionated, and viewed on glass depression well slides. If no 
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or weak signals were observed, Gal4VP16 integrations are attempted in a 14XUAS-
RFP background. Embryos displaying widespread fluorescence in expression domains 
consistent with the targeted gene are examined for junction fragments or raised to 
adulthood for outcrossing. 
 F0 Junction fragment analysis between the genomic locus and the targeting 
vector is carried out by isolating DNA from embryos followed by PCR. The following 
primers are used for junction fragment analysis and must be paired with gene specific 
primers (5’ to 3’): 
5’ pGTag junctions: 
R-Gal4-5'juncM  GCCTTGATTCCACTTCTGTCA    
R-RFP-5'junc CCTTAATCAGTTCCTCGCCCTTAGA 
R-eGFP-5'-junc  GCTGAACTTGTGGCCGTTTA 
3’ pGTag junctions:  
F-Gal4-3'juncM  GCAAACGGCCTTAACTTTCC   
F-Gal4-3'juncJ  CTACGGCGCTCTGGATATGT 
F-RFP-3'junc  CGACCTCCCTAGCAAACTGGGG 
F-eGFP-3'junc  ACATGGTCCTGCTGGAGTTC 
 PCR amplification of junction fragments can be a result of artifacts (Won and 
Dawid, 2017), so it is important to carryout control amplifications with injected embryos 
that lack the genomic gRNA. F0 analysis by PCR of junction fragments is carried out to 
examine correct targeting. F-Gal4-3'juncM and F-Gal4-3'juncJ are two alternate primers 
for amplification of junction fragments from the Gal4 cassette due to gene specific mis-
priming depending on the target loci. 
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 7.5 μL 2x Gotaq mastermix 
 5.5 μL dH2O 
 0.5 μL primer at 10 uM genomic primer 
 0.5 μL primer at 10 uM pGTag primer 
 14 μL total 
1. Aliquot 14 μL of mixed master mix into separate labeled PCR tubes. 
2. Add 1 μL of genomic DNA to each reaction as template. 
3. Cycle in a thermocycler with the following steps: 
  95oC  2 minutes 
  95oC 30 seconds ] 
  55oC 30 seconds ] x 35 cycles 
  72oC 30 seconds ] 
  72oC 5 minutes 
  4oC hold 
4. Run 5 μL of PCR product on a 1.2 % agarose gel in 1XTAE. Putative junction 
 fragments should give bands that are of predicted size. 
 F0 animals that are positive for the reporter gene are raised to adults then 
 outcrossed and examined for fluorescence as above. The Gal4VP16 system can 
 lead to silencing resulting in mosaic patterns in F1 embryos. F1 embryos 
 displaying fluorescence are examined for junction fragments as above, raised to 
 outcross to make F2 families or sacrificed at 3 weeks post fertilization for 
 Southern-Blot analysis of integrations. F0 and F1 identified fish can be incrossed 
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 or backcrossed to get an initial impression of the homozyogous phenotypes. It is 
 recommended that lines are continuously outcrossed once established. 
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In Brief  
 Welker et al. describe a vector tool set called pPRISM (plasmid for PRecise 
Integration with Secondary Markers) for efficiently engineering precisely targeted knock-
in alleles in zebrafish using short regions of homology.  These new vectors provide 
flexibility in the modification of the target locus by introduction of premature translational 
stop codons, 3’ in-frame fusions with RFP for visualizing protein localization, or the 
knock-in of RFP or Gal4/VP16 to follow the expression of the targeted locus.  
Additionally, these tools allow for the generation of tagged alleles with tissue specific 
expression of fluorescent proteins in either the heart or lens of the eye as secondary 
markers for visual genotyping of isolated lines. Using these vectors with engineered 
short homology to a CRISPR/Cas9 cut site in the targeted locus, high rates of somatic 
fluorescent protein gene expression (44.2%) and subsequent germline transmission 
(28.0%) of targeted knock-in alleles were observed.  
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Abstract 
 Previous work has utilized homology mediated end joining (HMEJ) for creating 
knock-ins in zebrafish at sites of directed DNA double-strand breaks (Hisano et al., 
2016 and Wierson et al., 2018). Here, we provide a suite of vectors, pPRISM plasmids 
or ‘plasmids for PRecise Integration with Secondary Markers’, that use short regions of 
homology for precise DNA integration at a CRISPR/Cas9 genomic double strand break 
(DSB).  The pPRISM vectors provide a variety of options for different knock-in cassettes 
to follow gene expression or mutate the targeted locus. Modification of the targeted 
locus is achieved by precise integration of one of four primary reports; a 2A-fusion of 
Tag-RFP or Gal4/VP16, introducing stop codons in all three frames to generate null 
alleles of the targeted locus, or a 3’ RFP fusion.  By using pPRISM vectors to engineer 
a 3’ fusion to monomeric (m) mRFP both expression of a targeted locus and localization 
of the targeted protein product can be visualized.  The inclusion of a secondary 
fluorescent reporter expressed from either a cardiac or lens promoter enables the 
targeted allele to be followed when generating knock-ins. This suite of vectors also 
contains type IIS restriction enzyme sites for Golden Gate cloning of the short homology 
arms and optimized gRNA sites for creating double strand breaks adjacent to the 
homology arms in the reporter cassette.  The vector suite provides flexibility for creating 
knock-in alleles with different functionalities while being able to easily keep track of each 
allele with secondary fluorescent reports in the heart or lens.  We observed somatic 
fluorescent expression from the heart or lens in 44.2% of the injected embryos when 
following the GeneWeld protocol using pPRISM vectors, and 28.0% of positively 
selected embryos transmitted alleles to the next generation. We anticipate this 
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expanded vector suite and the updated functionality for the online tool for homology arm 
design will enhance in vivo functional studies and diversify the utility of short homology 
directed gene editing. 
Keywords 
CRISPR/Cas9, knock-in, homology mediated-end joining, targeted integration, 
zebrafish, visual genotyping 
Introduction 
 With the advent of CRISPR/Cas, making double strand breaks (DSB) at precise 
regions of interest has allowed for the generation of a multitude of new mutants in 
model organisms (Ablain et al., 2015, Singh et al., 2015, Ma et al., 2016).  In addition to 
generating insertion and deletion mutants (indels), CRISPR/Cas has been used to 
create knock-in alleles using various DNA cargos (Hisano et al., 2016 and Wierson et 
al., 2018).  By cloning short stretches of homology matching the sequence surrounding 
a genomic DSB created by CRISPR/Cas into a donor plasmid, exogenous DNA can be 
efficiently and precisely integrated into a target genome.  Here, we describe a series of 
donor vectors, pPRISM or ‘plasmids for PRecise Integration with Secondary Markers’ 
that in addition to modifying gene product from a targeted locus are useful for visually 
following the resulting knock-in alleles through a tissue specific report included on the 
integration cassette. 
We show the functionality of using the pPRISM vectors utilizing the GeneWeld 
integration strategy with short 24-48 bp homology domains to generate knock-ins in 
zebrafish (Wierson et al., 2018).  GeneWeld integration is driven by inducing 3 DSBs; 
one in the genome and two on the donor vector containing short homology arms.  This 
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double cut strategy has been used in a variety of organisms to achieve high rates of 
integration (Wierson et al., 2018). The CRISPR mediated DSBs on the donor vector 
generate 2 homologous ends at the 5 and 3’ end of the cargo that likely drive precise 
integration into the genome through a homology mediated end joining pathway (HMEJ).  
In addition to the high somatic and germline transmission observed using this strategy, 
the advantages of using short homology domains compared to long homology domains 
(>500 bp, Zhang et al., 2017) for HMEJ strategies include simplicity of cloning and the 
ability to utilize sequence conservation in exon sequences between different inbred 
lines. 
There are multiple ways of modifying a target gene; including but not limited to 
inducing frame shift mutations through indels, to introduction of amino acid changes 
through single nucleotide polymorphisms (SNPs), to changing the gene product to a 
completely different protein.  Here, we define modification of the target locus as any 
mutation that is induced by a targeted DSB and is endogenously repaired resulting in 
altered coding sequence where expression is still driven by the endogenous promoter.  
We note that given reported differences between morpholino and indel phenotypes of 
some loci that modifying a locus by generation of an indel may be insufficient to act as a 
null allele for the purposes of phenotype analysis.  This may be due to upregulation of 
closely related genes (Rossi et al 2015), or by altered splicing around the indel (Mou et 
al 2017).  Modification of a target locus by exogenous DNA integration may prevent 
such complications by inclusion of in-frame termination and poly-A sequences.  Knock-
in alleles generated with pPRISM donors can modify target loci in four primary ways, 
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either by addition of a fluorophore to the target, or by integration of stop codons in each 
frame.  
Furthermore, unlike the non-insignificant time expenditure of keeping track of 
indel alleles, pPRISM knock-in alleles can be tracked by either endogenous expression 
of a fluorophore or by inclusion of a separate tissue specific promoter driving expression 
of a fluorophore from the same integrated cassette (referred to as secondary or 
transgenesis markers).  Following the example set by the transposon community for 
following isolated transgenics (Kwan, 2007), the pPRISM vectors utilize secondary 
markers to allow for tracking knock-in alleles with a method we refer to as “visual 
genotyping”, where the genotype can be inferred by visualization of the presence or 
absence of secondary markers included in the pPRISM cassette.   
Additionally, an update to the online design tool at the Gene Sculpt Suite 
(www.genesculpt.org/gtaghd/) allows for automated design of pPRISM compatible 
homology domains for Golden Gate cloning with the pPRISM vectors.  We show that 
efficiency of pPRISM integration is comparable to the pGTag vector series (28.0%, 
28/100 of F0 animals transmitted pPRISM alleles through the germline) and that using 
pPRISM vectors null alleles can be generated. These tools provide an enhanced tool 
set to generate precise knock-in alleles for a multitude of reverse genetics experiments, 
as well as provide a solution for quickly genotyping new generations without the need 
for screening by PCR.   
Design 
 pPRISM vectors were designed to be compatible with the GeneWeld targeted 
knock-in strategy described by Wierson et al., 2018.  The GeneWeld method utilizes co-
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injection of genomic guide RNA (gRNA), mRNA for expression of Cas9, a donor vector 
with short homology to the genomic target site, and unique guide RNA (UgRNA) with no 
known off targets in zebrafish for induction of precise genomic integration.  The UgRNA 
target sequence exists twice on the donor vector, once on either side of the integration 
cassette, and cleavage of these sites liberates the cassette and exposes of the 
homology arms for backbone free integration (Fig 1).  The cassette used in pPRISM 
vectors is adapted from a gene-break transposon vector (Clark et al. unpublished).  On 
either side of the cassette are type IIS restriction enzyme sites which enable Golden 
Gate directional cloning compatibility.  The cassette itself has dual-functionality resulting 
from two functional units which are referred to as the ‘primary report’ and the ‘secondary 
report’.   The primary report is used to modify the endogenous locus, and the secondary 
report is used to visually track animals that have integrations or to visually genotype 
animals carrying known alleles. 
 The primary report (Fig 1) is composed of a short linker, a coding sequence 
(CDS) for a fluorescent protein, and a strong termination poly-A sequence from the 
ocean pout (Zoarces americanus, Gibbs et al., 2000).  There are 4 different primary 
reports: 
 First, we describe the use of the plasmids containing the CDS for TagRFP as the 
primary report.  When the TagRFP CDS is integrated in frame into a target locus, it is 
expressed at endogenous levels linked to any upstream sequence through the short 
linker sequence for 2A peptide from porcine teschovirus-1 (Kim et al., 2011).  This is 
used to separate the endogenous protein peptide from the report protein and can be 
used to visualize cells expressing the target gene. Additionally, depending on the region 
104 
 
of the target locus this cassette is integrated into, these plasmids are predicted to 
generate null alleles.  We refer to vectors with this primary report pPRISM-2A-RFP, or 
the resultant knock-in as a 2A-RFP allele. 
 Second, we describe the use of the plasmids containing the CDS for Gal4/VP16 
as the primary report.  A target locus can be made to express the transcriptional 
activator Gal4/VP16 following precise in frame integration to the endogenous sequence 
with the 2A linker. This linker separates the remaining endogenous coding sequence 
from the Gal4/VP16 protein sequence.  This report can be used in systems containing 
the UAS system (Scheer et al.,1999, Balciuniene et al. 2013) to activate a fluorescent 
report which is useful for visualizing cells expressing targets at low endogenous levels. 
Additionally, depending on the region of the target locus this cassette is integrated into, 
these plasmids are predicted to generate null alleles.  We refer to vectors with this 
primary report pPRISM-Gal4, or the resultant knock-in as a Gal4 allele. 
  Third, we describe the use of the plasmids containing the CDS for mRFP as the 
primary report.  This cassette links mRFP to target loci via a glycine rich flexible linker 
sequence.  This protein fusion links the target gene product to monomeric (m) RFP.  
These vectors are intended to be used to make 3’ fluorescent tags of the endogenous 
protein, allowing for visualizing the cellular localization of the endogenous protein 
without interrupting gene function.  We refer to these vectors with the name pPRISM-
Fuse and to the alleles made with this cassette as Fuse alleles. 
 Fourth, we describe the use of the plasmids containing a 3x3 stop codon in place 
of the primary report.  The linker for these cassettes is made only of the codons that 
overlap the type IIS cloning site. We designed the 3x3 stop codon de-novo based on 
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two design constraints identified in the literature.  The 3x3 stop codon itself consists of 
nine stop codons arranged so that three are present per frame in tandem to ensure 
good signal (Liang et al., 2005) and so that the bases following each stop codon are 
optimal for termination (Poole et al., 1995).  We predict this 3x3 stop sequence to not 
activate the nonsense mediated decay (NMD) pathway due to its distance to the 
following ocean pout termination/poly-A sequence.  NMD is important for inducing 
genetic compensation through transcriptional adaptation (El-Brolosy et al., 2019, Ma et 
al., 2019) and we predict alleles made with these plasmids are able to prevent genetic 
compensation due to stabilization of the mRNA.  This would make these plasmids ideal 
for generating null alleles or for generating alleles where it is desirable to not express 
exogenous fluorophores in cells of interest.  We refer to these vectors at pPRISM-Stop 
and the resulting knock-in alleles as Stop alleles. 
 The secondary report (Fig 1) is composed of a short promoter, a mini-intron, a 
coding sequence with a nuclear localization signal, and a transcriptional termination and 
poly-adenylation (polyA) sequence. The promoter is either gamma crystallin (ꝩ-cry) 
which drives tissue specific expression in the lens of the eye (Yang et al., 2005) or 
cardiac myosin light chain (cmlc2) which drives tissue specific expression in the heart 
(Boecker et al. 2004). The mini-intron is the same for all six variations and was shown to 
enhance robust expression (Clark et al., 2011).  There are three secondary colors Tag-
BFP, mRFP, or eGFP, which can be paired with either of the two promoters.  This 
makes for six possible secondary reports, allowing for up to six visually distinct alleles to 
be generated at a single locus or for distinguishing multiple loci and/or alleles.  This can 
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be used to quickly identify and sort homozygous animals, trans heterozygous, and 
heterozygous animals from crosses between pPRISM knock-in alleles. 
 Between the 4 primary reports and the 6 secondary reports there are 24 vectors 
available in this tool set. The web tool design at <www.genesculpt.org/gtaghd/> has 
been updated with algorithms for OCYRUS-C (Oligonucleotide deCYner for Rigorous 
Integration of Specialized Cassettes) to allow for computationally generated homology 
arm oligos with overhangs for cloning into pPRISM vectors. Additionally, for pPRISM-
Fuse vectors it is recommended to include the remainder of coding sequence from the 
site of the genomic CRISPR DSB to the last codon before the stop codon.  Including the 
remainder of this sequence is necessary to maintain the full C-terminus of the 
endogenous protein.  When using pPRISM-Fuse, adding all exonic sequence 
downstream of the genomic CRISPR DSB without any base changes will introduce both 
a genomic CRISPR guide target in the donor vector as well as an unintended 
complimentary target that the 3’ homology arm can bind.  To prevent these 
consequences OCYRUS-C can automatically compute long oligos that contain 
homology sequence linked to the remaining coding sequence.  These long oligos will 
automatically have any codons that overlap with the genomic CRISPR target and the 3’ 
homology arm shuffled and will destroy any reconstituted protospacer adjacent motifs 
(PAM) that correspond to unwanted CRISPR targets in the donor.  Codons are shuffled 
(the wobble bases are adjusted) to give the same final protein sequence with 
consideration for the codon usage of the target species (Nakamura et al., 2000), while 
disrupting the genomic CRISPR target, and avoiding the addition of any type IIS 
restriction sites in the computed oligo.  The update also includes the option to add a 
107 
 
unique restriction site to the shuffled region for ease of genotyping fuse alleles by 
restriction digestion of short PCR amplicons.  These longer oligos can be ordered as 
output by the tool and used the same as the homology arm oligos previously described 
for annealing (Wierson et al., 2018) or they can be ordered as geneblock sequences for 
use with pPRISM-Fuse to alleviate design constraints for tagging gene products with a 
3’ fluorescent tag.  A geneblock is the full double stranded sequence of the desired oligo 
synthesized de novo.  When ordering geneblocks, the following sequences should be 
added to either end to reconstitute the BfuAI recognition sites for digestion: 
5’acctgccaca and 3’acacgcaggt. 
Results 
Validation of Report Function 
 To validate that each of the primary and secondary reports function, clones 
containing short homology to the targeted gene were generated and injected with the 
UgRNA, the targeting gRNA and nCas9n mRNA.  Each fluorescent primary report was 
tested for at least two loci and expression of the fluorescent report was verified by 
florescent microscopy in the predicted cell types (Fig. 2).  In the case of pPRISM-Stop 
constructs, F0 animals following injection were tested for precise integrations by 
junction fragment analysis of animals displaying the secondary report.   Following 
transmission of each kind of allele, transmitted alleles were verified in F1 animals by 
junction fragment analysis on either side of the integrated cassette.   
For each secondary report, because these promoters are widely used in the 
literature, functionality was confirmed for at least one locus for each color to ensure that 
they work as part of the pPRISM cassettes.  The pPRISM knock-in alleles containing 
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the ꝩ-cry promoter driving expression of a fluorescent report in the lens of the eye were 
screened on day three post fertilization (dpf) and confirmed to have the expected 
fluorophore expressed in the lens tissue (Fig. 2).  For the pPRISM knock-in alleles 
containing the cmlc2 promoter driving expression of a fluorescent report in the heart 
were screened on day two or three and imaged on day three confirming expression of 
the expected fluorophore in heart tissue (Fig. 2). 
Somatic Expression of Primary and Secondary Reports  
 The overall somatic efficiency of pPRISM expression of primary and secondary 
reports in F0 injected embryos was 44.2% for six genes, which included cx30.3 and 
cx43.4 gap junction proteins, msna and vegfaa genes involved in vascular development, 
and myo7aa and nf2b genes involved in hearing loss.  These fluorescent reports may 
reflect both precisely integrated and extrachromosomal expression of the injected 
vectors (data not shown).  This average can be broken down to the average efficiency 
of fluorescence expression from the primary report following injection (61.9% at cx43.4) 
and expression of the secondary report (42.8% averaged across five loci) (Table 1).  
Germline Transmission Frequency  
 Animals displaying both the primary report and the secondary report, or in the 
case of Stop alleles animals only expressing the secondary report, were raised to 
adulthood.  Adults were outcrossed and the resulting embryos were screened for both 
reports. We found a germline transmission efficiency of 33.8% (28 founders transmitted 
a knock-in allele out of 100 screened animals, percentage was measured by averaging 
the transmission rates across 11 loci, Table 2).   
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Visual Genotyping 
To verify that multiple pPRISM alleles can be distinguished when crossed, two 
isolated lines of pPRISM-Stop alleles at the locus myo7aa were crossed.  One line 
contained the secondary report ꝩ-cry GFP and the other contained cmlc BFP.  On 3 dpf 
embryos were screened for both secondary reports and the expected ratios of four 
classes of embryos were observed in the expected ratios (Fig 3).  
Functional Effect of Knock-in Alleles 
 To verify that a knock-in allele can be used as a null, isolated knock-in allele 
phenotypes were compared to MO phenotypes and to indel allele phenotypes at the 
same locus.  We found that for the locus msna, embryos homozygous for a pPRISM-
Stop allele develop vascular defects and cardiac edema starting around 3 dpf. This is 
consistent with the phenotype observed in MO knockdown of msna (Wang et al., 2010), 
and unlike the indel phenotype where no abnormalities were observed (data not 
shown).   
Discussion 
 Precision in genetic engineering has the potential to become an essential 
technique for both basic research and for practical application in biological fields.  The 
pPRISM vector suite improves accessibility of precise genome editing by providing 
vectors where cloning short homology arms is quick and straightforward. The vectors 
provide several ways to make null alleles and visualize expression without further 
cloning steps, and pPRISM alleles can be visually genotyped for ease of tracking of 
alleles and animal husbandry. 
110 
 
 Expression of primary reports requires in-frame integration, thus knowing the 
expected frame of the cut by a given CRISPR target is the responsibility of the 
researcher.  Even though all CRISPR sites are not in frame, an integrated exogenous 
DNA sequence can be made to be in frame by adding bases at the 3’ end of the 
homology arm to fill out or ‘pad’ the cut codon.  The online homology arm design tool 
OCYRUS-C can predict the frame when referencing ensemble.org and provide the 
necessary bases for the padding nucleotides or otherwise pick suitable bases when a 
known number of padding bases is indicated. 
 pPRISM-2A-RFP and pPRISM-Gal4 vectors can all be used to generate null 
alleles by targeting close to the 5’ end of a target gene.  With each of these kinds of 
alleles the mRNA from the locus generates two separate peptides. The first is a short 
peptide, a truncated portion of the normal protein.  So long as this peptide is not a 
functional domain on its own, it should have no effect on cell function.  The second 
peptide is the fluorophore or transactivator separated from the endogenous peptide by 
the action of the 2A peptide.  Likewise, null alleles generated with pPRISM-Stop vectors 
will only produce a small peptide up to where the integration is targeted.  Because these 
integrations generate a peptide from partial endogenous sequence, it must be noted 
that in cases where the integration is targeted to more 3’ regions of the gene, the 
endogenous peptide may give a dominant negative phenotype.  In this way other alleles 
of interest may be generated depending on the target locus and the location of the 
CRISPR DSB.  
 Fuse alleles generated with pPRISM-Fuse need not be targeted to the 3’ end of a 
gene, though it is recommended.  Because the remainder of the coding sequence can 
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be added directly to the cassette, genes with few efficient CRISPR target sites near the 
3’ end can be targeted closer to the 5’ end at the cost of necessitating longer sequences 
to clone into the 5’ homology arm site, losing of effects from splicing, and higher risk of 
inducing genome rearrangements due to synthetic duplication along the chromosome. 
 We found that gene specific expression of a florescent primary report is an 
indicator of precise in-frame integration at a targeted locus and correlates with 
transmission to the next generation, but alleles should be confirmed by sequencing of 
junction fragments in the F1 generation.  For pPRISM-Stop alleles or those where the 
primary report fluorescence is at levels too low to visualize, the secondary report can be 
used to determine if an F0 animal is likely to carry the intended integration event.  The 
presence of only a secondary marker does not indicate precise in-frame integration 
because the promoter of the secondary report is independently expressed from the 
target locus.  Previous work with these secondary reports has shown that the short 
promoter can be ectopically expressed from both circular and linear plasmid as well as 
when the cassette is integrated randomly into the target genome.  We observed ectopic 
expression of up to 10% of injected embryos displaying the report when injecting ꝩ-cry-
eGFP control plasmid into WIK animals (data not shown).  Therefore, while the 
secondary report can be used to enrich a raised population for integrations transmitted 
alleles will still need to be screened by genotyping for isolation of lines.  Following 
isolation of a line the secondary report should maintain in linkage with the allele due to 
the compact arrangement of the cassette. 
To compare the pPRISM plasmids with the pGTag plasmids described in 
Wierson et al., 2018 the main difference is in the size of the cassette (around 4 kb for 
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pPRISM plasmids compared to 1.5 - 2 kb for pGTag plasmids), however this change in 
size did not produce a significant difference between the rates of somatic efficiency (two 
tailed T-test p = 0.404,  pGTag overall average 39.3%, pPRSIM overall average 44.2%). 
If we account for a 10% decrease in somatic efficiency due to ectopic or off-target 
secondary reports we still find no significant difference in somatic efficiency (two tailed 
Student’s T-test p = 0.383, pPRSIM adjusted average 35.1%).  This suggests that size 
of the cassette is not a primary contributing factor to integration efficiency, though as the 
donor vector increases in size the molarity of the vector in the injection mixture may 
become an important factor. 
Currently, 28.0% (from the transmission rates of 11 loci totaling 28 transmitting 
animals of 100 screened, Table 2) of screened animals have transmitted a secondary 
report to the next generation.  These transmitted lines are being screened for precision 
using junction fragment analysis and sequencing, currently three of four pPRISM-Stop 
lines have been confirmed to be precise on the 5’ end by sequencing.  Previous work 
with the pPRISM vectors and the locus cx43.4 gave a transmission rate of 27.3% (3/11) 
with precise 5’ integrations of a 2A-RFP allele.  These rates are comparable to those 
published using the same technique (Wierson et al., 2018), and the slightly lower rates 
may be ascribed to many of these integrations being attempted without a primary report.  
The ectopic expression of the secondary report may obfuscate the precise numbers 
until we finish data collation for publication, though we note that 28% is higher than 
described elsewhere. 
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Limitations 
 The primary limitation of the vector series is that they are designed to work in 
zebrafish.  We note that the individual parts of each vector are known to work in mouse 
and other systems. However, alternate secondary markers may be desired, and unique 
restriction sites for swapping promoters and fluorophores to tune these tools for other 
species of interest were designed into the cassettes.   
Methods 
 We followed the methodology described in Wierson and Welker et al 2018, with 
the following addendums, 1) the oligo b for homology arms in the pPRISM vectors is 5’-
GAAG-3’. 2) homology arms are not held strictly to 48 bp in instances where the arm 
would overlap intron exon boundaries are shortened to the nearest multiple of 3 or 4 bp 
to keep the homology arms inside the target exon. 3) For pPRISM-Stop vectors padding 
nucleotides are not added to the homology arms unless there is a reason to maintain a 
given amino acid. 4) pPRISM-Fuse cassettes are intended for making 3’ protein fusions, 
thus require the addition of any remaining codons 3’ of the CRISPR cut. CRISPR 
targets as close to the stop codon as possible are recommended to limit the number of 
additional bases needed to be included in the 5’ homology arm.  Homology arms are 
designed as previously described with the following changes.  a) To the end of the 5’ 
homology domain all remaining bases of the coding sequence besides the stop codon 
are added, instead of just those bases needed to complete the codon. b) At least one 
‘G’ in the PAM in the 5’homology oligos should be mutated to result in a silent mutation. 
c) In all cases where the 3’ homology arm would overlap with 20 or more base pairs of 
the completed coding sequence, the overlapping codons in the 5’ homology arm oligos, 
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3’ of the homology (the sequence containing the remainder of the codons), should be 
shuffled to prevent unwanted recombination during integration.   
Codon shuffling is performed by utilizing a codon usage table for the target 
organism.  For each codon select and change the endogenous codon (in the oligo) to 
the next best codon with similar (+/- 2 units) or better usage score coding for the same 
amino acid. Note: leucine, serine, and arginine codons have more alternate codons, and 
for these choosing the most different base pair composition should take precedence 
over usage score. d) The 3’ homology arm may be omitted if codons are unable to be 
satisfactorily shuffled. e) For 5’ homology oligos longer than 150 bp, it may be cheaper 
to order a gene-block (a synthesized dsDNA strand composed of a designed sequence) 
with the following additions to each end; the 5’ end should have “5’-acctgccaca-3’ added 
and the 3’ end should have 5’-acacgcaggt-3’ added. Then the gene-block should either 
be digested with BfuAI before cloning, or pre-blunt-cloned into an intermediate vector 
before digesting with BfuAI and purifying the correct size fragment for cloning into the 
pPRISM-Fuse vector of choice.  Alternatively, a long homology arms can be Gibson 
cloned into the 5’ homology arm site. 
Author Contributions  
 JMW wrote the manuscript, cloned the vectors, and captured images. TJW 
generated myo7a and cx30.3 lines, MT generated multiple clones and lines. KK 
generated the vimentin-Fuse line. ML generated the aqp lines. JEL, AW, JG, NJE 
Screened lines for transmission and assisted in obtaining images. CB assisted in initial 
cloning steps. 
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FIGURES 
  
Figure 1. Diagram of pPRISM plasmids, and graphic of GeneWeld strategy. A) shows a map of the 
pPRISM vector series.  Each vector contains a knock-in cassette flanked by UgRNA target sites for 
cassette liberation, BfuAI type IIS restriction enzyme sites flank a LacZ sequence for cloning of a 5’ 
homology arm and blue/white selection. BspQI type IIS restriction enzyme sites flank a filler sequence 
and enable cloning of a 3’ homology arm.  Each vector has one of four primary reports and one of six 
secondary reports. B1) shows a genomic target and the active portion of a donor vector.  CRISPR targets 
are underlined with red arrows, PAMs are indicated in bold, predicted cut sites are notated with ‘^’ 
homology arms are denoted in green (5’) and blue (3’), the ‘N’ in the donor plasmid represents the small 
non-homologous spacer sequence between the homology and the UgRNA site to end the length of 
homology at a specific length. B2) shows the expected end resection following cleavage by Cas9, and 
how the resulting ssDNA from the genomic DNA end and the donor DNA end are open for homologous 
covalent bonding. B3) shows the resulting precise integration. 
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Figure 2. Visualization of pPRISM component function.  A-B) show functionality of the visual primary 
reports.  A) shows a 2A-RFP allele of cx43.4 widely expressed including in the pineal gland and 
notochord at 24 hrs (scale bar = 100 µm), B) shows a Fuse allele of vimentin, lateral view of 3 dpf trunk 
expression in nervous system tissue (scale bar = 20 µm). C-H) show examples of each of the secondary  
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Figure 2 continued: 
reports at 3 dfp lateral view of the head. C) shows ꝩ-cry RFP expression after integration at cx43.4 (scale 
bar = 100 µm). D) shows ꝩ-cry GFP expression after integration at myo7a (scale bar = 100 µm). E) shows 
ꝩ-cry BFP expression after integration at cx43.4 (scale bar = 100 µm). F) shows cmlc2 RFP expression 
after integration at cx30.3 (scale bar = 100 µm). G) shows cmlc2 GFP expression after integration at 
msna (scale bar = 50 µm). H) shows cmlc2 BFP expression after integration at myo7a (scale bar = 100 
µm). 
  
Figure 3. Diagram of visual genotyping.  By establishing knock-in alleles with pPRISM lines can be 
identified by the color(s) of the secondary report(s).  By crossing two pPRSIM knock-in alleles progeny 
can be genotyped by day 3 without sacrificing the animals for DNA extraction.  Here a parent with a 
knock-in allele with the ꝩ-cry GFP secondary report (GE) is crossed with a parent with a knock-in allele 
with the cmlc2 BFP secondary report (BH).  The progeny (F1s) from this cross results in four expected 
genotype classes, those with both alleles expressing both secondary reports (either homozygous mutants  
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Figure 3 continued: 
or trans-heterozygous mutants depending on how many loci are involved), heterozygous animals with 
only one knock-in allele thus only expressing one of the secondary reports, and those that are wild type 
expressing no secondary report. Scale bar = 100 µm. 
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TABLES 
Table 1. Somatic integration efficiency. 
Gene 
name 
Plasmid 
version 
Zebrafish 
background 
Number 
injected 
Number 
primary 
report 
Number 
secondary 
report 
Percent 
expressing 
report 
cx30.3 pPRISM-Stop 
ꝩ-cry BFP 
WIK 96 N/A 59 61.5% 
cx30.3 pPRISM-Stop 
cmlc2 RFP 
WIK 109 N/A 74 67.9% 
cx43.4 pPRISM-2A-
RFP ꝩ-cry BFP 
Fli1:eGFP 45 32 N/A 71.1% 
  
Fli1:eGFP 38 20 N/A 52.6% 
msna pPRISM-Stop 
cmlc2 GFP 
pdb790 6 N/A 1 16.67% 
  pdb790 48 N/A 20 41.67% 
  pdb790 12 N/A 6 50.00% 
  pdb790 60 N/A 26 43.33% 
msna pPRISM-Stop 
cmlc2 GFP and 
pPSISM-Stop 
ꝩ-cry BFP 
pdb790 18 N/A 11 61.11% 
 
 
pdb790 32 N/A 7 21.88% 
myo7aa pPRISM-Stop 
cmlc2 BFP 
WIK 37 N/A 12 32.4% 
  WIK 54 N/A 21 38.9% 
  WIK 33 N/A 13 39.4% 
  WIK 39 N/A 6 15.4% 
myo7aa pPRISM-Stop 
ꝩ-cry GFP 
WIK 31 N/A 13 41.9% 
 
 WIK 64 N/A 47 73.4% 
nf2b pPRISM-Stop 
ꝩ-cry RFP 
WIK 27 N/A 3 11.1% 
  WIK 71 N/A 43 60.6% 
  WIK 91 N/A 32 35.2% 
nf2b pPRISM-Stop 
cmlc2 GFP 
WIK 46 N/A 31 67.4% 
  
WIK 132 N/A 79 59.9% 
vegfaa pPRISM-Fuse 
ꝩ-cry BFP 
Fli1:eGFP 30 N/A 3 10.0% 
     Overall 
average 
44.2% 
Table 1. Somatic integration efficiency. Gene name column shows the name of the target locus. 
Plasmid version shows which pPRISM vector was used in the given set of injections. Zebrafish 
background lists the genetic background for the experiment. Number injected refers to the total number of 
embryos injected for gene editing following the GeneWeld method. Number primary report shows the  
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Table 1 continued: 
number of injected animals that displayed a pPRISM primary report in the expected tissues. Number 
secondary report indicates the number of injected animals that displayed a pPRISM secondary report at 3 
dpf. N/A indicates that the report was unable to be screened for. Percent expressing report is the number 
of animals expressing either report divided by the total number of injected animals. Overall average is the 
average of the Percent expressing report column. 
Table 2.  Outcrossing and germline transmission. 
Genomic target pPRISM version F0s 
transmitting 
F0s 
screened 
Germline transmission 
percentage 
anxa2a pPRISM-Stop ꝩ-cry-RFP 4 13 30.8% 
anxa2b pPRISM-2A-RFP cmlc-
GFP 
4 4 100.0% 
aqp1a1 pPRISM-Stop ꝩ-cry-RFP 4 6 66.7% 
aqp1a1 - 
aqp1a2 
pPRISM-Stop ꝩ-cry-BFP 5 19 26.3% 
Cx30.3  pPRISM-Stop cmlc-RFP 3 5 60.0% 
flna Ex1  pPRISM-Stop ꝩ-cry-RFP 0 5 0.0% 
flna Ex4 pPRISM-Stop ꝩ-cry-RFP 0 8 0.0% 
flna Ex4 pPRISM-Stop ꝩ-cry-BFP 1 5 20.0% 
flna Ex46 pPRISM-Fuse ꝩ-cry-BFP 0 1 0.0% 
flnb pPRISM-Stop ꝩ-cry-BFP 2 3 66.7% 
flnb  pPRISM-Fuse ꝩ-cry-BFP 0 1 0.0% 
myo7aa pPRISM-Stop ꝩ-cry-GFP 1 2 50.0% 
myo7aa pPRISM-Stop cmlc-BFP 1 1 100.0% 
rab4a pPRISM-Stop ꝩ-cry-RFP 0 12 0.0% 
rab4a pPRISM-Stop ꝩ-cry-BFP 2 10 20.0% 
vegfaa  pPRISM-Stop ꝩ-cry-BFP 0 2 0.0% 
vegfaa  pPRISM-Fuse ꝩ-cry-BFP 1 3 33.3%  
Overall 28 100 28.0% 
Table 2. pPRISM outcrossing and germline transmission. F0’s raised to adulthood were outcrossed 
and screened for germline transmission pPRISM secondary reports. F0s transmitting/F0s screened x 100 
= Germline transmission percentage. F0s were considered screened if 75 F1 embryos were examined for 
fluorescence.  
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Abstract 
 Directional nodal flow initiated by motile cilia in the left-right (L-R) organizer of 
developing embryos is required for proper establishment of L-R asymmetry.  Previous 
work in Zebrafish has shown that morpholino knockout of the gap junction (GJ) protein, 
connexin43.4 (cx43.4), causes disruption of the L-R organizer, Kupffer’s Vesicle (KV), 
and correlated randomization of L-R asymmetry (Hatler et al., 2009). Here, we present 
phenotype analysis of an indel (10 bp deletion) mutant of cx43.4 showing that cx43.4 is 
required for KV inflation but is not solely responsible for proper L-R designation.  To 
examine further the role of cx43.4, we have generated knock-in alleles to follow cx43.4 
gene expression and determine the role of cx43.4 in morphogenesis of KV by altering 
single amino acids.  We show that a cx43.4 2A-RFP knock-in allele phenocopies the 
indel allele, and that a hemichannel cDNA knock-in allele (cDNA containing a SNP to 
disable the ability of the GJ to dock with other GJs) is sufficient for partial inflation of KV. 
Introduction 
 Though left-right (L-R) organizers are conserved across phyla (Wood et al., 
2005) the genetic components are only beginning to be understood (Amack et al., 2007, 
Becker-Heck et al., 2011). In zebrafish, Kupffer’s Vesicle (KV), an organ formed in the 
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tail bud at the end of gastrulation by dorsal forerunner cells diving into the embryo and 
inflating a luminal space, acts as the L-R organizer (Essner et al., 2005).  KV cells have 
motile cilia that extend into the luminal space which are responsible for the 
counterclockwise nodal flow that is required for establishment of L-R asymmetry. 
Connexin43.4 (cx43.4) a gap junction (GJ) protein has been previously been shown in 
morpholino (MO) experiments to be required for both KV development and for L-R 
establishment (Hatler et al., 2009).  Here, we show through analysis of several mutants 
that the gene connexin43.4 is required for KV formation and L-R asymmetry. Using 
point mutations knocked into the cx43.4 locus, we show that the gap junction protein 
can act as a hemichannel for signal transduction into the luminal space. 
 Morpholino phenotypes and mutant phenotypes do not always match, either due 
to off targets of the morpholino giving a more severe phenotype (Kok et al., 2015), or 
due to mutated exons being spliced around giving a less severe phenotype in the 
mutant (Chen et al., 2018).  Here, we compare two mutant alleles of cx43.4 in zebrafish.  
The first is a 10 bp deletion mutant (Δ10) and the second is a knock-in allele that inserts 
a 2A-TagRFP in frame after the 18th codon (2A-RFP).  We show the d10 allele is 
required for KV development, but has no effect on L-R establishment except in maternal 
zygotic embryos. Specifically, we show cx43.4 is required for inflation of KV by volume 
analysis, and show that a single functioning copy of cx43.4 is sufficient for complete 
inflation of KV.  For comparison to the indel allele, we show that the knock-in allele, 
generated using the GeneWeld method (Wierson et al., 2018), phenocopies putative 
null.  This demonstrates an application of knock-in alleles as a way to generate null 
alleles for reverse genetics experiments.  
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 Additionally, we explore the protein function of cx43.4.  Normally, GJ proteins 
propagate communication between cells by acting as gateways for small molecules 
(Wei et al., 2004).  Unpublished work by Hatler et al. suggest that cx43.4 has a novel 
function as a hemichannel, or a GJ that cannot interact with corresponding GJs, which 
is sufficient for proper KV development and recovery of L-R phenotypes when mRNA is 
co-injected with the MO.  Utilizing the GeneWeld method and the pPRISM vector series 
(Welker et al,. in prep), we engineered and precisely integrated mutant cDNAs 
corresponding to known functional variants for both hemichannel (Bao et al., 2004) and 
closed channel alleles (McLachlan et al., 2005). We show that animals homozygous for 
the hemichannel allele have an intermediate phenotype. 
Results 
Characterization of Δ10 allele phenotypes 
 To determine if a cx43.4 is required for L-R designation through KV formation we 
first generated an indel allele using TALENs to target the first coding exon of cx43.4.  
We isolated a 10 bp deletion (Δ10) which we predict to be a null allele due to a 
frameshift after 53 amino acids and prematurely terminate after 80 aa. First the effect 
the mutant cx43.4 had on left right asymmetry was examined in 30-48 hr old embryos 
using the looping of the heart as a readout (Table 1). We found that maternal zygotic 
cx43.4 mutants have defects in L-R asymmetry and the ratio of reversed hearts was 
lower than expected in these crosses when compared to the predicted ratio from the 
MO study (Hatler et al., 2009). An average of 16.4% embryos derived from a female 
Δ10/Δ10 crossed to a male Δ10/+ were observed to have heart reversals. Embryos from 
this cross are expected to be maternally mutant and zygotically mutant in 50% of the 
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embryos.  If laterality is randomized, half of the homozygous animals are predicted to 
display left-right axis defects or heart reversals (25% of the embryos).  The difference 
observed was statistically different from the predicted by chi square analysis p = 0.038.  
An average of 20.3% of embryos derived from a female Δ10/Δ10 crossed to a male 
Δ10/ Δ10 were observed to have heart reversals. Embryos from this cross are expected 
to be maternally mutant and zygotically mutant.  If laterality is randomized, half of the 
animals are predicted to display left-right axis defects or heart reversals.  The difference 
observed was statistically different from the predicted by chi square analysis p < 0.0001.  
The incomplete penetrance of this phenotype suggests that cx43.4 is not the sole 
requirement for determining L-R development or that other connexin genes may 
compensate for the loss of cx43.4.  
 To further understand the role of cx43.4 in L-R development, KV development 
was examined for disrupted morphology in the mutant animals. KVs were scored as 
either ‘KV plus’ for those visibly distinguishable in living embryos or ‘KV minus’ for those 
not visibly distinguishable under a dissection microscope at 20x magnification.  The 
mutant allele of cx43.4 was found to act like a recessive allele, it showed a Mendelian 
distribution of phenotypes across crosses between each kind of parental genotype pair; 
i.e. a cross between heterozygous parents resulted in 25% of offspring with the KV 
minus phenotype and between homozygous parents resulted in 100% of embryos with 
the KV minus phenotype (Table 2).  Animals that displayed the KV plus phenotype were 
confirmed by genotyping to be either wild type or heterozygous (n=16), while all KV 
minus animals were confirmed to be homozygous for the mutant allele (n=8). This 
demonstrates that cx43.4 is required for KV formation.  
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Quantification of Δ10 allele physical phenotypes 
 To examine further effects on KV development, immunohistochemistry was used 
to verify the presence of known cellular components.  Following immunohistochemistry 
staining of fixed 13-14 somite embryos with PKC ζ and acetylated tubulin, embryos 
were imaged with a confocal microscope (Figure 1A-D).  Counting the cilia in each 
image and mutant class revealed that each had around 50 cilia, indicating that the 
mutant phenotype is not due to loss of cells contributing to KV or a defect in 
ciliogenesis.  Additionally, PKC ζ appeared to localize to the cell borders in KV, 
suggesting cell polarity was intact.  
 Because loss of cellular components of KV was not detected, we hypothesized 
that the differences between the KV phenotypes is the amount of inflation of the luminal 
space.  To test this hypothesis, the volume of each KV was quantified by using the 
ImageJ (Rasband, 2015) software with the Volumest (Merzin, 2008) plugin to analyze Z-
stack images of each KV.   A significant 24 fold difference was found between the KV 
plus and minus classes (two sample Student’s t-test p = 1.02e-08) (Figure 1E), but no 
significant differences between wild type and heterozygous embryo KVs (two sample 
Student’s t-test p = 0.40) nor were there significant differences between zygotic and 
maternal zygotic KV minus (two sample Student’s t-test p = 0.73).  This suggests that 
cx43.4 is required for proper inflation of KV rather than specification of the cells that 
comprise KV. 
Generation of knock-in alleles 
 We hypothesized that cx43.4 may function as a hemichannel rather than a gap 
junction for transduction of a signal to the luminal space (Hatler, 2009).  To study this 
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change at endogenous levels we proposed to utilize the GeneWeld strategy (Wierson et 
al., 2018) to integrate modified cDNAs directly to the locus.  To test the efficacy of 
integrating a cassette precisely at the locus cx43.4, a 2A-RFP knock-in cassette from 
the pPRISM vector series (Welker et al., in Prep) was chosen for the ability to later 
visually genotype (infer the genotype of transgenic animals by the presence or absence 
of secondary/transgenesis markers included on the knock-in cassette) crosses by 
different secondary reports.  The 2A-RFP donor cassette lacked the universal guide 
sites found on the final pPRISM vectors, and instead was integrated by a single 5’ 
linearization event using a copy of the genomic target on the donor vector for 
linearization of the vector and exposure of the 48 bp of 5’ homology.  The 2A-RFP 
cassette when integrated precisely caused the locus to produce TagRFP instead of the 
cx43.4 GJ, showed that the expression pattern was normal by visualization of the red 
fluorescent report, and tagged the locus with a secondary report of gamma crystallin (ꝩ-
cry) BFP for visual genotyping based on the blue fluorescent signal.  Additionally, we 
predicted this 2A-RFP allele would give the same phenotypes as the null allele as no 
native protein would be expressed from this knock-in.  Precise targeting of cx43.4 was 
determined to have a somatically efficiency rate of 51.4% (Table 3), measured by the 
percentage of injected embryos that were RFP positive with broad expression matching 
expected patterns seen in previous in situ work (Essner et al., 1996).  Furthermore, 3 of 
11 F0s transmitted precise identical expression pattern alleles to the next generation 
(Table 4), these alleles were confirmed by sequencing and by observation of early 
expression patterns specifically in the notochord and tail bud as expected (Figure 2A).  
The resulting recovered alleles are only precise on the 5’ end and contain the vector 
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backbone (data not shown).  Additionally, visual genotyping of knock-in alleles using 
pPRISM vectors by selection of the secondary report was confirmed to match predicted 
genotypes by PCR and sequencing, n=12 (Figure 2C-D). 
Characterization of 2A-RFP knock-in allele phenotypes 
 To test whether the 2A-RFP knock-in allele was a null allele, in-crosses were 
performed to compare both heart reversal phenotype and KV phenotypes with the 
mutant allele.  We found that as with the Δ10 mutant allele, the 2A-RFP allele does not 
cause heart reversals when in-crossed (Figure 5) and it phenocopies the KV 
phenotypes of the Δ10 allele.  Additionally, both KV plus and KV minus classes were 
observed in embryos from in-crosses of the 2A-RFP allele in expected ratios based on 
parental genotypes (Table 6) and the genotypes of KV plus animals were confirmed as 
heterozygous or wild type based on PCR based junction fragment analysis, while the 
genotypes of KV minus animals were confirmed to be homozygous for the 2A-RFP 
allele (Table 5, genotyping not shown).  
 To determine if KV volumes of the 2A-RFP allele were comparable to those of 
the Δ10 allele a transgenic which expressed eGFP from the sox17 locus (Dasgupta et 
al., 2018) was utilized.  Sox17;eGFP is expressed in the dorsal forerunner cells that 
give rise to KV, and thus can be used as a proxy for immunohistochemistry staining for 
visualization purposes.  Animals that were wild type for cx43.4 in the sox17:eGFP 
background were identified, fixed at 13-14 somites, and used to measure control 
volumes for normal KVs, these volumes averaged 26260 µm3.  Two animals 
heterozygous for the 2A-RFP allele were crossed to produce heterozygous and 
homozygous animals, embryos between 13-14 somites were fixed and estimates of 
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volume were calculated for an additional 8 KVs (4 KV plus and 4 KV minus, Figure 4A-
B, E).  We found that the 2A-RFP allele had a phenotype closely related to the Δ10 
allele, where the heterozygous animals had KV plus volumes with an average of 26062 
µm3 (which was not significantly different from wild type, two tailed Student’s t-test p = 
0.9) and KV minus embryos had volumes with an average of 2415 µm3 a significant 11 
fold difference by a two tailed Student’s T-test p = 5.5e-6 compared to the control. 
These results demonstrate that the 2A-RFP allele behaved similarly to the Δ10 allele. 
Together, the heart reversals, KV visual phenotypes, and volume differences in 2A-RFP 
mutant embryos demonstrate a requirement for cx43.4 during left-right development 
and suggest that cx43.4 is expressed in KV at critical times for KV morphogenesis.   
Generation of altered cDNA knock-in alleles 
 The 2A-RFP allele confirmed that exogenous DNA can be precisely integrated 
and expressed from the cx43.4 locus. To directly probe the mechanism of cx43.4 in KV 
inflation altered cDNAs of cx43.4 were integrated at the locus using the GeneWeld 
method.  We generated 4 knock-in alleles where pPRISM vectors (Welker et al., in 
prep) were used to integrate different cDNAs with specific SNPs and tag each altered 
cDNA with a different colored secondary report.  First, a control allele was generated 
where the wild type sequence was integrated at the locus tagged with cardiac myosin 
light chain 2 – BFP (cmlc-BFP), referred to as WT-cDNA allele.  Second, a hemichannel 
allele, where the CDS contains a SNP that changes a conserved cysteine at position 64 
to a serine (C64S) which disables the GJ’s ability to dock with other GJs (Bao et al., 
2004), was integrated at cx43.4 and tagged with ꝩ-cry-RFP, called the hemichannel or 
C64S allele.  Third, a closed channel allele, where the CDS for cx43.4 contains a SNP 
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to change an arginine at position 75 to a tryptophan (R75W, McLachlan et al., 2005), 
was integrated and tagged with ꝩ-cry-GFP, called the closed channel or R75W allele.  
Finally, a double mutant containing both C64S and R75W mutations was integrated and 
tagged with ꝩ-cry-BFP, referred to as the double mutant or C64S,R75W allele (Figure 
3).  Expression of the secondary report following injection averaged 47.7% between 
each of the cDNA alleles (Table 3). Precisely integrated alleles were recovered at an 
average rate of transmission through the germline of 11.2% (Table 4).   
Analysis of control cDNA allele 
 To test if cDNA integration had an effect on the function of the targeted locus, we 
examined the WT cDNA allele as a control for abnormal effects of the cassette.  
Expression of the integrated cDNA from the genomic target was confirmed by RT-PCR 
(data not shown).  An in-cross between heterozygous animals from the F1 generation 
was performed and embryos were examined for heart reversals and for KV phenotypes. 
We found a low frequency of heart reversals similar to wildtype animals (Table 5) and 
no KV minus animals from 1044 animals from 3 independent crosses (Figure 6). KV 
plus embryos from a heterozygous by heterozygous cross were fixed at 13-14 somites 
and the volume of KV was measured.  KV volumes from the WT-cDNA heterozygous 
crosses averaged 25725 µm3 which is not significantly different from the wild type 
controls (two tailed Student’s t-test p = 0.37).  We conclude that WT-cDNA knock-in 
allele functions similar to the wild type allele and the change in termination/poly-A 
sequence does not observably affect cx43.4 function.  
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Analysis of hemichannel cDNA allele 
 To test whether cx43.4 hemichannels affect KV development, we confirmed that 
animals with the C64S knock-in allele expressed the hemichannel mRNA by RT-PCR 
(data not shown). In-crosses between animals heterozygous for the hemichannel allele 
were performed and the resulting embryos were examined for heart reversals and KV 
phenotypes.  The frequency of heart reversals was not different from the controls (Table 
5).  25.8% of embryos from these crosses were observed to have a KV minus 
phenotype by light microscopy at 20x magnification. Additionally, it was observed that 
when animals heterozygous for the hemichannel allele were crossed to animals 
homozygous for the Δ10 mutant allele 51.7% of the resulting embryos were found to 
have the KV minus phenotype (Table 6). This suggested that the hemichannel is not 
sufficient for normal KV inflation. 
. To determine the extent of KV inflation in hemichannel mutants, volumes for 10 
KVs (4 KV plus, 6 KV minus) were calculated from embryos from a cross between two 
animals heterozygous for the C64S hemichannel allele.  A significant 2-fold difference 
was observed between KV plus and KV minus in animals from this cross (two tailed 
Student’s T-test p = 1.2e-5).  The average volume of KV plus volumes from these 
embryos was determined to be 27100 µm3. There was no significant difference found 
between KV plus volumes between the control, the WT-cDNA, the 2A-RFP KV plus, and 
the hemichannel KV plus volumes by one-way ANOVA p = 0.755.  The average volume 
of hemichannel KV minus (13883 µm3) which corresponds to the homozygous 
hemichannel embryos was significantly different from the volume of KV minus from the 
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2A-RFP allele (two tailed Student’s t-test p = 5.5e-5.) (Figure 4).   This intermediate 
phenotype suggests that hemichannel is sufficient for partial in KV inflation. 
Analysis of closed channel cDNA allele 
 To determine if function of cx43.4 requires transmission of a small molecule or 
interaction of the C-terminal domain generation of a mutant R75W closed channel allele 
was attempted.  Somatic efficiency of integration was observed in 57.6% of injected 
embryos displaying the secondary report.  Of those animals that were raised to adult 
hood 38.9% (7/18) transmitted the secondary report to the next generation. However, a 
precise allele that expressed the mutant mRNA with the R75W SNP was unable to be 
recovered.  This suggested that the R75W allele may have lethal dominant negative 
effects. 
Analysis of double mutant cDNA allele 
 To test whether cx43.4 requires both docking with other GJ and C-terminus 
interactions a double mutant containing both C64S and R75W SNPs was generated.  
Expression of the mutant mRNA was confirmed by RT-PCR (data not shown) and 
crosses between heterozygous animals yielded 26.7% of embryos displaying the KV 
minus phenotype.  This matched the prediction that a closed GJ that is unable to dock 
will act as a null, and this result suggests that both transmission of a signal and docking 
are required in normal cx43.4 GJ functions.  
Discussion 
 Because the methods of cell staining for the KV volumes analysis of the Δ10 and 
2A-RFP alleles are different, we cannot direct compare the two. So, although there a 
24-fold volume difference for the Δ10 allele and an 11-fold volume difference for the 2A-
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RFP allele, there is only around a 1000 um^3 difference between KV plus and KV minus 
volumes between methods. Given that both the Δ10 allele and the 2A-RFP allele are 
similar to each other in visual phenotype and volume estimates, we can conclude that 
both alleles result in a loss of KV inflation.  
 Previous work in cell culture identified single amino acid changes that affect 
protein function of gap junctions of the related connexin43 (cx43).  For the hemichannel 
allele, Bao et al., 2004 described a C65S mutation that changes GJ function to that of a 
hemichannel.  By preforming clustalOmega (Chojnacki et al., 2017) alignments on the 
protein sequences of cx43 and cx43.4, we identified a corresponding conserved 
cysteine residue in cx43.4.  Previous work in cell culture showed with dye transfer 
experiments that the change in function was replicated with cx43.4 (Hatler, 2009).  
Remarkably, co-injection with the morpholino against cx43.4 with a mRNA encoding 
cx43.4 with the C64S mutation resulted in rescue of the KV and L-R phenotypes.   
 By integrating the cDNA directly to the locus, concerns over dosage of the 
transcript are mitigated because the new CDS is under the control of the endogenous 
promoter.  However, it was necessary to engineer an additional silent SNP into the 
coding sequence to prevent the genomic CRISPR from digesting the donor vector in an 
un-desired way.  This additional SNP destroys the PAM on the donor vector at the cost 
of shortening the homology arm by 5 bp compared to the 2A-RFP allele.  This change in 
homology length did not result in a noticeable drop in somatic efficiency.  Additionally, 
because the CDS contains the sequence that matches the 3’ homology arm, problems 
stemming from additional HMEJ targets were encountered when including the 3’ arm on 
the donor vector.  These problems were alleviated by not including the 3’ homology arm 
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during the successful integration attempts, and unlike the 2A-RFP allele the  backbone 
was not detected in the integration, likely due to the UgRNA present on the 3’ end of the 
pPRISM cassette allowing the backbone to be lost while the 3’ end of the cassette was 
integrated by NMEJ.  By integrating the full cDNA in the middle of the endogenous 
cDNA there is a tandem repeat of around 1 kb separated by around 3.5 kb which could 
lead to complications with chromosomal rearrangements.  
 Further thought on these design considerations suggests that for future cDNA 
alleles the PAM need not be destroyed in cases where the genomic CRISPR targets the 
anti-sense strand provided the cDNA construct shuffles codons (i.e. changing the 
wobble position of codons to result in the same amino acid and maintaining 
approximate codon usage values) spanning at minimum 17 bases down stream of 
where the cut would otherwise occur on the donor.  This should be sufficient to disrupt 
the genomic target sequence on the donor vector and prevent unwanted donor 
cleavage.  Additionally, shuffling all the codons that span what would be used for the 3’ 
homology would allow for the unhindered use of 3’ homology arms on the donor vector.  
To prevent tandem repeats, using a second CRISPR to delete more of the endogenous 
locus may be an avenue to improve this method. 
 Because this integrated cDNA lacks intron two there was concern that there may 
be unintended affects from the lack of intron processing.  To address this concern a 
control allele was generated, where the CDS from the wild type was integrated with only 
the silent mutation to destroy the genomic PAM on the donor.  To ask the question of 
whether KV inflation requires cx43.4 to transmit a small molecule or acts through C-
terminus interactions with other proteins, we changed a conserved residue in cx43.4 
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that was described in cx43 to force the GJ closed (McLachlan et al., 2005).  Preliminary 
results with transmission of the closed channel suggest that this allele has a lethal 
dominant negative effect.  Finally, the double mutant was generated to test the whether 
the function of cx43.4 requires both docking with other GJ and C-terminus interactions.   
 Recent work by Gokey et al., 2016 has suggested that there is there is a 
threshold size that KV needs to attain to function properly, and the intermediate 
phenotype of hemichannel KV minus volumes, suggests that cx43.4 hemichannels in 
vivo can function to restore KV volume above this threshold and thus allows for normal 
function in L-R development.  Furthermore, we suggest that this method of cDNA 
knock-in may be used to study other genes in a more nuanced way. 
 Transgenic alleles generated by precise genome knock-in can be engineered to 
be visually genotyped using the pPRISM vector series. For example, unlike the indel 
mutant for cx43.4, where zygosity of each animal is identified by PCR, a pPRISM 
knock-in allele has one of six distinct secondary markers which can be visualized by 
fluorescent microscopy.  This means that for each of the different cDNA knock-in alleles 
they can distinguished by the color of their secondary report. In-crosses between alleles 
means that the trans-heterozygous animals can be identified without the need for PCR.  
Conclusions 
 Our results here show that maternal/zygotic cx43.4 is required for inflation of KV 
and L-R development, and zygotic cx43.4 is sufficient for KV morphogenesis.  We also 
show that expression from a knock-in allele shows that cx43.4 is expressed at the right 
time and place to participate in KV morphogenesis and L-R development.  We show 
that precisely integrated mutant cDNAs can be used to generate specific mutant alleles 
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for in vivo cell biology studies.  Our novel finding was that cx43.4 can function as a 
hemichannel in KV development, by allowing partial inflation of KV.  Future directions 
will include examining the effects of the knock-in alleles on L-R asymmetry and volume 
analysis of the other 2 knock-in allele variants.  
Methods 
Mutant generation 
 A mutant allele for zebrafish connexin43.4 (cx43.4) was generated using 
TALENs.  Founders were identified by in-crossing and comparing the DNA size of the 
targeted region in progeny to wild type on a 3% agarose gel using primers 5’- 
CCGCATTGTTTTGACTGTTG-3’ and 5’- CAAATGCATCGTAGCAAACG-3’.  F1s were 
raised from founder in-crosses and then outcrossed to fli1-egfp fish to generate 
heterozygous fish. Heterozygous individuals were identified by gel analysis using the 
above primers and a 10 base pair deletion allele was isolated and propagated. 
Crosses and Screening 
 Fish were crossed and progeny were examined at 13 hours of development (8-
10 somites) under light microscope for presence/absence of KV at the anterior end of 
the notochord.  Embryos were separated at this time by phenotype and left to continue 
development. At 30 hours and 48 hours of development embryos were screened for 
laterality defects in the heart with florescent microscopy.   
Mutant KV tissue fixing and volume estimation 
 Embryos from crosses were collected at 13-14 somites and fixed in 4% 
paraformaldehyde for immunohistochemistry with monoclonal anti-tubulin and PKC ζ 
following the method in Hatler et al., 2009.  Immunohistochemistry stained embryos 
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were imaged on a confocal microscope at 40x. Volumes of KV were estimated using 
ImageJ (Rasband, 2015) with the plugin Volumest (Merzin, 2008). Confocal Z-stacks of 
KV were converted into a series of images, one for each layer of the stack. Z-stacks and 
were uploaded as RGB numerical image sequences. Volumes were estimated following 
the protocol from the quick start guide for Volumest with a few changes. Slice thickness 
for image sets was manually set to the distance between each image in the Z-stack, 
number of “slices to be estimated” was set to be 100% of the total number of slices 
were the KV, grid size was manually set to 15 µm, areas were hand traced, and volume 
was estimated for each image set three times from scratch to minimize human error in 
tracing. Final volumes were recorded as the average of the three estimates. Volumes 
were compared using R for statistical testing. 
CRISPR selection and cloning of integration vectors 
 A CRISPR for designed to the second exon of cx43.4 using CRISPRscan.org 
(Moreno-Mateos et al., 2015).  This CRISPR targets the reverse strand and cuts at the 
18th amino acid “5’-GAGCCATATCTTGCCCACGA-3'”.  A single homology arms of 
length 48 bp for the prototype pPRISM vector was taken from the sequence directly 
upstream of the cut site and linked to the sequence for the genomic guide for cx43.4, 
“5’- 
tgatGGGCCATATCTTGCCCACGAAGGGTTTTCTTACGCGGTTGTTGGATGAAATCT
CCAACCACTCCACCTTCGtg” similar to the bait strategy from Hisano et al., 2015. The 
plasmid contained a 2A-RFP terminated by the ocean pout termination poly-A 
sequence, and a secondary report of gamma-crystallin BFP.  Fli1:eGFP embryos were 
injected as described in Wierson et al 2018, with the change of no UgRNA was used.  
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RFP positive embryos were raised to adulthood and outcrossed.  3/11 animals 
transmitted precise integrations on the 5’ end of the cassette identified by junction 
fragment analysis using the primers F-5’-CGAGGACTGAGACGGTGGTA and R-5’-
gtgccctccatgtacagctt.  3’ integrations were identified with the primers F-5’-
gcatgggagctctgacgta, and R-3’-CAAATGCATCGTAGCAAACG.  One allele was chosen 
and outcrossed to Fli1:eGFP fish to generate heterozygous fish. Heterozygous 
individuals were identified by presence of the secondary report and confirmed by 
junction fragment analysis using the primers and propagated. 
 cDNA constructs were constructed stepwise first amplifying the necessary 
sequence from a previously cloned cDNA template.  Primers amplify from beginning of 
the homology arm to the end of the coding sequence, not including the stop codon but 
adding BfuAI recognition, spacer, overhang sequences, and non-homologous spacer 
sequence for cloning into pPRISM vectors; primers F-5’-
acctgCtgtgGCGGcccGTTTTCTTACGCGGTTGTTG, and R-5’- 
acctgCGtGtGAAGAGCATGGATCCCTTTTTCACA. This first amplicon generated with 
the proof-reading polymerase KOD (Thermo Fisher) was blunt end cloned using the 
Topo-Blunt cloning kit (Thermo Fisher). Several SNPs were engineered into this 
different clones of this plasmid by using primers to amplify around the plasmid; the first 
to destroy the PAM of the genomic CRISPR target without altering the amino acid 
sequence (F-5’-CACTCCACaTTCGTGGGCA and R-5’-
GTTGGAGATTTCATCCAACAACCG), the second to generate a C64S mutation to 
generate a hemichannel coding sequence (F-5’-
/5Phos/GAGAACGTTAGCTACGATGCAT and R-5’-
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/5Phos/ACAACCAGGTTGCTGGGTAT), and the third to generate a R75W mutation for 
a closed channel coding sequence (F-5’-/5Phos/CTCTCATGTCTGGTTCTGGGT and 
R-5’-/5Phos/AGTGGTGCAAATGCATCGTA).  Four cDNA versions were cloned; a 
control with only the PAM SNP, a hemichannel version with both the PAM and C64S 
SNPs, a closed channel with both the PAM and R75W SNPs, and a double mutant with 
all three SNPs.  These topo clones were then digested with BfuAI and the cDNA band 
was gel isolated and cloned into the different pPRISM-stop vectors so that they are 
each distinct by a corresponding secondary marker; the control with cmlc2-BFP, C64S 
with ꝩcry-RFP, R75W with ꝩcry-GFP, and C64S,R75W with ꝩcry-BFP.  3’ homology 
arms were not included on these plasmids. Plasmids were injected following the 
GeneWeld method.  Founders were identified by out-crossing and sequencing DNA of 
animals with the secondary markers using primers F-5’-CGAGGACTGAGACGGTGGTA 
and R-5’- TGTGCATAGCAAATCCCAAG.  F1s were raised and then outcrossed to 
Fli1:eGFP/Sox17:eGFP fish to generate heterozygous fish. Heterozygous individuals 
were identified and propagated. 
 Knock-in alleles were crossed and screened as above, with the exception of KV 
volume analysis, where the Sox17:eGFP transgenic described in Dasgupta et al 2018. 
was used to visualize KV cells. 
Author contributions 
 JMW wrote the manuscript, characterized the mutants, cloned the cDNA vectors 
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RGJ, JJE advised.  
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FIGURES 
 
 
Figure 1. Quantification of KV phenotypes. A-D show typical examples of KV phenotype classes. A) 
shows a typical wild type KV, B) shows a heterozygous KV, zygotic KV (C), and maternal zygotic KV (D). 
PKC ζ is stained in red, and cilia are stained green with acetylated tubulin. Scale bars = 10 µm. E shows  
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Figure 1 continued: 
a histogram comparing volumes of KV from each cross, with significant difference between KV plus and 
KV minus classes, Two sample T-test p = 1.02e-08. 
 
Figure 2. 2A-RFP Expression pattern and KV phenotypes. Shows the expression pattern of the cx43.4 
2A-RFP knock-in allele at widely expressed at both time points but notably (A-B) in the notochord and tail 
bud at 10 somites and (C-D) in the pineal gland and notochord at 48 hrs as expected.  A) shows a KV 
plus example embryo (scale bar = 50 µm), B) shows a KV minus embryo (scale bar = 50 µm), C-D) show 
a lateral view of the same embryo, C) showing off the ꝩcry-BFP secondary report (scale bar = 100 µm), 
and D) showing the endogenous expression pattern of cx43.4 (scale bar = 100 µm). 
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Figure 3. Diagrams of cx43.4 knock-in alleles. Diagram of wild type gap junction function, small 
molecules can bas between cells via docked GJs (A). A conserved cysteine residue mutated to serine 
causes GJ to be unable to dock with each other, forming ‘hemichannels where small molecules can travel 
between intracellular to extracellular space (B). A conserved arginine residue mutated to tryptophan 
causes GJs to be forced closed preventing any passage of small molecules through the channel (C).  A 
GJ with both mutations cannot dock with other GJ and does not permit passage of small molecules (D). 
Diagram of pPRISM allele donor constructs, the donor cassette is flanked on either side with gRNA target 
sequences for cassette liberation, followed by 48 bp of homology for the 2A-RFP allele, or 43 bp of 
homology for each of the cDNA alleles. Following the homology for the cDNA alleles is the remainder of 
the CDS containing necessary SNPs, followed by the ocean pout termination poly-A sequence and the 
corresponding secondary marker, no 3’ homology arm was used. 
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Figure 4. Knock-in allele KV volume analysis. Panels A-F show examples of typical KV plus (A, B, C, 
E) and KV minus (D, F) KVs from animals with sox17:eGFP in the background. Panels are split into 
Letter1 and Letter2, where Letter1 shows a single slice from the z-stack to illustrate what was imaged, 
and Letter2 shows a red outline of where the lumen of KV is located. Panel set A is of an example of wild 
type KV, panel set B is of an example of the WTcDNA knock-in allele KV from an in-cross, panel sets C 
and D are from 2A-RFP knock-in allele heterozygous in-crosses, and Panel sets E and F are KVs from 
hemichannel allele in-crosses. Scale bar = 20 µm. Panel G shows a histogram of volume estimates.  
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Figure 4 continued: 
There is no significant difference between KV plus embryos from controls or experimental embryos, one-
way ANOVA p = 0.755. There is a significant difference between KV plus and minus volumes from 2A-
RFP  in-crosses (Student’s T-test p = 7.7e-4), between KV plus and minus from hemichannel in-crosses 
(Student’s T-test p = 1.2e-5), and between KV minus from the 2A-RFP allele and the KV minus from the 
hemichannel allele (Student’s T-test p = 5.5e-5). 
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TABLES 
Table 1. Analysis of mutant heart asymmetry 
Maternal 
genotype 
Paternal 
genotype 
Cross 
number 
Normal 
heart 
looping 
Reversed 
heart 
looping 
Total 
number of 
embryos 
Percent 
reversed 
Standard 
deviation 
+/+ +/+ 1 57 0 57 0.0%  
  Overall 57 0 57 0.0% 0.00% 
Δ10/+ Δ10/+ 1 135 2 137 1.5%  
  Overall 135 2 137 1.5% 0.00% 
Δ10/+ Δ10/Δ10 1 200 1 201 0.5%  
  2 61 0 61 0.0%  
  3 85 0 85 0.0%  
  4 13 0 13 0.0%  
  5 35 0 35 0.0%  
  6 79 0 79 0.0%  
  7 40 0 40 0.0%  
  8 22 2 24 8.3%  
  Overall 535 3 538 1.1% 0.97% 
Δ10/Δ10 Δ10/+ 1 26 3 29 10.3%  
  2 39 11 50 22.0%  
  3 84 17 101 16.8%  
  Overall 149 31 180 16.4% 2.75% 
Δ10/Δ10 Δ10/Δ10 1 32 7 39 17.9%  
  2 24 7 31 22.6%  
  Overall 56 14 70 20.3% 1.64% 
Table 1. Analysis of mutant heart asymmetry. Table 1 shows the genotypes of each parent of each 
cross, Δ10 representing the 10 bp deletion mutant allele, + representing wild type. Cross represents the 
number of each replicate cross for the given parental genotype pair, ‘Normal heart looping’ is the number 
of embryos from that cross that had hearts that loop normally at 48 hrs., ‘Reverse Heart Looping’ is the 
number of embryos where the heart looping is reversed at 48 hrs, and the total  number of embryos 
screened is shown for each cross. ‘Percent reversed’ is the percent of reverse hearts over the total 
number of embryos from each cross. The ‘Overall’ line gives the sum of each column and then the 
average of the ‘Percent reversed’ column. Standard Deviation is calculated from the “Percent reversed” 
column. 
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Table 2. Analysis of mutant KV formation 
Maternal 
genotype 
Paternal 
genotype 
Cross 
number 
KV 
plus 
KV 
minus 
Total number 
of embryos 
Percent KV 
minus 
Standard 
deviation 
+/+ +/+ 1 57 0 57 0.0%  
  Overall 57 0 57 0.0% 0.00% 
Δ10/+ Δ10/+ 1 89 29 118 24.6%  
  2 142 56 198 28.3%  
  Overall 231 85 316 26.4% 1.31% 
Δ10/+ Δ10/Δ10 1 44 41 85 48.2%  
  2 7 6 13 46.2%  
  3 14 21 35 60.0%  
  4 41 38 79 48.1%  
  5 42 45 87 51.7%  
  6 42 19 61 31.1%  
  Overall 190 170 360 47.6% 3.51% 
Δ10/Δ10 Δ10/+ 1 11 18 29 62.1%  
  2 18 32 50 64.0%  
  Overall 29 50 79 63.0% 0.68% 
Δ10/Δ10 Δ10/Δ10 1 0 39 39 100.0%  
  2 0 31 31 100.0%  
  Overall 0 70 70 100.0% 0.00% 
Table 2. Analysis of mutant KV formation. Table 2 shows the genotypes of each parent of each cross, 
Δ10 representing the 10 bp deletion mutant allele, + representing wild type control, the genetic 
background is Fli1:eGFP. Cross number represents the number of the replicate of the given genotype 
pair. KV plus is the number of embryos from that cross that had visually detectable KVs at 8-10 somites, 
and KV minus is the number of embryos where the KV was not visually detectable. Percent KV minus is 
the number of KV minus embryos divided by the total number of embryos from each cross in a genotype 
pair. The ‘Overall’ line gives the sum of each column and then the average of the ‘Percent KV minus’ 
column. Standard Deviation is calculated from the “Percent KV minus” column. 
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Table 3. Somatic integration efficiency. 
Knock-in 
allele 
Experiment 
number 
Primary 
report 
positive 
Secondary 
report 
positive 
Total 
injected 
Percent 
positive 
selection 
Standard 
deviation 
2A-RFP 1 29 *N/A 61 47.5%  
 2 26 *N/A 46 56.5%  
 Overall 55  107 52.0% 3.18% 
WT cDNA 1 N/A 11 26 42.3%  
 2 N/A 34 89 38.2%  
 3 N/A 14 26 53.8%  
 4 N/A 8 32 25.0%  
 5 N/A 24 52 46.2%  
 Overall  91 225 41.1% 4.28% 
c64s 
Hemichannel 
1 N/A 6 12 50.0%  
 2 N/A 26 69 37.7%  
 3 N/A 8 36 22.2%  
 4 N/A 10 31 32.3%  
 Overall  50 148 35.5% 5.01% 
r75w Closed 
channel 
1 N/A 33 46 71.7%  
 2 N/A 46 83 55.4%  
 3 N/A 24 38 63.2%  
 4 N/A 20 36 55.6%  
 5 N/A 33 78 42.3%  
 Overall  156 281 57.6% 4.35% 
c64s, r75w 
Double 
mutant 
1 N/A 6 14 42.9%  
 2 N/A 40 61 65.6%  
 3 N/A 18 27 66.7%  
 4 N/A 14 42 33.3%  
 5 N/A 20 32 62.5%  
 Overall  98 176 54.2% 6.06% 
Table 3. Somatic integration efficiency. Table 3 shows the name of the allele being generated in the 
column ‘Knock-in allele’, as defined by the content of the primary report.  ‘Experiment number’ indicates 
separate injections of embryos. ‘Primary report positive’ is the number of injected embryos that display a 
primary report from the pPRISM cassette. ‘Secondary report positive’ is the number of injected embryos 
that display a secondary report. The *At the time of generation of the 2A-RFP allele we were unable to 
screen for presence of the secondary marker. ‘Total injected’ is the total number of embryos injected for a 
given replicate. ‘Percent positive selection’ is the number of embryos displaying a report over the total  
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Table 3 continued: 
number of embryos injected. The ‘Overall’ line gives the sum of each column and then the average of the 
‘Percent positive selection’ column. Standard Deviation is calculated from the ‘Percent positive selection’ 
column. 
Table 4. Transmission efficiency of precise pPRISM alleles at cx43.4. 
Knock-in allele Transmitting 
F0s 
Total 
F0s 
Percent of transmitting 
F0s 
Transmitting 
precise 
Percent 
precise 
allele 
2A-RFP 3 11 27.27% 3 27.27% 
WT cDNA 6 10 60.00% 1 10.00% 
c64s 
Hemichannel 
2 9 22.20% 1 11.10% 
r75w Closed 
channel 
7 18 38.90% In progress N/A 
c64s, r75w 
Double mutant 
3 8 37.50% 1 12.50% 
    Average of cDNA 
transmission 
11.20% 
Table 4. Transmission efficiency of precise pPRISM alleles at cx43.4.  ‘Knock-in allele’ indicates the 
name of the allele according to the content of the primary report of the cassette. Transmitting F0s is the 
number of F0 animals that transmit either report to the next generation following outcross. Total F0s is the 
number animals raised and screened by outcrossing to generate 75 or more F1 progeny or transmits an 
allele with a fluorescent report.  ‘Percent of transmitting F0s’ is the number of transmitting F0s over the 
total number of screened F0s. ‘Transmitting precise’ is the number of F0s transmitting a precisely 
integrated allele, confirmed by junction fragment analysis, and RT-PCR confirmation of expression of the 
mutant mRNA, or in the case of the 2A-RFP by the presence of both the primary and secondary reports 
from the pPRISM cassette. ‘Percent precise allele’ is the number of F0s transmitting precise alleles over 
the total number of F0s screened.  Average percent of cDNA transmission is the average percent precise 
alleles only of WT control, hemichannel, and double mutant alleles as the somatic precision was 
estimated differently from the 2A-RFP allele. 
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Table 5. Analysis of knock-in allele heart asymmetry 
Maternal 
genotype 
Paternal 
genotype 
Cross 
number 
Normal 
heart 
looping 
Reversed 
heart 
looping 
Total 
number of 
embryos 
Percent 
reversed 
Standard 
deviation 
+/+ +/+ 1 98 4 102 3.92%  
  2 116 0 116 0.00%  
  3 107 0 107 0.00%  
  Average 321 4 325 1.31% 1.07% 
2A-RFP/+ 2A-RFP/+ 1 21 0 21 0.00%  
  2 27 0 27 0.00%  
  3 190 2 192 1.04%  
  4 45 0 45 0.00%  
  5 166 6 172 3.49%  
  6 283 5 288 1.74%  
  Average 732 13 745 1.04% 0.52% 
2A-RFP/+ 2A-RFP/2A-
RFP 
1 273 3 276 1.09%  
  Average 273 3 276 1.09% 0.00% 
WTcDNA/+ WTcDNA/+ 1 245 7 252 2.78%  
  2 138 2 140 1.43%  
  3 424 4 428 0.93%  
  4 433 3 436 0.69%  
  Average 1240 16 1256 1.46% 0.40% 
c64s/+ c64s/+ 1 50 0 50 0.00%  
  2 298 10 308 3.25%  
  3 343 6 349 1.72%  
  4 142 3 145 2.07%  
  Average 833 19 852 1.76% 0.58% 
Table 5. Analysis of knock-in allele heart asymmetry. Table 5 shows the genotypes of each parent of 
each cross, 2A-RFP is the pPRISM 2A-RFP knock-in allele at the locus cx43.4, WTcDNA is the pPRISM 
knock-in allele where the WT CDS was integrated into the locus cx43.4, c64s is the pPRISM knock-in 
allele where the c64s hemichannel CDS was integrated into the locus cx43.4, c64s,r75w is the pPRISM 
knock-in allele where the c64s, r75w double mutant CDS was integrated into the locus cx43.4, Δ10 
representing the 10 bp deletion mutant allele, + represents wild type control, the genetic background is 
Sox17:eGFP. Cross number represents the number of the replicate of the given genotype pair. ‘Normal 
heart looping’ is the number of embryos where hearts looped normally at 48 hrs of development, and 
‘Reverse heart looping’ is the number of embryos where the heart looping was reversed at 48 hrs. 
‘Percent reversed’ is the number of embryos with reversed hearts divided by the total number of embryos  
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Table 5 continued: 
from each cross in a genotype pair. The ‘Overall’ line gives the sum of each column and then the average 
of the ‘Percent reversed’ column. Standard Deviation is calculated from the “Percent reversed” column. 
Table 6. Analysis of knock-in allele KV formation 
Maternal 
genotype 
Paternal 
genotype 
Cross 
number 
KV 
plus 
KV 
minus 
Total 
number of 
embryos 
Percent KV 
minus 
Standard 
deviation 
+/+ +/+ 1 112 0 112 0.00% 
 
  
2 116 0 116 0.00% 
 
  
3 127 0 127 0.00% 
 
  
Average 355 0 355 0.00% 0.00% 
+/+ 2A-RFP/+ 1 240 0 240 0.00% 
 
  
Average 240 0 240 0.00% 0.00% 
2A-RFP/+ 2A-RFP/+ 1 24 9 33 27.27% 
 
  
2 34 12 46 26.09% 
 
  
3 20 7 27 25.93% 
 
  
4 131 59 190 31.05% 
 
  
5 124 48 172 27.91% 
 
  
6 206 82 288 28.47% 
 
  
Average 539 217 756 27.79% 0.70% 
2A-RFP/+ 2A-RFP/2A-
RFP 
1 73 78 151 51.66% 
 
  
2 139 128 267 47.94% 
 
  
Average 212 206 418 49.80% 1.31% 
WTcDNA/+ WTcDNA/+ 1 160 0 160 0.00% 
 
  
2 428 0 428 0.00% 
 
  
3 456 0 456 0.00% 
 
  
Average 1044 0 1044 0.00% 0.00% 
C64S/+ C64S/+ 1 467 180 647 27.82% 
 
  
2 356 116 472 24.58% 
 
  
3 322 129 451 28.60% 
 
  
4 38 12 50 24.00% 
 
  
5 221 87 308 28.25% 
 
  
6 260 89 349 25.50% 
 
  
7 113 32 145 22.07% 
 
  
Average 1777 645 2422 25.83% 0.87% 
C64S/+ Δ10/Δ10 1 23 21 44 47.73% 
 
  
2 54 55 109 50.46% 
 
  
3 43 57 100 57.00% 
 
  
Average 120 133 253 51.73% 2.25% 
c64s,r75w/+ c64s,r75w/+ 1 77 28 105 26.67% 
 
  
Average 77 28 105 26.67% 0.00% 
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Table 6 continued: 
Table 6. Analysis of knock-in allele KV formation. Table 6 shows the genotypes of each parent of 
each cross, 2A-RFP is the pPRISM 2A-RFP knock-in allele at the locus cx43.4, WTcDNA is the pPRISM 
knock-in allele where the WT CDS was integrated into the locus cx43.4, c64s is the pPRISM knock-in  
allele where the c64s hemichannel CDS was integrated into the locus cx43.4, c64s,r75w is the pPRISM 
knock-in allele where the c64s, r75w double mutant CDS was integrated into the locus cx43.4, Δ10 
representing the 10 bp deletion mutant allele, + represents wild type control, the genetic background is 
Sox17:eGFP. Cross number represents the number of the replicate of the given genotype pair. KV plus is 
the number of embryos from that cross that had visually detectable KVs at 8-10 somites, and KV minus is 
the number of embryos where the KV was not visually detectable. Percent KV minus is the number of KV 
minus embryos divided by the total number of embryos from each cross in a genotype pair. The ‘Overall’ 
line gives the sum of each column and then the average of the ‘Percent KV minus’ column. Standard 
Deviation is calculated from the “Percent KV minus” column. 
Supplemental Table 1. KV volume analysis. 
Sample 
name 
Replicate Maternal 
genotype 
Paternal 
genotype 
KV phenotype Volume (um^3) 
Wild type 
Control KV 
1 +/+ +/+ plus 25207 
 2 +/+ +/+ plus 24098 
 3 +/+ +/+ plus 26139 
Mutant KV 
plus 
1 Δ10/Δ10 Δ10/+ plus 26726 
 2 Δ10/Δ10 Δ10/+ plus 25653 
 3 Δ10/Δ10 Δ10/+ plus 21610 
 4 Δ10/+ Δ10/Δ10 plus 20400 
Maternal 
Mutant KV 
minus 
1 Δ10/Δ10 Δ10/+ minus 1452.4 
 2 Δ10/Δ10 Δ10/+ minus 628.14 
 3 Δ10/Δ10 Δ10/+ minus 587 
Paternal 
Mutant KV 
minus 
1 Δ10/+ Δ10/Δ10 minus 1909 
 2 Δ10/+ Δ10/Δ10 minus 1153 
 3 Δ10/+ Δ10/Δ10 minus 822.59 
 4 Δ10/+ Δ10/Δ10 minus 319 
Sox17 
Control KV 
1 +/+ +/+ plus 26161 
 2 +/+ +/+ plus 26359 
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Supplemental Table 1 continued:    
Sample 
name 
Replicate Maternal 
genotype 
Paternal 
genotype 
KV phenotype Volume (um^3) 
WT cDNA 
Control KV 
1 WTcDNA/+ WTcDNA/+ plus 26803 
 2 WTcDNA/+ WTcDNA/+ plus 26161 
 3 WTcDNA/+ WTcDNA/+ plus 24802 
 4 WTcDNA/+ WTcDNA/+ plus 25413 
2A-RFP KV 
plus 
1 2aRFP/+ 2aRFP/+ plus 25998 
 2 2aRFP/+ 2aRFP/+ plus 23076 
 3 2aRFP/+ 2aRFP/+ plus 25228 
 4 2aRFP/+ 2aRFP/+ plus 29946 
2A-RFP KV 
minus 
1 2aRFP/+ 2aRFP/+ minus 3372 
 2 2aRFP/+ 2aRFP/+ minus 2086 
 3 2aRFP/+ 2aRFP/+ minus 2800 
 4 2aRFP/+ 2aRFP/+ minus 1400 
C64S KV 
plus 
1 C64S/+ C64S/+ plus 27087 
 2 C64S/+ C64S/+ plus 28056 
 3 C64S/+ C64S/+ plus 27906 
 4 C64S/+ C64S/+ plus 25349 
C64S KV 
minus 
1 C64S/+ C64S/+ minus 11936 
 2 C64S/+ C64S/+ minus 13885 
 3 C64S/+ C64S/+ minus 10139 
 4 C64S/+ C64S/+ minus 17806 
 5 C64S/+ C64S/+ minus 16026 
 6 C64S/+ C64S/+ minus 13507 
Supplemental Table 1. KV volume analysis. This table shows the numerical data used in Figures 1 and 
4. Sample name indicates the group of embryos that each replicate belongs to. Maternal and paternal 
genotypes are displayed, Δ10 represents the 10 bp deletion mutant allele, + represents wild type, the 2A-
RFP represents the pPRISM 2A-RFP knock-in allele at the locus cx43.4, WTcDNA is the pPRISM knock-
in allele where the WT CDS was integrated into the locus cx43.4, c64s is the pPRISM knock-in allele 
where the c64s hemichannel CDS was integrated into the locus cx43.4, the genetic background is 
Fli1:eGFP for the mutant Wild type control and mutant samples, and Sox17:eGFP for the Sox17 control 
and pPRISM alleles. The KV phenotype as determined from brightfield microscopy is listed as plus or 
minus. The Volume of KV is listed as an average of three independent measurements on each sample. 
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Supplemental Table 2. Primer sequences 
Primer 
name 
Primer sequence Purpose 
R-
pPRISM_st
op_61bp 
cggtggctgagacttaattact Primer for 5' 
junctions from 
pPRISM Stop 
vectors 
R-cx43.4-
cdna-amp2 
TGCAAAGAAAAGCAGACGAAT primer for cx43.4 
cdna creation from 
genomic 
transcripts 
F-
cx43.4cDN
Aamp1 
GAGCGTGTCTTTCATCGTCA primer for cx43.4 
cdna creation 
R-
cx43.4cDN
Aamp1 
tcagttaacggtggctgaga primer for cx43.4 
cDNA creation 
from pPRISM 
knock-in alleles 
R-cx43.4-
int-seq 
TGTGCATAGCAAATCCCAAG primer for 
sequencing SNP 
region of cx43.4 
F-
cx43.4cDN
A-uni 
acctgCtgtgGCGGcccGTTTTCTTACGCGGTTGTTG primer for cloning 
cx43.4 cDNA 
construct 
R-
cx43.4cDN
A-uni 
acctgCGtGtGAAGAGCATGGATCCCTTTTTCACA primer for cloning 
cx43.4 cDNA 
construct 
F-cx43.4-
5'juncNew 
CGAGGACTGAGACGGTGGTA primer for 
amplifying 5' 
junction fragments 
for cx43.4 knock-
in alleles 
F-pPH-
3'junc 
ttcagatcaattaaccctcacc primer for pPRISM 
3' junctions 
3'-
Cx43.4UK4
8-oliA 
AAGTGGGCAAGATATGGCTCACGTTATTCATCATCTTCCGCATTG
TTTTGAaaa 
3' oligo 
3'-
Cx43.4UK4
8-oliB 
CGGtttTCAAAACAATGCGGAAGATGATGAATAACGTGAGCCATAT
CTTGCCCA 
3' oligo 
R-
5'junction4
3.4 
gtgccctccatgtacagctt primer for cx43.4 
junctions 
F-
3'junction4
3.4 
gcatgggagctctgacgta primer for cx43.4 
junctions 
R-
3'junction4
3.4 
CAAATGCATCGTAGCAAACG primer for cx43.4 
junctions 
F-cx43.4-
5'Kin48PH_
2a 
tgatGGGCCATATCTTGCCCACGAAGGGTTTTCTTACGCGGTTGTT
GGATGAAATCTCCAACCACTCCACCTTCGtg 
5' homology arm 
for 2a-RFP allele 
R-cx43.4-
5'Kin48PH_
2a 
atcccaCGAAGGTGGAGTGGTTGGAGATTTCATCCAACAACCGCGT
AAGAAAACCCTTCGTGGGCAAGATATGGCCC 
5' homology arm 
for 2a-RFP allele 
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 Supplemental table 2 continued:  
Primer 
name 
Primer sequence Purpose 
F-cx43.4-
5'crispr1 
GCGGTTGTTGGATGAAATCT Primer for testing 
cx43.4 CRISPR 
effectiveness 
R-cx43.4-
5'crispr1 
CCCCACAACAGTCAAAACAA Primer for testing 
cx43.4 CRISPR 
effectiveness 
F-cx43.4-
r75w 
/5Phos/CTCTCATGTCTGGTTCTGGGT Primer for Cx43.4 
mutagenesis on 
cDNA plasmid 
R-cx43.4-
r75w 
/5Phos/AGTGGTGCAAATGCATCGTA Primer for Cx43.4 
mutagenesis on 
cDNA plasmid 
F-cx43.4-
c64s 
/5Phos/GAGAACGTTAGCTACGATGCAT Primer for Cx43.4 
mutagenesis on 
cDNA plasmid 
R-cx43.4-
c64s 
/5Phos/ACAACCAGGTTGCTGGGTAT Primer for Cx43.4 
mutagenesis on 
cDNA plasmid 
Cx43.4-
5'crispr1 
taatacgactcactataGGGCCATATCTTGCCCACGAgttttagagctagaa oligo a for gDNA 
synthesis 
Cx43.4-F ccgcattgttttgactgttg primer to check 
TALEN allele 
Cx43.4-R caaatgcarcgragcaaacg primer to check 
TALEN allele 
F-cx43.4 
Pam 
destruction 
/5Phos/CACTCCACaTTCGTGGGCA  Primer for 
introducing a 
silent mutation to 
destroy the PAM 
site 
R-cx43.4 
Pam 
destruction 
/5Phos/GTTGGAGATTTCATCCAACAACCG Primer for 
introducing a 
silent mutation to 
destroy the PAM 
site 
 
  
156 
 
REFERENCES 
Hatler, J. M., Essner, J. J. & Johnson, R. G. A gap junction connexin is required in the 
vertebrate left-right organizer. Dev Biol (2009). 
Wood, W. B. The left-right polarity puzzle: determining embryonic handedness. PLoS 
Biol 3, e292 (2005). 
Amack, J. D., Wang, X. & Yost, H. J. Two T-box genes play independent and 
cooperative roles to regulate morphogenesis of ciliated Kupffer's vesicle in zebrafish. 
Dev Biol 310, 196-210 (2007). 
Becker-Heck, Anita, et al. "The coiled-coil domain containing protein CCDC40 is 
essential for motile cilia function and left-right axis formation." Nature genetics 43.1 
(2011): 79. 
Essner, Jeffrey J., et al. "Kupffer's vesicle is a ciliated organ of asymmetry in the 
zebrafish embryo that initiates left-right development of the brain, heart and gut." 
Development 132.6 (2005): 1247-1260. 
Kok, Fatma O., et al. "Reverse genetic screening reveals poor correlation between 
morpholino-induced and mutant phenotypes in zebrafish." Developmental cell 32.1 
(2015): 97-108. 
Chen, Dafeng, et al. "CRISPR/Cas9-mediated genome editing induces exon skipping by 
complete or stochastic altering splicing in the migratory locust." BMC biotechnology 18.1 
(2018): 60. 
Wierson, Wesley A., et al. "GeneWeld: a method for efficient targeted integration 
directed by short homology." bioRxiv (2018). 
Wei, C. J., Xu, X. & Lo, C. W. Connexins and cell signaling in development and disease. 
Annu Rev Cell Dev Biol 20, 811-38 (2004). 
Welker, Jordan M. et al. pPRISM: an expanded tool set for precise genome editing. In 
Prep 
Bao, X., Chen, Y., Reuss, L. & Altenberg, G. A. Functional expression in Xenopus 
oocytes of gap-junctional hemichannels formed by a cysteine-less connexin 43. J Biol 
Chem 279, 9689-92 (2004). 
McLachlan, Elizabeth, et al. "Functional characterization of oculodentodigital dysplasia-
associated Cx43 mutants." Cell communication & adhesion 12.5-6 (2005): 279-292. 
Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015. 
Merzin, Markko. "Applying stereological method in radiology. Volume measurement." 
Bachelor's thesis. University of Tartu. 2008. 
157 
 
Hatler, Julia M. "Functional roles of the gap junction protein, Connexin43. 4, during 
vertebrate development." (2009). 
Essner, J. J., et al. "Expression of Zebrafish connexin43. 4 in the Notochord and Tail 
Bud of Wild-Type and Mutant no tail Embryos." Developmental biology 177.2 (1996): 
449-462. 
Dasgupta, Agnik, et al. "Cell volume changes contribute to epithelial morphogenesis in 
zebrafish Kupffer’s vesicle." Elife 7 (2018): e30963. 
Chojnacki, Szymon, et al. "Programmatic access to bioinformatics tools from EMBL-EBI 
update: 2017." Nucleic acids research 45.W1 (2017): W550-W553. 
Gokey, Jason J., et al. "Kupffer's vesicle size threshold for robust left–right patterning of 
the zebrafish embryo." Developmental Dynamics 245.1 (2016): 22-33. 
Moreno-Mateos, Miguel A., et al. "CRISPRscan: designing highly efficient sgRNAs for 
CRISPR-Cas9 targeting in vivo." Nature methods 12.10 (2015): 982. 
Hisano, Yu, et al. "Precise in-frame integration of exogenous DNA mediated by 
CRISPR/Cas9 system in zebrafish." Scientific reports 5 (2015): 8841. 
  
158 
 
CHAPTER 6.  DISCUSSION 
Contributions to the Field 
“I was born without claws (nucleases), without fangs (guide RNAs), without horns, 
without scales (integration vectors). So, I forged them in fire (solutions) and crafted 
them of steel (nucleic acid).” –unattributed blacksmith saying 
 Now that the tools are built, our work can begin. What started as a rotation 
project to characterize the phenotypes of a mutant allele quickly turned into something 
much larger. Following the idea to quantify the connexin43.4 (cx43.4) KV phenotype by 
volume estimation, and Wes Wierson’s achievement in precisely integrating an RFP at 
the gene noto, it made sense to try and resolve Julia Hatler’s experiments using mutant 
mRNA injections to rescue cx43.4 phenotypes.  A combination of Dr. Hatler’s testing 
function of mutant mRNAs by co-injection with morpholinos, and Dr. Wierson’s initial 
experiments leading to the GeneWeld strategy sparked the idea that precise integration 
of any desired coding sequence could be targeted to any locus in a genome.  This led to 
all of the work in this thesis, were I built the tools to approach a problem presented to 
me and am leaving behind physical tools for others to approach their own problems 
along with knowledge obtained from my research questions. 
 Chapter 2, the GeneWeld paper outlines a methodology that enables high 
efficiency genome engineering using CRISPR/Cas.  The work for this paper provides a 
series of 13 donor vectors for researchers to use (now at Addgene), a 6000-word 
protocol (separated out as chapter 3) detailing and codifying every step from picking a 
CRISPR target to screening injected embryos, and an online design tool to 
automatically design homology arm oligos for cloning into the donor vectors.  This paper 
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represents a new step forward in homology driven genetic engineering with a more 
efficient method and an easy to use tool set that enables researchers to target their 
gene of interest to generate transgenics.   
 Chapter 3, To my knowledge, the protocol I wrote for the GeneWeld paper is the 
most detailed protocol for genetic engineering available.  It was designed with 
undergraduate students in mind, and incorporated feedback from the laboratory class 
as we taught undergraduate students genome engineering for the first time.  The 
transparency and detail provided will be useful to additional sections of genome 
engineering courses at Iowa State University, and to other researchers around the world 
while they refine their own genetic engineering strategies. 
 Chapter 4, the pPRISM tool set paper describes an additional 24 vectors (soon to 
be available at Addgene) that can be used with the GeneWeld precise integration 
strategy, and describes additional use cases for different kinds of knock-in alleles.  
From simplifying genotyping by linking knock-in alleles to tissue specific secondary 
markers, to generating transgenics for cell specific fluorescent reports, to making null 
alleles, and to generating 3’ RFP fusions to visualize protein localization, this expanded 
tool set is a natural progression of the technology.  With a guide for how to use these 
tools researchers will be able to make new kinds of alleles and answer more complex 
research questions.  Currently, we have distributed plasmids from both vector sets to 
over 60 labs around the world, and we are still getting additional requests. 
 Chapter 5, the cx43.4 paper represents the capstone of preceding three 
chapters, it is an example of application of the tools for investigating in vivo biology 
questions. It answers two questions in terms of genetic engineering: How does a knock-
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in allele compare to an indel allele, and can a functionally distinct cDNA variant of a 
gene be integrated and expressed from the endogenous locus?  Both of the questions 
are important for the field as our tools and others begin to be more widely used.  
Showing that knock-in alleles phenocopy known nulls, lends confidence to using our 
tools to enhance reverse genetics studies.  Showing that we can engineer sequences to 
express RNAs with single amino acid changes, has eventual applications for medicine 
to repair disease causative SNPs, as well enhancements to reverse genetics studies.  
These first cDNA mutants are not perfect, but publishing these experiments lays the 
ground work for how to integrate mutant cDNAs and our discussion of the technique will 
help improve future studies.   
 Additionally, I have built 12 more pPRISM vectors for a future publication that can 
be used to generate CRE and Er-CRE drivers from any target locus and another six 
vectors for making conditional alleles.  These additional vectors will further expand our 
genetic engineering tool box and allow for cell lineage and timing specific studies.  
Future directions for the tool set may include delving into ways to further enhance 
integration efficiency, more detailed examination comparing knock-in alleles to indels 
that don’t have strong phenotypes, or development of additional vectors to knock-in new 
promoters in front of loci of interest or to edit single exons without altering the normal 
splicing of a locus. 
 The future of the field by my estimate, is not full of questions of “what can we 
do?”  I don’t think that making non-avian dinosaurs is impossible.  With effort and 
ingenuity genetic engineering has very few limits.  What I think the field needs at this 
point is public outreach, standards for how fast, and how far engineering should be 
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taken in small time intervals (for instance designer human babies is very irresponsible at 
this time, and probably for the next 5-10 years), and we need high standards for 
experiment documentation.  One laboratory group can only do so much by itself. 
 In summary, we have created a method for highly efficient genetic engineering 
along with a ‘plug and play’ series of more than 37 vectors available to researchers 
around the world with an online design tool and extensive documentation.  We have 
shown that the vectors work as intended and give real examples for use in a variety of 
experiments including in vivo functional studies.  We expect that the tools generated 
here have increase accessibility of genetic engineering, and will spur new insights into 
biological functions and evolve approaches to gene therapies through expansion from 
our methodology and cDNA knock-in experiments.  
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In charge of primary research for crystallization of small RNAs project.  
In charge of housekeeping and day to day lab maintenance. 
 
1) Conservation Project in Ecuador; The College of Wooster, OH  July 2010 – Aug. 2010 
PI: Lynn Loveless 
Ornithological survey and botanical survey in the Andes mountains,  
Ecuador.  
Acquired Laboratory Techniques and Skill Set: 
TALEN: synthesis and injection into zebrafish 
CRISPR: synthesis and injection into zebrafish  
Vector design, construction and mutagenesis  
RNAi: gene knockout and phenotype analysis 
RNA and protein purification: affinity and size exclusion chromatography, electrophoresis 
RNA and protein crystallization 
cDNA: library creation 
Molecular cloning: yeast and E. coli  
Western blotting and ELISA assays 
Microbiology: culture and identification of both bacterial and viral/bacteriophage samples 
Field Botany (1 season): ability to identify flowering US plant families to species level; specimen 
collection and preservation  
Entomological collection and preservation (5 years)  
Computer Programming and Software Skill Set: 
Rstudio: statistical analysis and limited programming 
Perl: programming experience 
MacVector/ApE/SnapGene/BioEdit: DNA sequence file analysis and annotation 
CellTrak: protist swimming phenotype analysis  
Excel: data management and storage 
Genbank/PubMed/zfin/ensemble: database browsing and data acquisition 
phylogeny.fr/Clustal Omega: multiple sequence alignment and  
Unicorn FPLC: control system for HPLC 
 
